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INTRODUCTION
According to recent statistics, one of every five deaths in the

u.s.

is from cancer (American Cancer Society, 1982).

Claiming over

1200 deaths per day, it ranks second to cardiovascular disease as the
leading killer in our country.

Because it can strike at any age, it is

no surprise that cancer has been called "the most feared disease of
the 20th century" (Holland, 1981).
cancer with death.

Indeed, many still equate the word

This equation was reflected in the pre-1970 psycho-

social oncology literature, which almost exclusively emphasized the
dying process and coping in the terminally ill cancer patient (e.g.,
Kubler-Ross, 1969).

One exception to this rule was the pioneering work

of Arthur Sutherland on the psychological impact of cancer and its
treatment on, for example, colon (Sutherland, Orbach, & Dyk, 1952) and
breast cancer patients (Bard & Sutherland, 1955).
Attention to the problems of the surviving cancer patient has
followed the progress of medical science in the treatment of cancer.
In the early 1900's, surgery was the only treatment for cancer, so
cure was possible only when the lesion was detected early and completely excised.

The introduction of radiation therapies in the 1930's,

and the addition of chemotherapy in the 1950's have dramatically improved the prognosis for many types of cancer.

At present, a projected

38% (46% if one excludes death from other causes) of cancer patients
diagnosed this year will still be alive in five years (American Cancer
Society, 1982).

Many of these will be off treatment, and may go on
1

2

to live out their full life span.

However, all of them hold a respon-

sibility to their health which requires vigilance toward symptoms of
relapse.

Cancer is therefore better defined today as a chronic life-

threatening illness, than as a fatal disease.

Thus, today's "cured"

cancer patient faces the same tasks as those suffering from any serious
chronic illness.

The National Cancer Institute has identified two

general tasks which the cancer patient must confront:

1) coping with

illness and its complications, such as pain or paralysis;

and 2) cop-

ing with life as it is altered by illness (Blumberg, Flaherty, &
Lewis, 1980).
tasks.

The present study is concerned with the second of these

This task, relating to quality of life, has been further sub-

divided into four general categories:
emotional balance;

a) preserving a reasonable

b) preserving a satisfactory self-image;

serving relationships with family and friends;

c) pre-

and d) preparing for

an uncertain future (Blumberg et al., 1980).
The advent of multimodal cancer treatment (including surgery,
radiation, and chemotherapy) has ushered in a new era of cancer survival which makes the study of the above tasks possible.

The paradox

of this medical advancement lies in the legacy which it leaves behind:
that most successfully treated cancer patients must face a new spectrum of problems that are related to the late (physiological) effects
of treatment. 'The normal physiology of virtually every organ or
structure of the body can be impaired more or less by radiation therapy, chemotherapy, and their combinations" (D'Angio & Ross, 1981, p.
45).

Consequently, whereas multimodal therapies have had dramatic

positive effects on the survival rates of some cancers, they have also

3

increased the risks of morbidity and mortality in the post-five-year
period.

These include risk of relapse, heightened risk of second

malignancies (Li, 1977; Li, Cassady, & Jaffe, 1975), increased risk of
carditis, pericarditis, and pneumonia (Desforges, Rutherford, & Piro,
1979; Jaffe, 1975), and permanent sterility (Sherins & DeVita, 1973;
Sutcliffe, 1979).

Because of this, the study of late, or delayed

psychological effects of cancer and its treatment is a necessary one.
Globally, there are two conceptual models for understanding
adaptation to survival from serious illness.

The first views the

direction of adaptive response as anticipatory vis-a-vis the prospect
of death.

This approach postulates a mechanism of anticipatory grief

in the face of threatened loss, analogous to the experience of actual
loss sustained in mourning proper.

This approach borrows heavily from

the phase-theory description of terminality by Kubler-Ross (1969).
Thus, the patient, confronted with the diagnosis of cancer, is said
to undergo a fixed sequence of bereavement responses, including
denial, anger, bargaining, depression, and acceptance.

Following

from this scheme, the surviving cancer patient is said to be in a
protracted state of anticipatory grief which gives rise to anxiety,
depression, vulnerability, and death-related concerns.
The second conceptual model for survivor adaptation, and that
embraced by this study, views the direction of adaptive response as
residual vis-a-vis the past stressor of diagnosis and resulting treatment.

In the medical psychology literature, the conceptualization of

diagnosis (Katz, Weiner, Gallagher, & Hellman, 1970), the experience
of illness itself (Lipowski, 1970), and the initiation of treatment

4

(Cohen & Lazarus, 1973; Janis, 1958) with life-threatening illnesses,
are seen as stressors which are disruptive to homeostatic functioning.
At present, the majority of studies of cancer survival lie in the area
of adaptation to diagnosis and treatment itself.

The next clinical

event associated with psychological disruption is disease recurrence,
frequently responded to with elevated depression and anxiety, because
the patient is confronted with the failure of treatment (Silberfarb,
1982;

Silberfarb~

Maurer, & Crouthamel, 1980).

Subsequent risk for

increase in anxiety and depression are also expected at cessation of
a successful course of treatment, when the patient confronts the twin
demands of separation from the therapy milieu and re-entry into personal lifestyle (Holland, Rowland, Lebovits, & Rusalem, 1979; Sutcliffe, 1979).

There is also widespread confirmation that trait

classification of global adaptational capability (Koocher & O'Malley,
1981), coping adequacy (Penman, 1979), ego strength (Worden & Sobel,
1978), and level of distress (Sobel & Worden, 1979), as measured on
various state variables, differentiate poor from good adjustment
during these periods.
The next logical step in psychosocial adaptation research is the
investigation of long-term sequelae.

In a recent comprehensive re-

view article, the understanding of the long-term impact of cancer is
given as one of the key questions which remains unanswered in psychosocial oncology (Freidenbergs, Gordon, Hibbard, Levine, Wolf, &
Diller, 1981-82).

Information in this area is cited as essential to

"facilitate the development of a systematic psychosocial intervention
program for the cancer patient" (p. 315).

5

This study attempted to evaluate psychological functioning in a
successfully treated sample which is not currently plagued by treatment
side-effects or by reactions to recurrence.

All patients have

been disease and treatment free for a minimum of six months.
abled

This en-

an unprecedented retrospective study of psychological adjustment

in young adult male Hodgkin's disease patients who have been successfully treated.

Besides the general cancer variable, the independent

variables of interest wereseverity of disease stage (early vs. late)
and time off treatment (recent vs. distant).

Dependent measures as-

sessed psychosexual dysfunction, psychiatric symptomatology, mood
states, death anxiety, self-esteem, coping style (thinking), psychosocial problems in interview, and readiness for intimacy (intimacy
motivation).
Adaptation is the central concept in this study.

The term

"adaptation" is preferred over "coping" (adaptation under difficult
conditions), "mastery" (behavior in which frustration is surmounted),
and "defense" (response to danger).

As

explained by White (1976) and

Sutherland (1956), adaptation (to cancer) would focus on the chronic
process of adjustment (to cancer) and its subtle intrustions upon
homeostatic functioning.
farb (1982).

This is the outlook preferred also by Silber-

Thus, the young adult cancer patient is constantly con-

fronted with the realization that he is different from those around
him.

He must make adjustments to account for the unique stressors of

untimely disease, debilitating treatment, and chronic uncertainty.
This study attempts to measure these adjustments by comparing Hodgkin's
disease patients to an age-matched healthy comparison group, and to
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themselves across the variables of disease stage severity and time off
treatment.

Dependent measures were chosen and hypotheses made accord-

ing to the available cancer survivor literature.
The choice of young adult men as the target population for this
study came in part from consideration of relevant developmental tasks
in this age group.

For example, Erikson (1950) considers the central

task of this group to be the development of a capacity for intimacy,
or a sense of mutuality with a loved partner, with whom the individual
regulates work, procreation, and recreation.

Young adulthood is a time

of beginnings in personal, social, and occupational spheres.

The

impact of a major disease at this time in life is usually both a surprise and a source of resentment.

In the case of all participants

chosen for this study, it was the first time they experienced any real
threat to their lives.
To summarize, this study attempts to identify problems in adaptation to cancer which young men face in the post-treatment period.
Because of its view on adaptation as described by White (1976), the
investigation concerns itself as much with day-to-day adaptational
difficulties as it does with more overt problems which may surface.
Each individual is seen as striving toward suitable compromise rather
than mastery in the face of adversity, and so the study will at times
seek to determine unique patterns of adjustment rather than necessarily a picture of psychiatric morbidity or exaggerated stress-response
syndromes.
It was decided on methodological grounds to limit the investigation to one form of cancer (Hodgkin's disease) and one sex (male).
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Men were chosen over women on the supposition that they would represent a more homogeneous group with regard to occupational goals, and
because literature to be reviewed later has identified the young male
patient as at higher risk for post-treatment interpersonal difficulty
(Leiber, Plumb, Gerstenzang, & Holland, 1976).
was chosen for three reasons:

Hodgkin's disease

1) its status as a "good prognosis"

cancer, with five-year survival rates ranging from 70% (late stage)
to 90% (early stage) (American Cancer Society, 1978);
dence in young adults;

2) peak inci-

and 3) the debilitating quality of the com-

bined modality treatment for Hodgkin's disease.

REVIEW OF THE RELATED LITERATURE
This chapter is divided into two main sections.

The first sec-

tion describes Hodgkin's disease in terms of its pathology, staging,
and treatment.

Specific attention will be given to treatment proce-

dures at Memorial Hospital in New York City since the current sample
comes from there.

The second main section reviews the available liter-

ature on the late psychological and psychosexual effects of successful
treatment of Hodgkin's disease in particular and cancer in general.

At

the end of the second section arepresented the hypotheses of the study.
Hodgkin's Disease and Its Treatment
Hodgkin's Disease:

Description and Epidemiology

Definition of the disease.

Hodgkin's disease is a form of lym-

phatic cancer which accounts for approximately 40% of all malignant
lymphomas.

Lymphomas in turn account for around 5% of all cancers

(American Cancer Society, 1982).

It can strike at any age, but inci-

dence generally follows a bimodal curve, peaking between 15 and 34,
and then again after age SO.

In this 15-34 age group, 66% of all

lymphomas are Hodgkin's lymphomas (Schottenfeld, 1976).
Hodgkin's disease usually presents as a painless rubbery swelling, usually in the supraclavicular or cervical node areas.
and mediastinal node masses are also common.

Axillary

It may or may not be

associated with symptoms such as fever, night sweats, or weight
loss (Ultmann & Stein, 1979).

Pruritis and alcohol sensitivity are

other possible symptoms which are much less common.
8
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Hodgkin's disease is diagnosed histologically, where the essential feature is the presence of the multinucleated "Reed-Sternberg"
giant cell.

Thus, a patient must receive a biopsy before diagnosis

can be made definitively.

Once diagnosis is established, the disease

must be subclassified and staged.

Subclassification is according to

the Rye (Rye, New York Conference, 1966) histologic classification
system (Lukes, Craver, Hall, Rappaport, & Rubin, 1966), and includes
four subtypes.

The first three, lymphocyte predominant, mixed cellu-

larity, and lymphocyte depleted, are on a continuum of the same basic
"diffuse" pattern.

The lymphocyte predominant subtype has an abundance

of normal lymphocytes, sparsely distributed granulocytes, and only
occasional malignant Reed-Sternberg cells.

The lymphocyte depleted

subtype involves most of the normal lymphocytes replaced by fibrosis
and usually an abundance of Reed-Sternberg cells.

The mixed cellular-

ity subtype lies between these two extremes, with moderate numbers of
lymphocytes and granulocytes as well as readily-identifiable-but-notabundant

Reed-Sternberg cells.

The fourth histologic subclassifica-

tion is the nodular sclerosing subtype, a qualitatively different
subtype which shows a nodular patterning of cells and "lacunar" ReedSternberg cells (i.e., retraction of cell cytoplasm, leaving the ReedSternberg cells in an apparent space, or "lacuna").

This nodular

sclerosing subtype is the most common (60%), especially in the young
adult patient group (Schottenfeld, 1976).

Compared to the lymphocyte

depleted and mixed cellularity subtypes, it is also the most benign
in terms of its progression in the absence of treatment (Desforges,
Rutherford, & Piro, 1979).

10
Staging of Hodgkin's disease.

While histologic subclassifica-

tion is important in helping to determine appropriate treatment and
prognosis, staging is critical.

The stage of Hodgkin's disease is the

single most important prognostic indicator and is usually the best
guide to appropriate treatment (Ultmann & Stein, 1979).

The commonly

accepted staging criteria are those which were established at a 1971
oncology conference in Ann Arbor, Michigan (Carbone, Kaplan, & Musshoff,
1971).

These Ann Arbor criteria delineate four distinct stages:

Stage I (involvement of a single lymph node region or of a single
extralymphatic organ or site);

Stage II (involvement limited to one

side of the diaphragm, either of two or more lymph node regions or
localized involvement of an extralymphatic site and at least one lymph
node region);

Stage III (involvement of lymph node regions on both

sides of the diaphragm, which may include localized involvement of an
extralymphatic site or spleen);

and Stage IV (diffuse or disseminated

involvement of one or more extralymphatic organ or any liver involvement, with or without associated lymph node involvement) (from
Desforges et al., 1979).

Each patient is then further classified as

either "A" (asymptomatic) or "B" (symptomatic).

The three cardinal

symptoms, at least one of which is necessary for "B" status, are:
1) unexplained weight loss of at least 10% of total body weight in the
past six months;
centigrade;

2) unexplained fever, with temperatures above 38°

and 3) night sweats.

are IA, IIA, IliA, IIIB, and IVB.

The most common stages diagnosed
IB is especially rare, and liB and

IVA somewhat rare (Schottenfeld, 1976).

Some diagnosticians also

like to add the subscript "s" to denote splenic involvement (connnon
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in later stages), and the subscript "e'' to denote the involvement of an
extralymphatic site primarily or by direct extension (e.g., mediastinal
mass which has extended to involve a lung) (Ultmann & Stein, 1979).

This

study did not concern itself with the "s" or ''e" subscripts because they
are not deemed critical in the staging process at Memorial Hospital.

That

is, decisions about appropriate treatment at Memorial are generally made
by determination of stage number and the presence or absence of B symptoms.
Treatment of Hodgkin's Disease
Before discussing the four specific patient protocols relevant to
this study, a general review of the development of Hodgkin's disease treatment over the past 50 years will be furnished as background information.
Background:

Development of the treatment of Hodgkin's disease.

The three general treatment modalities for Hodgkin's disease in particular and cancer in general have been mentioned.
radiation, and chemotherapy.

They are surgery,

Prior to 1950, radical surgery followed

by diffuse radiation was the principal treatment (Kaplan, 1980).

The

five-year survival rate during the 1940-1949 decade was 25% (Schottenfeld, 1976).

Over the past 30 years, the development of megavoltage

radiotherapy apparati, with "mantle" and "inverted Y" fields constructed to protect the body outside of the lymph node areas has permitted much more aggressive (high voltage) radiation treatment.

This

helped bring the five-year survival rate to around 42% by 1960.
Combined with the disadvantages of cosmetic disfigurement of radical
surgical techniques, this improvement in radiation technology has led
to the wane of surgery as a common primary treatment for any but the
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most severe cases of Hodgkin's lymphomas (Kaplan, 1980).

Surgery is

still indicated for some cases of extralymphatic organ involvement,
however (e.g., splenectomy).
The third modality, chemotherapy, has recently introduced even
more dramatic survival rates, to the point where some are willing to
use the term "cure" for Hodgkin's disease (e.g., Des forges et al.,
1979).

After World War II experimentation with mustard gases, it was

discovered that nitrogen mustard and its derivatives were effective
against leukemias and lymphomas (Kaplan, 1980).

This drug was first

shown to be effective against Hodgkin's disease by Rhoads (1948), in
a clinical trial at Memorial Hospital.

In the 20 year period follow-

ing World War II, numerous other tumoricidal agents have been introduced and used in various combinations (see Krakoff, 1981).
It is an accepted fact in cancer medicine that chemotherapy
for Hodgkin's disease using more than one agent (called "combination
chemotherapy") is more effective than chemotherapy with single agents,
when considering response rates (how many people of those treated
enter remission) and length of remission period (Carter & Goldsmith,
1976; DeVita, Serpick, & Carbone, 1970; Krakoff, 1981; Wittes &
Lacher, 1976).

The first successful combination chemotherapy regimen

for Hodgkin's disease, ·tried by Lacher and Durant (1965), included
vinblastine and chlorambucil.

They achieved a complete response rate

(percent of patients who show no evidence of disease after treatment)
of 62% in early stage patients.

But the most dramatic advancements

during this period took place within the National Cancer Institute of
the National Institutes of Health (NCI).

The first NCI combination
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for Hodgkin's disease included cyclophosphamide, vincristine, methotrexate, and prednisone given in conjunction with radiotherapy

(~fuxley,

DeVita, Bruce, & Frei, 1967).
A second and more successful combination chemotherapy devised at
NCI by DeVita and colleagues (Canellos, Schein, Chabner, Bagley, &
Young, 1973; DeVita & Serpick, 1967; DeVita, Serpick, & Carbone, 1970)
is referred to as the

'~OPP"

regimen.

MOPP is the acronym for

~ustar

genR(nitrogen mustard), QncovinR(vincristine), £rocarbazine, and £rednisone.

Initial reports of this regimen on 43 patients in an uncon-

trolled study claimed 81% complete remission and 14% partial remission,
for an overall response rate of 95%.

Seven year disease-free survival

was reported in 15 (43%) of the 35 complete remission patients (DeVita
et al., 1973).
Since 1973, research in the treatment of Hodgkin's disease has
centered around this MOPP regimen, usually comparing it to radiation
therapy alone or to other combinations of chemotherapeutic agents.

So

far, some combinations of drugs have been found to be as effective as
MOPP, but none has been proven definitively better (Desforges et al.,
1979).
In summary, research and advancements over the past 50 years in
the science and technology of radiation therapy, and in the use of
combinedtumoricidalchemical agents has transformed Hodgkin's disease
from an almost invariably fatal illness to one that is quite frequently
cured.

Recently the American Cancer Society (1978) has reported 90%

five-year survival in early stage disease.
Research on the treatment of Hodgkin's disease at Memorial Sloan-
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Kettering Cancer Center is dedicated to further improvement of response
and survival rates.

This research consists of randomized clinical

trials of various combinations of chemotherapy and radiation treatment
for different stages of the disease.

The next subsection will describe

the four clinical trial treatment protocols which are relevant to this
study.
Hemorial Hospital treatment protocols.

Memorial Hospital for

Cancer and Allied Diseases is the treatment unit of the Memorial SloanKettering Cancer Center.

Located on the East side of Manhattan, it is

a major tertiary referral hospital for patients with cancer from all
parts of the country.

The hospital provides care for approximately

16,000 inpatients per year and records nearly 140,000 outpatient visits
per year (1980 hospital statistics).

Except for initial biopsy and

staging procedures, as well as disease or treatment complications,
all of the treatment for Hodgkin's disease is done on an outpatient
basis.
After a patient with suspected lymphoma is given a biopsy and
Hodgkin's disease is histologically diagnosed, staging is the next step.
It is the severity of disease stage which determines the placement into
treatment protocol.

Two of the four relevant treatment protocols are

for early stage patients and two for late stage patients.

They will

be discussed in that order.
Table 1 presents a summary of the four Memorial Hospital Hodgkin's
disease treatment protocols.

The first early stage protocol was in

effect from 1975 to 1981, while the second has been in operation since
then (1981-present).

The first protocol (M.H. #75-103) called for six
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Table 1
Basic Overview of Four Memorial Hospital
Treatment Protocols
Years
in Use

Disease Stages Treatment
Applicable
Length

75-103

19751981

Early:
IA, IB, IIA,
IIB, IliA

7 months

MOPP
3500 rads
(@ 5000 rads
for IIIA)

81-103

1981present

Early:
IA, IIA, IIIA

5 months

3500 rads

75-104

19751979

24 months
Late:
IIB (unfav.)
IIIA (unfav.)
IIIB, IVA, IVB

79-17

1979present

Late:
IIB, IIIB,
IVA, IVB

11 months

Estimated
Radiation

Chemotherapy
Agents

Protocol
Number

@

5000 rads

3500 rads
(more as
needed)
@

MOPP or TBV
MOPP/ABDV

MOPP/ABDV
or
MOPP/ ABV/ CAD
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28-day cycles of the MOPP chemotherapy regimen with one month of involved field radiation "sandwiched" in between the six cycles.

Each

cycle consisted of 14 days on treatment and 14 days off treatment.
Day 1 and 8, nitrogen mustard 6 mg/m 2 i.v.

Dosages were as follows:

(max. 10 mg), and vincristine 1.4 mg/m2 i.v. (max. 2 mg);

Days 1-14,

procarbazine 100 mg/m 2 p.o. (max. 150 mg), and prednisone 40 mg/m2 p.o.
(cycles 1 and 4 only).

When patients could not tolerate the nausea

and vomiting from the nitrogen mustard, cyclophosphamide 650 mg/m 2 i.v.
(i.e., "COPP"), or Thio-tepa 15-18 mg/m 2 i.v. (i.e., "TOPP"), was substituted.

Also, other deviations from this protocol were occasionally

made for individual patients due to drug reactivity, drug toxicity,
poor early response, or side-effect intolerance.

The same is true of

all four protocols.
The seven month treatment protocol just discussed was proposed
because of high relapse rates reported for early stage patients who
were successfully treated with radiation alone (40-60%).

It was con-

ceptualized as an attempt to heighten survival rates in "favorable"
prognosis patients who would previously have received the more standard
radiation-only treatment.

Memorial Hospital investigators included

stages IA, IB, IIA, liB, and IliA in this "favorable" group.

Exper-

ience with patients on this protocol showed that liB patients had
significantly more non-complete responders, and so this subgroup was
switched to the late stage group for the more recent protocols.
The second early stage protocol (//81-103) began in 1981 and has
been used with stages IA, IIA, and IliA patients.

Prior experience

with early stage patients at Memorial Hospital revealed clear gains
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in induction and duration of remission with the combined modality
approach over the radiation-only approach (Koziner, Braun, Garrett,
Nisce, Young, Lee, & Clarkson, 1978).

However, concern over the addi-

tive risks to endocrine and gonadal function and the increase in
future second malignancies from highly cytotoxic agents in combination
with radiation has led to efforts at finding a chemotherapy regimen of
equal (if not better) efficacy to MOPP, which might have lowered long
term health risks.

Thus, the second early stage protocol randomized

patients into one of two groups:

MOPP plus segmental radiotherapy,

or "TBV" plus segmental radiotherapy.

TBV (Thio-tepa, vinblastine,

and bleomycin) is hoped to be connected with less post-treatment
oncogenicity and fewer post-treatment gonadal disturbances than MOPP.
Results are not yet available on this.
The treatment schedule on protocol #81-103 was as follows:

four

28-day cycles of MOPP (or TBV) with a one-month period of radiation
therapy "sandwiched" in between.

MOPP dosages are the same as in

protocol #75-103, but there are now two fewer chemotherapy cycles (six
lowered to four).
five months.

Total treatment time is therefore cut from seven to

The TBV dosages are:

Days 1 and 15, Thio-tepa 35 mg/m 2

i.v., vinblastine 6 mg/m 2 i.v. (max. 10 mg);

and days 4-12, 18-26,

bleomycin 2 mg/day subcutaneously.
The two late stage protocols are M.H. #'s 75-104 (1975-1979) and
79-17 (1979-present).

These involve more aggressive treatments which

attempt to produce complete remission rates superior to the MOPP plus
radiotherapy regimen typically used.

Protocol #75-104 used eight

drugs (MOPP/ABDV) plus radiation over a course of 24 months.

This
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approach alternated (by monthly cycle) the use of MOPP with that of
ABDV (adriamycin, bleomycin, DTIC, and vinblastine), a combination
found to be as effective as MOPP by Bonadonna, Zucali, and Monfardini
(1975).

In the first four months

cycles of MOPP and ABDV.

the patient received alternate

The fifth month was for radiation treatment.

The sixth through ninth months proceeded identically to months one
through four.

Months 11, 13, 15, 17, 19, 21, and 23 were alternating

MOPP, then ABDV cycles.

The even numbered months were reserved for

immunotherapy in half the group and no treatment in the other half.
MOPP dosages were essentially the same as in protocols described
earlier.

ABDV cycle schedule of drugs and dosages were:

Days 1 and

15, adriamycin, 25 mg/m2 i.v., vinblastine 6 mg/m2 i.v. (max. 10 mg),
and DTIC 250 mg/m 2 i.v.;
subcutaneously.

and Days 4-12, 18-26, bleomycin 2 mg/day

From 1975 until 1979, this was the standard treatment

for Hodgkin's disease patients of stage IIIB, IVA, and IVB, as well
as certain liB and IliA patients with "unfavorable" prognosis.

As

with other protocols, variations in these drug and dosage schedules
occurred in individual cases where clinical considerations of toxicity,
drug intolerance, or disease course overrode research interests.
The fourth and final protocol relevant to this study (#79-17)
has been used with stages liB, IIIB, IVA, and IVB at Memorial Hospital
since 1979.

It

compares the earlier-mentioned eight-drug schedule

(#75-104) to a still newer 10-drug regimen.

Total treatment time is

shortened (by lessening the number of cycles given) from 24 months to
11 months in the late stage group.

The drug schedule and dosage of

MOPP/ABDV cycles is the same as that outlined in the previous protocol.
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The 10-drug regimen, MOPP/ABV/CAD (MOPP + ABV + CCNU, alkeran, and
DVA), is administered in the following order (28 day cycles):

CAD-

MOPP-ABV-CAD-MOPP-ABV-radiation-two weeks rest-CAD-MOP (no prednisone)ABV.

Cycle schedule of drugs and dosages are nearly identical to

other protocols for MOPP, ABDV, and ABV.
follows:

Day 1, CCNU 100 mg/m2 p.o.;

Days 1-4, alkeran 6 mg/m2 p.o.

The CAD cycle schedule is as

Days 1 and 8, DVA 3 mg/m2 i.v.;

Note that the patient is afforded

three to four weeks rest in each CAD cycle.
It is hoped that this fourth protocol, with the addition of new
agents, will eradicate residual tumor cells resistant to the first two
combinations (MOPP/ABDV).

Less attention is paid to possible late

toxicologic effects of treatment (e.g., sterility, leukemia, secondary
non-Hodgkin's lymphoma, chronic carditis) in these late stage treatment
protocols than in those for early stage disease.
The continual advent of new cytotoxic agents, and their addition
to existing chemotherapy combinations, represent an increase in physiological side effects and future health risks to the patients.

That is,

not only are treatments becoming more successful with time, but they
are also becoming more toxic to the patients.

Attention will now

turn to a brief review of late physiological effects which have been
associated with these treatments.

The discussion will be divided into

radiation effects and chemotherapy effects.

Because late stage

patients are generally treated with slightly more radiation and always
receive much more chemotherapy (in dosage and duration), they are
obviously at higher risk for all that is described in the next two
subsections.

The fact of greater treatment severity in late stage
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patients was one reason for conceptualizing the study hypotheses in
terms of early versus late stage differences.

That is, not only are

late stage patients "sicker," and therefore closer to death, than
early stage patients, they also receive a more aggressive treatment
with more debilitating and potentially lethal aftereffects.

This will

be discussed later, but is mentioned now for the reader's consideration
while reviewing delayed treatment effects and risks incurred by all
patients.
Radiation treatment:

Physiologic effects and potential risks.

Radiation treatment (RT) for Hodgkin's disease is a focused attempt to
limit lethal doses of radiation to the area of the lymph nodes and
organs involved in the disease.

The refined techniques of "mantle"

and "inverted Y" field irradiation have reduced many of the complications of RT for lymphoma.

However, the proximity of the lymph nodes

to so many vital organs means that risk, while reduced, is by no means
eliminated.

One can consider the risks of RT in Hodgkin's disease

starting from the most anterior nodes (neck and armpits), moving down
to the most posterior ones (gonads

and groin).

Stage I and II

patients by definition receive RT to one or the other side of the
diaphragm, while Stage III.and IV patients get RT to both sides.
Beginning with the most anterior nodes and working downward,
long-term pituitary and thyroid abnormalities, including alterations
in serum thyrotropin and reports of thyroid disease, have been associated with neck irradiation (Schimpf£, Diggs, Wiswell, Salvatore, &
Weirnik, 1980).

Radiation induced bone sarcoma (Smith, O'Connell,

Huvos, & Woodward, 1980), malignant peripheral nerve sheath tumors
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(Foley, Woodruff, Ellis, & Posner, 1980), and radiation myelopathies
(Word, Kolokhe, Aron, & Elson, 1980) have also been reported.

The

risk of secondary leukemia is also slightly elevated (Desforges et al.,
1979).

Increased susceptibility to later infections, especially

when paired with splenectomy and/or chemotherapy, is another known risk
of radiation (Donaldson, Glatstein, & Vosti, 1978).

Post-treatment

cardiac and pulmonary complications, such as carditis, pericarditis,
pericardial effusions, chronic pericardial disease, pneumonitis, and
transient pulmonary dysfunction have frequently been identified (e.g.,
Cole, Pollack, Sutton, Slawson, Singleton, & Weirnik, 1981; Gross,
1977).

In certain cases, the addition of chemotherapy to radiation has

an additive effect on radiation complications.

For example, prednisone

after radiation may draw out a latent pneumonitis or pericarditis when
discontinued abruptly, and bleomycin seems to combine with radiation
in a way which is hazardous to lung tissue (Desforges et al., 1979).
A final radiation complication relates to reproductive function.
In men, aspermia results in 70-100% of patients irradiated below the
diaphragm, despite efforts to shield the gonads (Speiser, Rubin, &
Casarett, 1973).

Reports of return of spermatogenesis in these

patients range from 0% to 80% over a three-year post-treatment period.
Chemotherapy:

Physiologic effects and potential risks.

The use

of combination chemotherapy plus radiation therapy in early stage
Hodgkin's disease is controversial, because evidence for its superiority over radiation therapy alone is mixed, and because it is associated with so many more complications.

The risk of secondary acute

leukemia and non-Hodgkin's lymphoma from combined modality treatment
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has been recognized by many investigators (Arsenaau, Canellos, Johnson,

& DeVita, 1977; Cadman, Capizzi, & Bertino, 1977; D'Angio, Clatworthy,
Evans, Newton, & Tefft, 1978).

Pedersen-Bjergaard and Larsen (1982)

staged and treated 391 Hodgkin's disease patients from 1970-1981.

Of

the 312 treated with combined chemotherapy and radiation or chemotherapy
alone, 17 developed preleukemia or an acute myeloproliferative syndrome
with bone marrow abnormalities.

A Kaplan-Meier estimate of the cumu-

lative probability of leukemic complications was 3.9 + 1.3% five years
after treatment began, and 9.9

± 2.9%

at nine years.

Of the 79

patients treated with radiation alone none had any leukemic complications

(~

<.01).

The risk of non-Hodgkin's lymphoma at 10 years off

treatment has been reported at 4.4% (Krikorian, Burke, & Rosenberg,
1979).
Combination chemotherapy has also been associated with lowered
immunity against common infections (e.g., Steele & Han, 1978), and
frequent susceptibility to herpes zoster (Cunningham, Mauch, Rosenthal,

& Canellos, 1982).

Chemotherapy for Hodgkin's disease is connected

to almost certain sterility in males.

The best current estimate is

between 80-90% sterility three years after treatment (Chapman, Sutcliffe, Rees, Edwards, & Malpas, 1979; Schilsky, Lewis, Sherins, &
Young, 1980; Sherins & DeVita, 1973).

A retrospective study of 52

young adult men over three years off treatment yielded an estimate of
over 90% sterility in men who had been treated with six cycles of MOPP
chemotherapy (Cunningham et al., 1982).

This 90% figure has been con-

firmed here at Memorial Hospital in a prospective study of 60 men
treated for Hodgkin's disease over the past four years (Redman, 1983).
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This is a tremendously significant issue for successfully treated
young men who are faced with return to "normal life," most often realizing that they will very likely never father children in a 'normal 1' way
(Sutcliffe, 1979).

What is more, a recent prospective study by Chapman,

Sutcliffe, and Malpas (1981) found 16 (43%) of 37 men to be functionally
subfertile before initiation of treatment.

A more recent study (Viger-

sky, Chapman, Berenberg, & Glass, 1982) has confirmed this figure, and
found it to be significantly greater than that in other malignancies.
This clearly suggests compromised fertility as a result of the disease
itself, implying that efforts to bank sperm prior to treatment may not
be a viable alternative for these patients.

In the 1981 study,lOO%

(14 of 14) of the patients tested became persistently azoospermic
after only two cycles of chemotherapy with MOPP.
Taken drug-by-drug, in single administration the alkyllating
agents of chemotherapy (nitrogen mustard, cyclophosphamide, and
Thio-tepa) have been associated with bone marrow toxicity, nausea and
vomiting (which can linger on after treatment is over via conditioning),
myelosuppression, alopecia, and hemorrhagic cystitis (Wittes & Lacher,
1976).

The vinca alkaloids (vinblastine, vincristine) have been linked

to RNA synthesis inhibition, myelosuppression, and neurotoxicity,
especially peripheral neuropathies, which can last for life (Wittes &
Lacher, 1976).

Procarbazine is also linked to nausea and vomiting

which can persist, reduced white blood count from myelosuppression, and
thrombocytopenia.

Prednisone, a glucocorticoid agent, is associated

with the usual spectrum of steroid-related side effects (Cushingoid
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symptoms), which are usually reversible.
In summary of this section, three points were highlighted.

Re-

cent years have brought new advances and success to the treatment of
Hodgkin's disease.

Successful treatment generally includes both

radiation and chemotherapy.

The exact combination and intensity of

treatments are dependent upon the stage of the disease at diagnosis.
Although treatment has become quite successful, it does exert a more
general impact on the body which results in unpleasant side effects
and potential long-term health problems.

There is also some question

about the possible psychological and psychosocial impact of this newly
achieved successful treatment for Hodgkin's disease.

The next main

section will review the literature relevant to these possible psychological concerns.
Psychological Adjustment to Cancer and
Its Treatment:

Literature Review

Background Literature
As

emphasized in Chapter 1, adaptation to (rather than coping

with, mastering, or defending against) cancer is the central concept
of this study.

The literature review will focus on the empirical

research which has been done on cancer survivors off treatment.

While

the crisis model, as introduced by Lindemann (1944) is not central to
the study, it is intermixed with the idea of adaptation in that all
individuals with cancer seem to cope through a gradual integration of
this life-threatening crisis (Holland, 1982b; Weisman, 1976).
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Therefore, a brief overview of research in coping with cancer survival
influenced by the crisis theory model will also be presented.
As early as the 1950's, Sutherland and colleagues had clinically
identified a heightened incidence of post-treatment anxiety and depression in successfully treated cancer patients (Bard & Sutherland,
1955; Sutherland, 1956).
colon cancer patients.

Their work was primarily with breast and
Systematic investigation of these observations

pinpointed examples of anxiety about recurrence (including hypochondriacal concerns), development of dependent personality features, and
increases in obsessive-compulsive and paranoid reactions, as well as
general family strife (Sutherland, 1956).

In his discussion of these

findings, Sutherland postulates that a cancer patient's pattern of
adaptation, defined as "a system of beliefs and behavior designed in
order to bring the individual's physical and emotional needs in harmony with the demands of the environment," is threatened by cancer.
With the homeostasis of the organism threatened, the patient is then
subjected to loss of self-esteem and anxiety secondary to the subjective
isolation of being a cancer patient.

Bard and Sutherland (1955)

followed 20 breast cancer patients prospectively, from the pre-operative period to recovery.

From their findings, they formulated three

phases of adaptation to mastectomy (and cancer treatment in general):
1) anticipatory phase, where the patient speculates with fear and
uncertainty about the damage to self and disruption of previous levels
of adaptation;
occurs;

2) operative phase, where the actual injury (crisis)

and 3) reparative phase, where the patient attempts to

reestablish his or her previous level of adaptation by a variety of
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techniques.

This study is intended to focus upon this third, repara-

tive phase of adaptation to cancer.
Based upon her review of the psychosocial oncology literature,
Holland (1981) has outlined eight psychiatric syndromes relevant to
cancer patients.

Six of them hold some relevance to patients off all

treatment and free of disease;

that is, patients in Bard and Suther-

land's (1955) reparative phase.

They are:

1) acute stress reactions

such as reactive anxiety and depression, including prolonged or delayed reactions to survival and cure;

2) major psychiatric disorders

(DSM III Axis I pathology) with onset during or after treatment;

3)

anxiety disorders such as conditioned nausea, conditioned vomiting,
phobias, or panic reactions;
chondriasis;
treatment;

4) somatoform disorders such as hypo-

5) psychosexual disorders resulting from the illness or
and 6) personality disorders which can complicate and

interfere with post-treatment adjustment.

"Quality of life" after

treatment, according to Holland (1981, 1982a, 1982b) depends to a
great extent upon the patient's prior level of emotional adjustment
and the presence of emotionally supportive persons in the environment.
The concepts of crisis and stress management are relevant to
this study inasmuch as adaptation to cancer survival entails some
measure of protracted distress.

Ever since Hans Selye first formulated

the concept of "stress" as a syndrome with physiologic correlates and
potential vulnerabilities to the distressed organism (Selye, 1936),
researchers have been intrigued by the relationship between stress and
illness onset (Lazarus, 1974, 1976; Selye, 1975; Tache, Selye, & Day,
1979).

A kind of reversed approach to this involves the
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conceptualization of illness (and treatment) as a stressor in itself
which can lead to further organism distress (Caplan, 1981; Horowitz,
1976).

Lindemann (1944) pioneered this idea in his study of person-

ality changes due to distress in the bereaved friends and relatives of
the Coconut Grove fire victims.

Application of this idea to cancer

patients by Horowitz and colleagues (Horowitz, 1976; Horowitz, Wilner,

& Alvarez, 1979) views cancer adaptation as a process parallel to
stress-response syndromes in general.

In a study of cancer patients

at the point of diagnosis and during treatment, Horowitz, Wilner, and
Alvarez (1979) found cancer patients to use alternating combinations
of intrusive and avoidant thinking styles.

They measured this with

their Impact of Events Scale, a 15-item, self-report inventory.

The

pattern of coping which they detected in their cancer sample was similar to, though less dramatic than, that fqund in their stressresponse clinic outpatients.
Caplan (1981) has presented a model for understanding stressresponse behavior such as that seen in cancer patients.

His focal

construct is '\nastery," defined as behavior which both reduces the
physiologic and psychologic manifestations of emotional arousal during
and shortly after the stressful event;

and mobilizes the individual's

internal and external resources, thereby developing new capabilities
which lead to the person's changing of the environment or his/her
relation to the environment, so that threat is reduced or so that
alternate sources of satisfaction replace what is lost.

In the case

of cancer, one's health and certainty about the future are the lost
entities.
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Caplan also explains four interdigitating phases of mastery in
the face of stress:

The first is escape or avoidant behavior which

enables the individual to tolerate the intensity of the stress;

the

second involves acquisition behavior in which the individual attempts
to change unfortunate circumstances and their aftermath.

One can

easily parallel these first two phases to the general periods of diagnosis and treatment of the illness itself.

The third and fourth

phases are more relevant to this study in that they seem to describe
the post-treatment adaptational challenge.

Phase three entails intra-

psychic behavior which defends against intrapsychic emotional arousal.
Denial or avoidance of anxiety, hostility, depression, and grief are
the most common mechanisms.

The fourth and final phase, according to

Caplan, involves synthetic intrapsychic behavior which integrates the
stressful experience (diagnosis and treatment) and its sequelae
(chronic uncertainties) by internal readjustment.
Following the general idea of crisis theory that individuals
resolve crises within six to eight weeks (see Talpin, 1971), Lewis,
Gottesman, and Guttstein (1979) studied 35 cancer patients over a 28
week period after surgery.

They found this notion of rapid crisis

resolution not applicable to their cancer sample.

Measuring anxiety,

helplessness, depression, self-esteem, and general level of crisis,
five variables considered by crisis theorists to be basic indicators
of crisis, they found that scores were still rising eight weeks after
surgery, regardless of its outcome.
scores beginning to decline, however.

Follow-up at 28 weeks did find
The results suggested either

the inapplicability of a straightforward crisis model for cancer
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patients or the need for modification of the time needed for crisis
resolution in a cancer population.

In a follow-up to this study,

Gottesman and Lewis (1982) compared 31 female cancer surgery patients
to 15 medical surgery patients and 15 healthy women.

Both cancer and

surgery groups scored higher than healthy women on the Halpern Crisis
Scale.

However, the cancer sample scored as significantly more help-

less than the surgery patients.

Discriminant function analysis re-

sulted in 73-82% accuracy of placement into the three groups, suggesting that cancer surgery and non-specific medical surgery may represent
separate types of crisis.

The increase in helplessness in the cancer

sample was evidence for a different, perhaps more depressive, reaction
in the cancer patient sample.

This provides indirect evidence for

cancer adaptation as a process which is distinct from and more prolonged than adaptation to general medical illness and surgery.

Inci-

dentally, this study also found that the average time needed by the
cancer surgery sample for crisis resolution was 15 weeks;

again

longer than the expected six to eight weeks.
Studies on the Problems of Return to Premorbid Lifestyle in Successfully Treated Cancer Patients
Chronologically, the first event associated with adaptation to
cancer survival is the return to premorbid lifestyle immediately after
treatment ends.

The process of reentry of the treated cancer patient

into society's mainstream and the return to his or her premorbid lifestyle has been referred to as the "Lazarus Syndrome."

This analogy to

the biblical character who returned from the dead is not so farfetched when one considers the many accounts from patients and
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clinicians of patients' being treated by significant others as either
dead or dying during the treatment period (e.g., Sveinson, 1977;
Zubrod, 1975).

The sense of being somehow different from others and

permanently changed by the cancer experience has been described by a
cured Hodgkin's disease patient as follows:
marks the start of a new way of life.

11

(the diagnosis of cancer)

Up to this point, the man/woman

has enjoyed normal health with no major problems.
serious illness, he puts everything else aside.
life" (Sveinson, 1977, p. 83).

But now, with a
He starts a new

Thus, the termination of treatment and

reentry into "normal" life can be seen as a stressor in itself, characterized by a letdown of the struggle against death and the challenge
of return to normalcy (Holland et al., 1979; Sutcliffe, 1979; Zubrod,
1975).
Clinical case reports of post-treatment disruption of basic
psychosocial areas of socialization, financial security, vocational
development, and sexual functioning are abundant in the literature
(e.g., Bronner-Huszar, 1971; Cohen & Wellisch, 1978; McCollum, 1978).
Some of the intruding factors in this disruption include lowered
self-esteem (Bronner-Huszar, 1971; Eisenberg & Goldenberg, 1966),
increased anxiety (Bronner-Huszar, 1971; Gorzynski & Holland, 1979),
death-related concerns and uncertainty about the future (Clapp, 1976;
Cohen & Wellisch, 1978; Gorzynski & Holland, 1979; Kagen-Goodheart,
1977; Spinetta & Maloney, 1975), and disruption of defense mechanisms
(D'Angio & Ross, 1981; Hackett & Weisman, 1969; O'Neill, 1975).

In

their description of case reports, Cohen and Wellisch (1978) depict
the surviving patient and family as thrown into a state of chronic
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catastrophe--a psychosocial "limbo"--where current relationships and
future plans are constantly off balance because of disease uncertainty.

Their observations were based upon patients recently completing

treatment, and so the question of possible abatement of this feeling
of being in limbo remains unanswered.
There have been some systematic empirical studies of cancer
patients in the six-month period following diagnosis and treatment.
Weisman and Worden (1976-77) studied 120 cancer patients, 18 of whom
were Hodgkin's patients, over a 100-day period following diagnosis.
They found that as treatment progressed, the young adult patients
viewed their cancer more as a threat to their life plans (career,
marriage, family) than as a direct threat to their life.

They iden-

tified a 100-day post-diagnosis period, called the "existential
plight," in which fears of abandonment, loneliness, loss of control,
pain, panic and the unknown were high.
quickly in the Hodgkin's disease (N
patients, as compared to lung

(! = 19)

patients.

(~

=

These concerns lessened most
18) and breast cancer (N

= 23), colon

(~

=

37)

= 23), and melanoma

This observation of different peak distress points

for different cancer sites signified the importance of studying disease sites separately rather than under one general rubric of cancer
patients.
Perhaps the most comprehensive short-term follow-up of treated
cancer patients has been done at the New York University Medical
Center (Gordon, Freidenbergs, Diller, Hibbard, Levine, Wolf , Ezrachi,

& Lipkins, 1979).

The authors studied 308 breast, lung and melanoma

patients at four points in time over a six-month period (point of
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diagnosis, point of hospital discharge, three months after discharge,
and six months after discharge).

Assessment was done by semi-struc-

tured interview (Problem Oriented Record) and a short battery of
psychological tests.

In their sample, the main problem at diagnosis

was worry about disease, whereas by the time of hospital discharge it
had shifted to difficulties with negative affects such as depression,
anxiety and anger.

At three- and six-month follow-up, problems were

more widely distributed (and reduced in intensity) across the following areas:

physical discomfort, concern about treatment, mobility,

finances, family/marital problems, social problems, worry about disease, negative affects, and disturbed body image.
Many investigators have attempted to identify patients at high
risk for maladaptation to cancer treatment and survival.

Two general

approaches to this have been the study of defenses or coping style in
good versus poor adjusters, and empirical efforts to correlate pretreatment psychological test scores with post-treatment adjustment.
The first approach has, in almost every investigation, identified the
ubiquitous and highly adaptive nature of denial during the treatment
and early post-treatment periods (Chodoff, Friedman, & Hamburg, 1964;
Hackett & Weisman, 1969; Penman, 1979).

However, the functional

adaptabilityofdenial lessens as remission extends, and some investigators have identified actual increases in psychological distress
and disturbance in the off-treatment period, presumably due to the
lifting of denial and exposure of the denied affects of depression,
anxiety, and hostility (OtNeill, 1975; Spinetta & Maloney, 1975).
It has been suggested that the ability to ultimately externalize
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previously denied affects is associated with longer survival, possibly
due to the release of distress.

Derogatis, Abeloff, and Melisaratos

(1979) studied 35 women with metastatic breast cancer, and found that
those women Who lived one year or longer had higher psychological symptom profiles and higher levels of dysphoric affects than those who
died within one year, on the SCL-90-R, Affects Balance Scale, and the
Global Assessment Scale.

A negative correlation between psychological

distress and likelihood of recurrence was also documented in melanoma
patients (Rogentine, VanKammen, Fox, Rosenblatt, Docherty, & Banney,
1978).

Perhaps, then, the unleashing of previously constrained emo-

tionality may not only be of high incidence in the cancer survivor, it
may actually be a partial prophyllactic against relapse through some
cathartic mechanism of stress reduction.

This hypothesis would be

consistent with the claim by other investigators that the best mechanism of coping with cancer and survival is not blind (unconscious)
denial, but a conscious suppression of negative affects only after
they are acknowledged and felt (Koocher & O'Malley, 1981; Weisman &
Worden, 1976-77).

These "suppressors," then, can be described as

people who are able to put their worries as.ide and go on with their
lives while in crisis.

The survival period would then be a time for

further integration and resolution of that which had previously been
suppressed.
The above formulation of optimal coping over time is one which
has received widespread empirical support.
data which are inconsistent with this.

However, there are some

These would include accounts

that psychological distress tends to drop over time (D'Angio & Ross,
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1981), and that longer survival times have also been associated with
patients who have been able to maintain smooth relationships with
family and friends (Weisman, 1975).
The second general approach to studying post-treatment psychosocial difficulty is the attempt to identify patients at high risk for
psychological distress in the post-treatment period with the use of
pre-treatment parameters.

Using examiner ratings of post-treatment

distress in patients six months off-treatment, Weisman and Worden
(1977) were able to account for 40-60% of the variance of psychological
distress with knowledge of disease stage and prognosis.

That is,

medically sicker patients were significantly more distressed six months
off~treatment.

This is contrasted to studies which have found little

(Gordon et al., 1979) or no (Hyerowitz, Sparks, & Spears, 1979) relationship between disease or treatment severity and post-treatment distress.

Some studies (Horris, Greer, & White, 1977; Schonfield, 1972)

have found pre-treatment anxiety and depression to be better predictors
than disease or treatment severity, of post-treatment distress in
patients less than one year off-treatment.
A comprehensive study by Sobel and Worden (1979) followed 133
cancer patients, including 20 with Hodgkin's disease, over a period of
six months.

They found pre-treatment HHPI scale scores (especially on

the "neurotic triad" of hypochondriasis, depression, and hysteria)
accounted for 41% of the overall variance of the dependent measures of
emotional distress.

Dependent measures included the Profile of Mood

States' Index of Vulnerability, Inventory of Current Concerns (six
problem areas), and actual number of physical symptom complaints.
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They were able to correctly place 75% of their 133 patients into high
or low distress groups, on the basis of pre-treatment MMPI scores.
This concludes the review of the literature in this subsection:
studies on cancer patients' difficulties with smooth return to premorbid lifestyle.

The focus of this subsection was on the treatment and

early post-treatment periods.

Psychosocial disruption and difficulty

in the treatment and reentry periods has been extensively documented.
Not only has

a

relatively high prevalence of such disruptions as

negative affects, low self-esteem, and psychosocial dysfunction been
established, some investigators have successfully identified poorer
post-treatment copers on the basis of pre-treatment symptomatology
and personality profile.

There is little doubt that the six-month

period after treatment is difficult for a great many patients.

The

focus of study in this group of patients tends to be on the identification of high risk patients and determination of correlates to
psychosocial dysfunction.

Psychosocial research is not so advanced

in patients who are farther off treatment, however.
The review will now turn to a discussion of studies which have
addressed longer-term issues in cancer survival.

To a great extent,

this division of the review is artificial in that the process of
adaptation is believed to begin with diagnosis (if not onset of first
symptom) and move continuously through life.

What follows is a

summary of available literature on psychological adjustment to cancer,
limited to the period of disease-free survival of longer than six
months.
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Studies on Psychological Adjustment to Long-Term Survival from Cancer
Of greatest relevance to the present study is that body of
research which has examined long-term adjustment to survival from
cancer.

Since so little research has been done on Hodgkin's disease

patients in particular, the review will include other more commonly
studied populations:

mixed diagnostic groups and breast cancer

patients.
Psychosocial studies of cancer .survival:
groups.

Mixed diagnostic

Many investigators have reported quite favorable overall

psychological adjustment to successful cancer treatment (Brown, Haddox, Posada, & Rubio, 1972; DeRugna & Buchheim, 1979; Holmes & Holmes,
1975).

In a study examining the prevalence of general post-treatment

difficulties, Iszak, Engel, and Medalie (1973) surveyed 345 patients,
91 of whom were considered "cured" at the time of assessment.

They

found, predictably, that the cured subgroup had the greatest need for
vocational services and the lowest need for medical services.

Prob-

lems identified in the cured group, as assessed by the authors'
"Ability Index" questionnaire, were continued difficulty with physical
stamina and with the "psychological trauma" posed by diagnosis and
treatment.

Need for social services, including both practical

assistance and psychotherapeutic intervention, was acknowledged in
33% of 345 patients (Iszak, Engel, & Medalie, 1973).
A similar prevalence study of psychosocial problems acknowledged
by 810 patients off-treatment for an average of 2.5 years found 93%
of them still struggling with problems of fatigue (Greenleigh Associates, Inc., 1979).

Of this 93%, one in five viewed the fatigue to
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be incapacitating.

The authors speculate that, in the absence of any

legitimate physiological reason for this high figure, it may provide
indirect evidence for lethargy as a depressive equivalent in this population.

All patients were over 45, 70% were women, and around half

had either breast or uterine cancer.

Patient historical accounts

revealed an apparent six-month lag from treatment cessation to the
development of depressive symptoms, again suggesting gradual relaxation of defenses (cf. O'Neill, 1975; Spinetta & Maloney, 1975).
Sexual dysfunction was the most frequently cited marital problem (47
of 567 married subjects).

Other problems included spouse anger or

fear of cancer, financial difficulty, spouse withdrawl or spouse alcoholism.

While 23% complained of deterioration in their family role

satisfaction, 35% claimed their situation had improved as a result of
their cancer experience.

Health and life insurance readjustments were

problematic for 24% of the patients.

The percentage of patients

employed dropped significantly, from 54% (premorbid level) to 47%.
The areas of work adjustment and work discrimination have received a good deal of attention in the literature.

The available

evidence on work discrimination is split between reports of little or
no overt or covert discrimination toward the cured cancer patient
(Reynolds, 1977; Stone, 1975), and assertions of both outright
(Feldman, 1978) and subtle (American Cancer Society, 1976) work and
hiring discrimination.

In the American Cancer Society study, out of

130 of the most employable recovered cancer patients (age 25-50,
employed at the time of diagnosis, and skilled), 22% reported one or
more job rejections.

Many on-the-job reports of subtle mistreatment
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such as hostility from co-workers, unnecessary transfers to encourage
resignation, lack of salary advances and health benefit rejection were
common (American Cancer Society, 1976).
Research on work adjustment in post-treatment patients also
delivers mixed results.

For example, Gordon and colleagues found one-

third of 136 patients off treatment to be experiencing vocational
adjustment difficulties (Gordon, Freidenbergs, Diller, Hibbard, Levine,
Wolf,

Ezrachi, & Francis, 1977), while Wheatleyandothers found 74

off-treatment cancer patients to be no different from other employees
at the Metropolitan Life Insurance Company in absenteeism, turnover,
job performance, or insurance costs (Wheatley, Cunnick, Wright, & Van
Keuren, 1974).

Not one of the 74 patients was fired for any reason.

They had been off treatment for a range of one month to 25 years.

One

explanation for this difference between study findings in the area of
work adjustment could be the method of data collection:

Gordon and

colleagues used patient self-report while the Wheatley et al. study
used employer records.

It could be, therefore, that the patient

experiences a sense of difficulty in adjusting which is not easily
detected by gross measures of work performance kept by employers.
Alternately, it could be that the patients truly are adjusting well,
and their subjective sense of maladjustment might represent a more
non-specific problem of general distress.
Schonfield (1972) has attempted to predict those patients who
will experience post-treatment work readjustment difficulty.

In his

study of 42 male and female patients, using 63 items of the MMPI and
an anxiety questionnaire given before starting treatment, he
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demonstrated that pre-treatment anxiety (especially about situational
concerns) and a low morale loss score on the MMPI were good predictors
of later difficulty returning to work.

All but nine of 42 patients

returned to work within nine months of treatment.

Stage of disease

and severity of treatment were not effective predictors of successful
return to work.
In a more general study, Mages andMendelsohn (1979) examined 60
patients with various cancer sites, most of whom had received a radiation-only treatment regimen.
six-year survivors.

Some of these patients were three- to

Their findings indicated marked increases in self-

image, values and physical capacities over time, but little change in
level of dysphoria on the Gaugh-Heilbrun Adjective Checklist.
also reported improvements in

distractibil~ty,

They

absent-mindedness and

concentration, as well as an increase in focus on home and family
concerns over time.

Women were more able than men to preserve their

sense of self-esteem over time off treatment.

The authors comment

that in their young adult patients, the cancer experience impeded the
development of their self-sufficiency and resulted in delay and disruption of the smooth establishing of adult roles.
A study by Kennedy, Tellegen,

Kennedy, and Havernick (1976)

examined 22 advanced cancer patients (various sites), aged 20-69,
5-20 years off treatment.

They found the men to have a significantly

higher mean stress-reactivity level on the Differential Personality
Questionnaire.

Women had a higher mean social closeness score.

That

is, women particularly valued close and friendly personal relationships,
while the men appeared at higher risk for post-treatment distress.
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Interestingly, all cancer patients in their study showed a greater
appreciation for life, people, time, and interpersonal relationships
when compared to matched samples of chronic diabetes patients and
normal (healthy) controls.

They were less concerned than the compar-

ison groups.with the 'non-essentials" of life.

The authors conclude

that cancer, when met with successful treatment, is a good catalyst
for character development.

They base this conclusion on the finding

of generally positive adjustment without significant psychosocial
distress, as measured by physician assessment, semantic differential
ratings, the Differential Personality Questionnaire, and unstructured
interview (Kennedy et al., 1979).
A final psychosocial study of diagnostically mixed cancer
patients assessed 20 patients aged 29-78, 1-33 years post-diagnosis
(Shanfield, 1980).

Based upon data from unstructured interviews, the

author concluded that fear of cancer, then fear of significant object
loss, were the numbers one and two concerns, respectively, of the
surviving cancer patient.
sample.

Mild depression was detected in 25% of the

Physical vulnerability was named as a consequence related to

the fear of recurrence.

Shanfield also identified a sense of exis-

tential resolution with death which the successfully treated patient
feels.

With this sense of resolution comes a heightened sense of life

appreciation, according to Shanfield's data.
Psychosexual studies of cancer survival:
groups.

Mixed diagnostic

In accord with other studies (Greenleigh Associates, 1979;

Shanfield, 1980), Sutherland (1960) identified the fear of rejection
as the main source of anxiety in the off-treatment cancer patient.
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According to Sutherland, this fear of rejection or abandonment can be
expected to show itself through sexual dysfunction.

Golden and Golden

(1980) have suggested that the frequently observed desexualization of
the cancer patient is often an interpersonal (rather than personal)
dysfunction in that it is often the healthy partner who initiates, or
at least actively colludes with, disengagement.

Lamb and Woods (1981)

have discussed the public image of cancer which, despite the many
recent treatment advances, is still one of a terminal or chronic
passive illness.

This would militate against an unconflicted accep-

tance of the recovered patient's return to an active, vigorous sex
life.
Many authors (e.g., Grinker, 1976) have emphasized the primary
influence of psychological rather than physiological causes for
impotence·and general sexual dysfunction in cancer patients.

One

piece of evidence for this assertion is that sexual dysfunctions often
continue well into the post-treatment period, virtually nullifying the
possibility of drug- or disease-related etiology.

These reported

post-treatment dysfunctions have been attributed to decreased libido,
concern over performance, defective body image, fear of rejection,
gender identity disturbance, fear of disease contagion, and depression
(Chapman, 1982; Grinker, 1976; Schain, 1982; Sutcliffe, 1979; Wise,
•
1978).
The bulk of the writing in the area of sexual dysfunction in
cancer patients of mixed diagnostic categories has been based upon
case reports and clinical experience.

The absence of systematic

empirical attention to this area is striking.

However, there have been
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careful studies of sexual dysfunction in the specific diagnostic
classes of Hodgkin's disease and breast cancer patients.

These will

be discussed later, along with psychosocial studies of those specific
groups.
Before discussing breast cancer and Hodgkin's disease patient
studies in particular, one empirical study of male and female cancer
patients (various sites) in treatment will be described, because it
holds relevance to one of the study's aims.

This study explored

communication and fulfillment of affectional needs in 36 patients and
their spouses (Leiber et al., 1976).
Affectional Needs and Behavior

Based upon

~he

results of an

Scale and upon interview material,

the authors concluded that desire for sexual intercourse decreased in
37% of all patients, while the desire for non-sexual physical closeness increased in 49% of patients.

Women patients were more likely

to have their affectional needs met than men.

They were also the most

depressed of the four groups of subjects (male patients, female patients, husbands and wives).

An interesting finding which holds

direct relevance to the current study was that male patients experienced the greater disparity of needs and alteration of sex roles in
relation to their wives, as compared to female patients.

Therefore,

they had greater potential for marital tension and discord.

The

authors speculate that it is more difficult for the young adult man
than the young adult woman to assimilate the passivity and dependency
of the patient role.

The young man's burgeoning sense of competence

may be more acutely threatened by·the impact of untimely disease.
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This is one reason for selecting men as the focus of study in this
investigation:

they may be at higher risk for psychosocial and

psychosexual maladjustment.
In summary of previous investigations of cancer survival, many
of the studies on mixed diagnostic groups have been quite extensive
with regard to sample size, but very global when one considers the type
of inquiry.

Previous studies have tended to focus on the presence of

general depressive symptomatology and quality of life as reflected in
self-report.

Findings have been inconsistent, surely due in part to

differing methodologies and unclear criteria for "disturbance."

Re-

search reports on the impact of cancer in the survival period have
run the full gamut of conclusions, from positive character growth
through no significant change to heightened risk of depression,
anxiety, fatigue, work maladjustment and discrimination, and interpersonal difficulties.

Reports of post-treatment psychosexual dys-

function in the general cancer population have been more impressionistic and superficially documented than carefully empirical in their
basis.

Systematic exploration of this particular area is notably

lacking in the general psychosocial oncology literature.
Psychosocial and psychosexual studies of cancer survival:
Breast cancer patients.

The fact that breast cancer, if detected

early, has long been amenable to successful treatment with combined
surgery and

radiotherapy has led to extensive psychological study of

survival .in this particular disease group.

The insult of cancer upon

such a culturally valued sexual body part can have potentially farreaching psychosexual ramifications (Derogatis, 1980).

The following
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studies will only highlight the many studies in the area of psychological adjustment to breast cancer survival.

Characteristic

of research in this area, these studies reveal a pattern of mixed
results.
Eisenberg and Goldenberg (1966) tested 252 breast cancer patients
immediately after mastectomy and 18 months later.

They found persis-

tent decrements in self-esteem and an actual drop over time in the
percentage of patients who held a positive attitude toward their
future, from 54% down to 39%.

This drop may again represent a lifting

of defenses in the recovery phase of survival.
In an extensive mail survey of 826 breast cancer patients randomly selected from the Memorial Hospital registry of 5,472 patients
treated for breast cancer between 1949-1962, 84% of survivors off
treatment for five or more years had, by their own criteria, fully
resumed their premorbid lifestyles (Schottenfeld & Robbins, 1970).
Many of this group (14%) said that it took them over six months posttreatment to do so.

This suggests that around 30% of these patients

failed to successfully resume premorbid functioning within six months
of completing treatment.

Comparing five-year survivors to 10- and

15-year survivors, they found that severity of disease did tend to
slow down the process of return to earlier occupational status: Within the five-year group only, ratings of women with regionally spread
disease were lower than those with localized disease.
A very well-controlled study has compared 134 breast cancer
patients, most of whom were five or more years off treatment, to 139
age-matched controls and 121 neighborhood controls (Craig, Comstock,
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& Geiser, 1974).

All were given the same 28-item general health and

quality of life questionnaire.

There were no significant differences

in level of employment, attitude toward life, view of the future,
leisure activities, or psychiatric symptoms.

The only differences

between groups which reached significance were that the cancer patients rated their current health as poorer and rated themselves as
more physically disabled than the two control groups.

Both of these

differences have clearly realistic bases, and were therefore not seen
as signs of maladjustment in these women.
A prospective investigation, using the "Ability Index" from an
earlier study (Iszak & Medalie, 1971), followed 221 breast cancer
patients over a three-year off-treatment period (Iszak, Feller, Brenner,
Medalie, & Tugendreich, 1975).

All patients, including 90 with stage

I and 131 with stage II disease, had the same treatment:
mastectomy plus radiation.
living;

167

Radical

One year after treatment, 201 (91%) were still

(75%) were still alive at three years.

General problems

surveyed by the Ability Index included subjective complaints about
medical treatment, reduced ability to support themselves, change in
relationships with family and friends, and emotional well-being visa-vis health concerns.

Comparing survivors one year off treatment to

themselves three years off treatment, they identified a slight drop
(21% to 15%) in patients with ambulatory limitations, increases in
sexual disturbances over time (12% to 18%

fr~quency),

improvement in

ability to support oneself financially over time (30% disabled to 20%
disabled), and a slight drop in social (extrafamilial) contact over
time.

There was no change noted in familial relationships over

time~
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lending support to the common notion that one aspect of adpatation to
cancer survival entails some withdrawal from the milieu of friends and
increased focus on family togetherness.

Patients at both times of

assessment demonstrated difficulties in lack of self-confidence, fear,
frustration, and anger about the future, at a frequency of approximately 25%.
The results from this comprehensive study (Iszak et al., 1975)
reflect a mixed picture of adaptation.

There is some indication of

life enhancement from the cancer experience, but somewhat more evidence
for mild psychosocial disruption.

Another study has supported this

figure of 25% psychological distress after one year off treatment, but
asserts that this figure drops over the following four years (Maguire,
1976).

Morris, Greer, and White (1977), on the other hand, reported

that 30% of their 69 breast patients were psychologically distressed
one year after treatment, and that this figure did not drop in the
second year.

They used psychological tests and a different structured

interview, so the different measures and different criteria for distress (self-report vs. test scores) could explain why one group found
this drop and the other did not.

The study by Morris and colleagues

compared 69 breast cancer patients to 91 women with benign breast
disease both cross-sectionally and longitudinally.

Two years after

diagnosis and surgery, 83% of the cancer group and 76% of the benign
group had successfully resumed premorbid work and marital functioning.
A final study to be reported here, exemplary of research in
breast cancer survival, examined 49 post-mastectomy patients four
years after treatment (Woods & Earp, 1978).

Through structured
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interview they determined that women who complained of more physical
symptoms during and after treatment were also those who were in
psychological distress.

~reater

Incidence of sexual dysfunction remained high

four years off treatment for these women, and was related to marital
discord.

The authors conclude that social support (including family

and social service assistance) has a buffering effect upon the psychosocial adjustment difficulties of the cured breast cancer patient.
Psychosocial and psychosexual studies of cancer survival:
Hodgkin's disease patients.

Very little has been done in the specific

study of Hodgkin's disease patients off treatment.

The greatest

emphasis has been on psychosexual adaptation, since the known sterilizing effects of combination chemotherapy and radiation have led
oncologists to be concerned about psychosexual dysfunction which might
arise from this impairment.

Once again, the research in this area

has yielded mixed findings.
In conjunction with their initial trials of }IDPP chemotherapy,
Sherins and DeVita (1973) found 16 treated Hodgkin's disease patients
to experience normal ejaculation in the face of abnormal spermatogenesis.

In a larger study, 74 Hodgkin's disease patients were assessed

an average of 27 months after treatment (Chapman, Sutcliffe, Rees,
Edwards, & Malpas, 1979).

Compared to a rate of 74% during treatment,

46% of all patients complained of decreased libido and sexual performance in the post-treatment period.

Few of this 46% were subjectively

distressed about their difficulty, however.
rendered impotent.
their impotence.

Six of 54 men were

Four of these cases had no physiologic basis for
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In a related study, Chapman, Sutcliffe, and Malpas (1981) interviewed 47 male Hodgkin's patients about general quality of life and
subjective personality changes as well as psychosexual dysfunction.
Most of these patients were studied prospectively, from the pre-treatment period through treatment cessation.

Twenty-one of them were post-

treatment patients who made retrospective ratings of the treatment
and survival periods.

Half of all patients stated their libido had

not returned to pre-treatment levels.

They did, however, acknowledge

a gradual increase in libido and general quality of life over the
years while in complete remission.

Other findings of the study in-

cluded a tendency toward increase in violent behavior and irritability
in the post-treatment period.

Irritability, for example, was given

as a "status quo" affect in 84% of patients recently off treatment, as
opposed to 16% of pre-treatment patients.

The authors concluded that

the emotional response of a young man becoming ill may represent a
particular vulnerability in that the dependency of illness and the
sterilizing effect of treatment are decidedly "unmasculine" experiences which can challenge the smooth transition into adulthood (cf.
Leiber et al., 1976).
In a larger study (Cunningham et al. , 1982) , 156 male Hodgkin's
patients, ranging from 43-141 months off treatment, were interviewed.
Most of them (112) were between the ages of 15-40.

Using gross career

criteria and patient comparisons of lifestyle changes contrasting
retrospective pre-treatment ratings to current ratings, they concluded
that nearly all of the sample had led "normal" p.ost-treatment lives.
Of 263 (male and female) patients, four had severe physical
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complications and only two displayed serious psychiatric disturbance
(Cunningham et al. , 19 82) •
Two other psychosocial studies with Hodgkin's disease patients
also hold importance for the current study.

The first was a mail sur-

vey of socialization skills in 30 adolescents an average of three
years off treatment (Mitchell, 1982).

Using the Aschenbach Child

Behavior Checklist, the author found that adolescents with Hodgkin's
disease did not show the predicted decrease in socialization abilities.
Mitchell did determine that patients who had more severe disease, and
·therefore were subjected to more aggressive combined modality treatment, displayed lower activity levels than those who had less severe
disease.

This suggested some element of fatigue, or perhaps develop-

mental lag, secondary to greater isolation from the peer group in
recovered adolescents with later stage disease.

All patients showed

restriction in their drive for independence, presumably related to the
dependency induced by the sick role (cf. Chapman et al., 1981; Leiber
et al., 1976).
The final study relating specifically to Hodgkin's disease
patients compared 37 Hodgkin's patients aged 18-45 to 28 young adult
parents of leukemic children (Morrow, 1980).

Morrow used the "PAIS,"

or Psychosocial Adjustment to Illness Scale (Morrow, Chiarello, &
Derogatis, 1978).

The parent group was shown to have greater overall

psychological distress than the Hodgkin's group.

Of the 37 Hodgkin's

patients, 32 were off treatment for two or more years (M

= 5.5

years).

Morrow (1980) also found that both the parents and the 32 Hodgkin's
patients more than two years off treatment had higher anxiety scores
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on the Gottschalk-Gieser (1969) Content Analysis Scale than the
scale's normative sample.

Unlike the parent group, however, the

Hodgkin's patients did not score any higher than the normative sample
on level of hostility.
To summarize, the research done with Hodgkin's disease patients
specifically has often been superficial in its methodology and has produced inconsistent results.

Some studies have identified reduced

libido, fatigue, anxiety, irritability, and depression which linger
on into the post-treatment period.

Others have denied the presence

of such problems.
While not strictly a study of Hodgkin's disease survivors, one
final investigation will be discussed in this section.

Koocher and

O'Malley (1981) undertook an extensive investigation of childhood
cancer survivors which offers data relevant. to understanding the
long-term adjustment difficulties of survivors of Hodgkin's disease
as well as other childhood cancers.
The realization that no study had comprehensively assessed
mental health or psychological adjustment in childhood cancer survivors,
led Koocher and colleagues to initiate extensive investigation of this
area (Koocher & O'Malley, 1981; Koocher, O'Malley, Gogan, & Foster,
1980; O'Malley, Koocher, Foster, & Slavin, 1979).

Koocher and

O'Malley's (1981) book, titled "The Damocles Syndrome," takes its
name from the story of Damocles, who assertedly was forced to sit at
a banquet in the court of Dionysus under a sword suspended by a single
hair, to depict the precariousness of his fortunes.

Such uncertainty
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is presented by the authors as the dilemma

which all successfully

treated cancer patients face during the initial years following treatment, if not for their entire lives.
Since the conceptualization and execution of Koocher and O'Malley's
work has contributed greatly to the thinking behind the current investigation, it will be summarized in some detail.

The book presents the

results of their intensive examination of 117 childhood cancer survivors and a comparison group of 22 children with various chronic diseases.

The children with cancer had either neuroblastoma, leukemia,

osteosarcoma, non-Hodgkin's lymphoma, or Hodgkin's disease.

Mean age

at diagnosis was 5.5 years, and mean age at testing was 18.

All

children were at least five years post-diagnosis.
The authors of the study identified "uncertainty of survival" as
the chief independent variable.

Thus, they did not pay close atten-

tion to time off treatment or disease severity as potential factors.
They did, however, compare different diagnostic categories to each
other on some of the measures.

Dependent measures were administered

to all subjects and included Srole's (1962) Combined Adjustment Rating
Scale, a standardized interview including mental status examination,
Rutter and Graham's (1968) Standardized Psychiatric Interview (for
the 7-12 year old subjects), the Wechsler Intelligence Scale's Information, Similarities and Vocabulary subtests, the Vineland Social
Maturity Scale, Conte's (1975) Self-Rating Depression Scale, Conte's
(1975) Death Anxiety Questionnaire,

the Bendig (1956) short form of

the Taylor Manifest Anxiety Scale, Bills' (1961) Index of Adjustment
and Values (a self-esteem measure) and TAT cards 1, 3GF, 8BM, 13B,
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and 14 as well as Waechter's (1971) four drawings of hospital scenes.
These nine stories of each participant were scored for content

r~flect

ing sadness, loneliness, individual_ reflection, and story resolution.
The principal (global) finding of their study was that 47% of 117
long-term survivors of childhood cancer showed some degree of adjustment difficulty as measured by the Combined Adjustment Ratings of two
independent raters (interrater Pearson's

~

= .85).

This percentage was

significantly greater than that for the smaller group of children with
chronic illness.

Within the cancer group, the highest incidence of

adjustment difficulty was in the Hodgkin's disease subgroup (64%).
The authors proposed two interpretations for this.

One was that be-

cause this was the oldest subgroup of patients, it may indicate that
psychosocial adjustment to childhood cancer is more problematic for
older children and adolescents than for younger children.

This makes

intuitive sense in that the developmental tasks of adolescence are
in direct opposition to the dependency which sickness and recovery
engender.

The second interpretation offered was that the more pro-

longed treatment which Hodgkin's disease patients receive by comparison to other childhood cancers may increase the sense of uncertainty
and danger which the young patient experiences.

A related issue is

that many Hodgkin's patients receive splenectomies which can prolong
immunodeficiencies.

Successfully treated Hodgkin's patients may

therefore be required to take antibiotics as immunotherapy long after
treatment ends;

an ever-present reminder of continued vulnerability.

In this same investigation (Koocher & O'Malley, 1981), no differences were found between the general cancer group and the chronic
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illness comparison group in verbal intelligence or social maturity.
Likewise, cancer patients did not show elevated death anxiety, manifest
anxiety, or depression.

Self-esteem as measured by self-report was

not significantly lower.

Multiple regression analysis showed higher

intelligence and higher socio-economic status to be good predictors of
positive adjustment.

As implied earlier, age at diagnosis was also a

good predictor of positive adjustment, with younger patients faring
better.

Time since diagnosis, while not built into the hypotheses of

the study, did show itself to be a good predictor of adjustment (the
more time elapsed, the better).

Disease severity did not.

Koocher and 0 'Halley conclude their book with a formulation of
adaptation to cancer based upon their empirical findings and their
review of the literature.

They conclude that the "stress" of cancer

is greatest at the point of diagnosis and initiation of treatment, and
that it slowly diminishes over time, nearly reaching baseline at five
years post-diagnosis.

During the course of this decline, various

events such as recurrence, symptom distress or death in the family can
disturb the settling process and initiate elevations in stress.

The

patient, in a state of heightened vulnerability due to the protracted
working through of the impact of cancer and its treatment, is likely
to be more easily over-excited and distressed.

This, according to the

authors, is optimally dealt with through adaptive denial which is
best described as a conscious suppression of feelings, and an increase
in activity to counterbalance the passivity of illness.

The almost

universal use of denial, in 99% of patients (O'Halley et al., 1979),
is again a powerful testimony to its effectiveness if not necessity.
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Psychosocial and psychosexual studies of cancer survival:
mary.

Sum-

In general, the research on cancer survival, Hodgkin's disease

patients included, has yielded mixed results.

Quite often, protracted

and exaggerated psychological symptomatology such as depression,
anxiety, somatization, fatigue, and irritability have been reported.
Evidence for significant psychosexual dysfunction, particularly as it
is affected by body image and interpersonal concerns, has been presented.

Psychosocial areas of occupational functioning and marital

satisfaction have also been cited as problematic.

On the other hand,

.there are investigators who deny the presence of significant psychosocial or psychosexual disruption in the cancer survivor.

Some have

even emphasized the positive, growthful aspects of having suffered
through and endured the ordeal of successful cancer treatment.

In

some studies, both positive and negative effects have been known to
coexist, possibly exerting separate influences upon adaptation.
There are several problems with the experimental methodology
to date which may contribute to the inconsistencies and inconclusiveness
of the results outlined.

First, investigations have differed greatly

in their use of control or comparison groups.

Some have used no com-

parison group at all, opting to compare their findings to established
base rates, normative data, or mere common

sense~

Second, measurement

of dependent variables has often been global, and has tended to rely
upon non-standardized interview responses rather than structured
questionnaires or more in-depth projective tests.

A third problem

with past research is that the groups being studied have often been
quite heterogeneous.

Many studies have neglected to differentiate
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diagnostic categories within the cancer variable.

Of those which have,

efforts to isolate effects of disease stage, treatment severity, or
length of time off treatment have usually been minimal or non-existent.
Therefore·, more extensive study of cancer survival, focusing on specific diagnostic groups, specific treatment regimens,

and clearly delin-

eated survival periods seems necessary to help clarify the current
confusion about the psychosocial aspects of cancer survival.
Hypotheses of the Study
The present study attempts to identify psychosocial and psychosexual liabilities which may accompany survival from successful cancer
treatment.

Unlike most other studies, it limits itself to the study

of one diagnostic group, Hodgkin's disease, so that the variables
of diagnosis and treatment may be held relatively constant.

Also,

unlike other studies, it focuses exclusively upon young adult men, a
group of patients identified in the literature as at high risk for
psychosocial and psychosexual distress.

The selection of a "good

prognosis" cancer minimizes the realistic threat to survival so that
the study of patient uncertainty will be, as much as possible, a
psychological one.
The three independent variables of interest are:
Hodgkin's disease and treatment (N
matched non-patients);
early stage vs. N
off treatment (N

= 30

= 30

months off treatment).

=

60 patients vs. N

1) history of

=

20 age-

2) severity of illness and treatment (N
late stage patients);

= 30

and 3) length of time

less than 24 months vs. N

= 30

more than 30

This is the first.known study which systemat-

ically examines the combined contribution of these variables to
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adaptation in cancer survival.
Guided by the literature just reviewed, the following hypotheses
were generated prior to the study:
1. Patients will appear more disturbed than non-patients on
self-report measures of psychosexual functioning, psychological symptom
distress, self-esteem, death anxiety, and coping adequacy, and on
interview ratings of global adjustment.

Because of conflicting studies

reporting both increased need for interpersonal closeness and decreased
ability to achieve this, it was hypothesized that patients would show
different (perhaps higher, perhaps lower) capacity for intimacy than
non-patients.
2. On semi-structured interview, patients will show greater
difficulty in work adjustment, a heightened appreciation for life, and
higher self-ratings of overall quality of life than the non-patient
sample.
3. Late stage patients will appear more disturbed than early
stage patients on self-report measures of psychosexual functioning,
psychological symptom distress, self-esteem, death anxiety, and
coping adequacy, and on interview ratings of global adjustment.

They

should also be different than early stage patients in intimacy capacity (motivation).
4. On semi-structured interview, late stage patients will show
greater difficulty with work adjustment, a lower appreciation of life,
and lower self-ratings of overall quality of life than the early stage
patients.

Late stage patients are also expected to show greater sub-

jective disturbance in physical stamina, sleep, eating habits, and
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concentration abilities (possible depressive equivalents).

Addition-

ally, they should have greater difficulty with the prolongation of
conditioned nausea and anxiety during the off-treatment period.
5. Patients recently off treatment will appear more disturbed
than those off treatment for longer periods of time, on self-report
measures of psychosexual dysfunction, psychological symptom distress,
self-esteem, death anxiety, and coping adequacy, and on interview
ratings of global adjustment.

They also should be different from

patients distantly off treatment in capacity for intimacy (intimacy
motivation).
6. On semi-structured interview, patients recently completing
treatment should show greater difficulty with work adjustment, a lower
appreciation for life, and lower self-ratings of overall quality of
life than those patients distantly off treatment.

Patients recently

completing treatment are also expected to show greater subjective
disturbance in physical stamina, sleep, eating habits, and concentration ability (possible depressive equivalents).

They should also

acknowledge a higher incidence of conditioned nausea and anxiety
during the off-treatment period.

METHOD
Subjects
The study sample consisted of 80 men ranging in age from 21 to
46 years at the time of assessment.

Sixty of these men were Hodgkin's

disease patients at Memorial Sloan-Kettering Cancer Center, off all
treatment and showing no clinical evidence of disease for at least six
months.

The other 20 participants were age-matched healthy volunteers

who had never suffered any life-threatening physical illness or debilitating medical treatment.
Patients potentially eligible for study were Memorial Hospital
male Hodgkin's disease patients between 18 and 50, who had received
their diagnosis before age 45.

With this as a starting point, treat-

ment protocol records of 151 patients listed as at least six months
off treatment were reviewed.

In this review, 33 patients were exclud-

ed for the following reasons:

recent relapse (15), death (5), formal

psychiatric history which predated cancer diagnosis (3), serious
(life-threatening) physical illness in addition to cancer diagnosis
(2), and non-fluency in English (2).

"Formal psychiatric history"

was defined as prior hospitalization or
not outpatient psychotherapy alone.

outpatient medication, but

Of the remaining 118 patients,

14 were placed on low priority eligibility because they were between
24 and 30 months off treatment.

This was done to help separate

patients more cleanly into the two time-off-treatment cells.
these 14 patients had to be approached for study.
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None of

59
Patients were placed into one of four mutually exclusive cells
for analysis.

The design was essentially a 2 (disease stage) by 2

(time off treatment) factorial layout with an appended comparison
group (see Figure 1).

The disease stage variable was broken down

into "EARLY" (IA, IB, IIA, IIIA) and ''LATE" (IIB, IIIB, IVA, IVB), as
is the custom at Memorial Hospital.

The time off treatment variable

was broken down into "RECENT" (6-24 months off treatment) and "DISTANT"
(over 30 months off treatment).

The combination of these two factors

resulted in four patient groups:

Early stage recently off treatment

(ER); early stage distantly off treatment (ED); late stage recently off
treatment (LR); and late stage distantly off treatment (LD).
From the pool of 104 eligible patients, prospective participants were recruited either by phone or in person when they came in
for their check-up.

The last 10 patients were carefully selected to

ensure equal cell sizes.
cipate.

Of 69 patients asked, 62 agreed to parti-

Six of the seven refusals came from men who stated that they

would prefer not to be reminded of the treatment experience.
seventh refuser would not say why he declined.

The

Two of the 62 patient

participants were excluded from all analyses because they withdrew
themselves from the study midway through their session.
The age-matched non-patient group was subjected to the same
background inclusion criteria:

age 20 to 46, absence of formal psy-

chiatric history, absence of life-threatening physical illness, and
fluency in English.

Sixteen of them were either friends (12) or

relatives (4) of the patients.

This method of recruitment through

the patient sample was chosen with the dual goal of informal matching
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DISEASE STAGE
PATIENT GROUP

Early

Late

(IA,IB,IIA,IIIA)

(IIB,IIIB,IVA,IVB)

Recent
(6-24 mo.)

N =

Distant
(over 30 mo.)

N = 15

15

N

= 15

TIME OFF
TREATMENT
N = 15

N

COMPARISON GROUP

= 20

(non-patients)

FIGURE 1
Study Design

(~

= 80)

by similarity and to reduce the potential bias of volunteerism.
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After

canvassing the entire sample of patients for volunteers, four comparison participants were still needed.
hospital contacts.

These were obtained through extra-

The interviewer knew none of them personally.

Table 2 contains the demographic and socioeconomic characteristics of the sample.

The apparent equivalence across the five groups on

race, marital status, religion, family income bracket, and presence of
children has
dependence.

been confirmed by non-significant x 2 tests of statistical
The only variable which differed significantly across

cells was the Hollingshead Two-Factor Index of Social Position (Hollingshead, 1957), IC1,74)

=

3.19,

E

<.05.

This Two-Factor Index combines

education (weight = 3) and occupation (weight = 5) into an estimate of
social position.

Mean comparison determined that the non-patient group

had a somewhat higher social status than the combined patient sample,
and the ''Late Recent" patient group was somewhat lower than the other
three patient groups.
Returning to the patient sample, all but four were treated according to one of the four Memorial Hospital treatment protocols discussed
in the literature review.

Of these 56 patients, 29 (52%) were treated

with combined MOPP and involved field (local) radiation, 16 (28%) were
treated with eight-drug chemotherapy (MOPP/ABDV) and local radiation,
six (11%) with 10-drug chemotherapy (MOPP/ABV/CAD) and local radiation,
and five (9%) with MOPP and local radiation followed by 8- or 10-drug
chemotherapy and local radiation after relapse.

The other four

patients were treated before these protocols existed.

Two received

radiation alone, and two were treated with MOPP chemotherapy alone.
The mean time off treatment for the patients in the two "recent"
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Table 2
Socio-Demographic Characteristics of the Sample

Variable

AGE

RACE
white
hispanic

Total
NonPatients

Patients
Early
Recent
(,!!=15)

Early
Distant
(N=l5)

Late
Recent
(,!!=15)

Late
Distant
(N=l5)

(N=20)

(N=80)

M=31.5
SD=7. 0

M=32.0
SD=7. 8

M=30.5
SD=7 .6

M=32.5
SD=5.0

M=29.4
SD=5.2

M=31.1
SD=6.5

14
1

14
1

14
1

14
1

20
0

76
4

MARITAL STATUS
single
married
sep. I div.

7 (46%)
8(53%)
0(0%)

6 (40%)
8(53%)
1 (7%)

8(53%)
6(40%)
1(7%)

3 (20%)
11 (73%)
1 (7%)

11 (55%)
8 (40%)
1 (5%)

35 (44%)
41 (41%)
4 (5%)

CHILDREN
yes
no

6 (40%)
9(60%)

6(40%)
9(60%)

7(47%)
8(53%)

4(27%)
11 (73%)

5 (25%)
15 (75%)

28(35%)
52(65%)

10(67%)
1 (7%)
4(26%)
0(0%)

8(53%)
6(40%)
1(7%)
0(0%)

8(53%)
5 (33%)
1 (7%)
1(7%)

8 (53%)
3 (20%)
4(27%)
0(0%)

12(60%)
4 (20%)
4 (20%)
0(0%)

46 (57%)
19(24%)
14 (18%)
1(1%)

1(6%)
4(27%)
4(27%)
4 (27%)
2(13%)

2 (13%)
3(20%)
3 (20%)
6 (40%)
1(7%)

4 (27%)
3 (20%)
7 (4 7%)
1(6%)
0(0%)

0(0%)
5(33%)
2 (14%)
3(20%)
5 (33%)

2 (10%)
4 (20%)
4 (20%)
7 (35%)
3 (15%)

9 (11%)
19(24%)
20(25%)
21 (26%)
11(14%)

M=45.6
SD=l2.5

M=40.4
SD=l2.3

M=37.7
SD=l2.1

M=48. 9
sn=l4.2

M=50.6
SD=ll.2

M=45.1
sn=l2.4

RELIGION
Catholic
Protestant
Jewish
none
INCOME BRACKETl
$0-10,000
$10-20,000
$20-30,000
$30-50,000
over $50,000
HOLLINGSHEAD
INDEX

1

)
Annual family income
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groups was 13.2 months (11.8 months for late stage patients and 14.6
months for early stage patients).

The mean time off treatment for the

two "distant" groups was 55.4 months (50. 7 months for late stage
patients and 60.1 months for early stage patients).

Within the time

off treatment variable, differences across stage were not significant
for both comparisons.
Materials
The dependent measures were organized into three categories:
patient responses and ratings in interview, objective self-report
measures, and experimenter ratings.

These three categories will be

described separately.
Interview Ratings and Responses:

A Revised Problem Oriented Record

The Problem Oriented Record (POR) is a structured clinical interview which surveys 12 areas of life performance:

problems with medical

treatment, hospital service, mobility and housework, vocational problems,
financial, family and social problems, worries regarding disease, and
problems with affect, body image, and communication (Gordon, Freidenbergs, Diller, Hibbard, Levine, Wolf, Ezrachi, & Lipkins, 1978).
Each problem is scored for two components:

problem existence

(yes or no) and severity weighting of a problem (1-10 scale).

The

interview constructors selected this format because it provided specific scores for known problem areas of the cancer patient, and also
lent sufficient flexibility to allow patients to "talk through" any
uncomfortable feelings aroused by the interview.

The POR has been

demonstrated as useful with three separate cancer diagnoses:
lung, and melanoma (N = 136).

breast,
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Because FOR was designed for use with cancer patients currently
in treatment and only recently off treatment, substantial revision of
the record was necessary.

Some treatment-relevant questions were

omitted, many questions were reworded to accommodate the sample, and
some questions were added because they were believed to hold special
relevance for the surviving patient (e. g.,

11

Do

you feel that you appre-

ciate life more fully than you did before your illness? 11 ;
are you about having a recurrence?") •

"How worried

Appendix A shows the revised

version of the FOR used in this study.
Self-Report Measures
Derogatis Sexual Functioning Inventory (DSFI).

The DSFI (Dero-

gatis, 1975,1978) is a 256-item inventory broken down into 11 subscales
of psychosexual and psychological functioning.

Nine of these scales

(information, experience, drive, attitudes, gender role, fantasy,
body image, satisfaction) tap sexual domains and the other two (psychiatric symptoms and affects balance) measure psychological domains
which correlate with sexual functioning.

The eight scales designated

as relevant to this study were drive, gender role, fantasy, body image,
satisfaction, global satisfaction, psychiatric symptoms, and affects
balance.

High scores on the drive, fantasy, satisfaction, global

satisfaction, and affects balance subscales are associated with positive adaptation, or low impairment.

The reverse is true of the body

image and psychiatric symptoms subscales, where high scores reflect
high impairment.

A high gender role score indicates hypermasculinity,

and a low score, hyperfemininity (in men).

Appendix B shows the DSFI.
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Internal consistency and test-retest reliability coefficients of
the primary symptom dimensions are generally quite high, ranging from
.56 to .97.

Construct validity was demonstrated

(~ =

380) by principal

components analysis, separating normals from known sexual dysfunctioning patients, using subscale factors to account for 52% of the variance.
Discriminant function analysis achieved a 77% hit rate using the same
sample of 380 (Derogatis & Melisaratos, 1979).
Brief Symptom Inventory (BSI).

The BSI is a delineated version

of the psychiatric symptoms subscale of the DSFI.

This 53-item index

(Section V of the DSFI) is a shortened form of the more familiar
Symptom Check List-90 (SCL-90).

Psychiatric symptoms subsumed under

nine dimensions (somatization, obsessive-compulsiveness, interpersonal
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid
ideation, and a psychoticism) are rated by the participant on a 5-point
Likert-type scale of intensity for the time period of the past two
weeks by the participant.
severity

There are also summary scores of global

of symptoms (total score

~

53), positive symptom total (total

#of symptoms endorsed), and positive symptom distress index (average
rating per symptom endorsed).
retest reliability

(~

= 60)

Internal consistency

(! =

719) and test-

coefficients for the nine dimensions and

three global indices range from .68 to .91 (Derogatis & Spencer, 1982).
Concurrent validity with the SCL-90 has been shown in a sample of psychiatric outpatients

(!

= 500) through correlation coefficients above

.90 for all dimensions and indices.

Convergent validity with the MMPI

was demonstrated with 209 symptomatic volunteers (Derogatis & Spencer,
1982).

The dimensions relevant to this study are somatization,
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interpersonal sensitivity, depression, phobic anxiety, paranoia, hostility, anxiety, global severity of symptoms, and positive symptom
total.
Impact of Events Scale (IES).

The IES is a 15-item measure of

response to stressful life events along two constructs, intrusion and
avoidance (Horowitz, Wilner, & Alvarez, 1979).

The scale designers

have found it useful in studying a person's response to the same traumatic event over long periods of time.

Each item describes a reaction

to the identified stressor (in this study, the diagnosis of cancer)
which the subject endorses as present or absent along a weighted 4point scale, with "O" = not at all, "1" = rarely, "3"
"5"

= often.

sometimes, and

A high score is thus associated with high distress.

Internal consistency (.78, .82) and test-retest (.89, .79) reliability
of the intrustion and avoidance scales, respectively, were amply demonstrated on a sample of traumatized outpatients suffering from.posttraumatic stress syndromes

(~

= 66).

Construct and discriminant valid-

ity as well as test sensitivity were demonstrated in comparing this
high distress group to 110 normal medical students recently after their
first exposure to cadaver dissection, !(1,172)
intrusion and !(1,172)

=

73.0,

~

= 212.1, E

<.0001 for

<.001 for avoidance (Horowitz et al.,

1979).
Rosenberg Self-Esteem Scale (RSES).
inventory of self-esteem (Rosenberg, 1965).

The RSES is a 10-item
It is intended to measure

the more conscious "self-acceptance" aspect of self-esteem.

The scale

was constructed with 5,024 adolescents, using the Guttman procedure,
and thus the conditions of unidimensionality of scale and cumulativeness
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of the items underlie the scoring.

The 10

items revolve around liking

or disliking of self, and are answered on a 4-point Likert-type scale
(strongly agree, agree, disagree, strongly disagree) which forces
agreement or disagreement on each item.

The 10

items are collapsed

to six levels of self-acceptance, and thus each subject can receive a
score ranging from 0 to 6.
esteem.

Low scores are associated with high self-

Rosenberg (1965) achieved a Guttman scale reproducibility

coefficient of .92.

Test-retest coefficients

reported at .85 (Silber & Tippett, 1965).

(! = 28)

have been

The same authors found the

RSES to correlate from .56 to .83 with several similar measures (N

=

44), suggesting acceptable concurrent validity.
Death Anxiety Questionnaire (DAQ).

The DAQ is a 15-item inven-

tory of attitudes toward death and dying (Conte, Bakur-Weiner, &
Plutchik, 1975).

Each item is rated on a 3-point scale from 0 ("not

at all") to 2 ("very much").

A high score reflects high death anxiety.

Split-half reliability of scores on a heterogeneous adult sample
100) has been reported at .76.
alpha) on a separate sample

(! =

Internal consistency (coefficient

(! = 230)

was found to measure .83.

current validity coefficients were .51 and .58 when compared

Con-

to the

Templer Death Anxiety Scale and the Dickstein Death Concern Scales,
respectively (N

= 40).

Somewhat lower but still significant correla-

tions with the Manifest Anxiety Scale
Zung Self-Rating Depression Scale

(~ =

(~

=

.27) and an age-corrected

.40) confirm the clinical ob-

servation that death anxiety is related, though not equivalent to,
anxiety and depression (Conte, Bakur-Weiner, & Plutchik, in press).
This lends the DAQ sufficient construct validity for research
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usefulness.

The scale has been demonstrated as useful with pediatric

cancer patients by Koocher and colleagues (Koocher, 0 'Halley, Gogan,

& Foster, 1980) as well as by its authors.
Experimenter Ratings
Global Assessment Scale (GAS).

The GAS is a rating scale for

evaluating the overall psychological functioning of a subject during
a specified (one month in this study) time period (Endicott, Spitzer,
Fleiss, & Cohen, 1976).

The scale values range from 1 to 100.

anchor points are given at

10 decile intervals.

Ten

The rater first

selects the decile of best fit, then

pinpoints the placement within

that decile according to impression.

Higher scores represent greater

psychological health.

The GAS was designed to improve upon the com-

parable Health Sickness Rating Scale (HSRS) of Lubarsky (1962) by
providing more anchor points and more behavioral descriptors, and by
eliminating diagnostic constraints.

It covers three major dimensions

of psychopathology, impairment in daily functioning, reality testing,
and potential for suicide or violence.

One great advantage of this

scale is the proportion of the score range which relates to nonpsychiatric persons.

Scores from 61 to 100 apply to people who are

generally considered by those around them to be psychologically
healthy.

It was expected that most participants would score within

this upper range.
Five studies of interrater reliability have yielded intraclass
correlation coefficients from • 69 to • 91.

Concurrent and discriminant

validity are reported as adequate when the GAS is compared to the HSRS,
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Mental Status Examination, and to ratings by relatives (Endicott et
al., 1976).
The experimenter trained himself in the rating of GAS scores by
listening to taped GAS interviews of 10 breast cancer patients done
at the same institution.

After this, 15 interviews were rated while

blind to the expert's GAS score.

(£

=

Interrater agreement was sufficient

.95) to stop with confidence after 15.

The GAS interview itself

is unstructured, with the experimenter responsible for adequate questioning into recent disturbances of sleep, appetite, mood, psychological symptoms, self-esteem, social and work activities, interpersonal
relationships, and the like.
Intimacy Motivation.

This is a relatively objective, content-

based scoring system applied to the story productions of six (in this
study) TAT-like cards (McAdams, 1980),

Intimacy motivation is defined

by its author as "a recurrent preference or readiness in an individual
for experiences of warm, close, and communicative exchange with others"
(McAdams, 1981, p. 1).

It has been demonstrated to be a more uni-

dimensional analogue to the affiliation motive of Atkinson, Heyns, and
Veroff (1954), because it emphasizes measurement of only the more
positive (approach) aspects of the affiliation motive.

The theoretical

bases for specific categories of the intimacy motive came from the
writings of H.S. Sullivan, A. Maslow, D. Bakan, and M. Buber (see
McAdams, 1980).

These underpinnings were integrated with the now-

traditional approach of using the Thematic Apperception Test (TAT) to
measure various social motives.

The first such approach was by

McClelland and colleagues on achievement motivation (McClelland,

7'0

Atkinson, Clark, & Lowell, 1953).
The scoring system consists of 10 thematic categories which are
applied to each story.

At least one of two "prime" categories (rela-

tionship produces positive affect;

non-instrumental dialogue) must be

present for scoring to continue on that story.
ies are:

The eight subcategor-

psychological growth and coping gained from a relationship,

commitment to or concern for another, time-space transcendence, union
of characters, harmony in a relationship, surrender to outside control,
escape to intimacy, and connection with the outside world.

Each cat-

egory receives 1 point for its presence, making 0-10 the range of
possible scores per story.

The scoring system as outlined in the

manual is quite detailed and objective, thereby yielding high interrater reliability coefficients: 92% category agreement for the two
"prime" categories, and Spearman rho = • 89 for N
1980).

=

60 stories (McAdams,

Internal consistency has been demonstrated by principal com-

ponents factor analysis which found six categories loading heavily
on an intimacy factor and accounting for 30% of the total score variance.

Construct validity has been supported by high correlations

between Intimacy Motive Score and behavioral ratings of intimacy, r
(41)

=

.70, E <.001 (McAdams & Powers, 1981).

The experimenter trained himself according to the instructions
in the scoring manual, reviewing 210 practice stories in sets of 30,
comparing scores to expert scoring along the way.

On the last 60

stories, category agreement for the two prime tests was£= .93 for
the "relationship produces positive affect" category, and r
the "non-instrumental dialogue" category.

=

.90 for

Rank-order agreement between
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experimenter and expert on the last 60 stories was rho = .92.
The six pictures used in this study depicted the following:
a) two figures sitting on a park bench near a river, b) a young woman
and an older man walking through a field with horses and a dog, c) a
man and a woman on a trapeze, d) a ship officer speaking with another
man, with a ship in the background, e) a man covering his eyes, standing near a bed with his hand outstretched over a younger man lying
on a couch (TAT Card 12M).
land and Steele (1972).

Pictures a and c can be found in McClel-

Pictured can be found in McClelland (1975).
Procedure

Assessment Session
After a patient was determined by chart review to be eligible
for study, he was either telephoned or approached in person at the
Memorial Hospital lymphoma clinic.

Each patient was then told that

the departments of hematology and psychiatry were involved in "a
study of the psychological aspects of successful treatment for Hodgkin's disease," and that his participation would be appreciated.
He was informed that the study was voluntary, would entail two to
three hours of his time, and could be scheduled at his convenience.
Upon verbal consent, an appointment was then scheduled.

The location

of interview and testing was either the clinic itself, the patient's
home, or the experimenter's office.
All patients were seen in one session.

At the outset of the

session, the rationale and purpose of the study were explained briefly,
and consent received (see Appendix C for consent forms).

To facilitate
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good rapport, patients were interviewed first.

After collecting basic

demographic information, data for the Problem Oriented Record and the
Global Assessment Scale were collected.
four short questionnaires:

Each patient was then given

Rosenberg Self-Esteem Scale, Death Anxiety

Questionnaire, Impact of Events Scale, and a measure of stressful
recent life changes (Holmes & Rahe, 1967).

The purpose of this fourth

questionnaire was to ensure similar levels of external stress as
measured by recent life changes in the five study groups.

Non-signi-

ficant t-tests across groups on this measure confirmed no differences
in stressful life events (e.g., recent divorce, recent death in the
family) across groups.

Participants were allowed to fill out the

above four questionnaires in any order they chose.

The examiner

remained present for this period with all participants.
Upon completion of the short questionnaires, each participant
was given the Derogatis Sexual Functioning Inventory (which includes
the Brief Symptom Inventory) and the TAT cards.
filled out in any order.
booklet.

These also could be

Instructions for the DSFI are in the test

For the TAT, instructions were as follows:

"Here are six

pictures.

I'd like you to write down an imaginative story for each

picture.

The story you tell is entirely up to you but it should have

a beginning, middle, and end."

In cases where patients were seen in

the clinic, the experimenter frequently left the patient alone while
he completed these more time-consuming tasks.

The GAS ratings were

done after termination of the assessment session.

At the end of the

session, patients were asked if they would be willing to ask a friend
or relative of similar age to participate in the same study.
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Potential non-patient subjects were contacted by telephone and
asked to participate "as a member of a comparison group in a study of
the psychological aspects of Hodgkin's disease and its treatment."
After verbal consent, appointments were scheduled at their convenience.
After obtaining written consent (see Appendix C, control form), the
session proceeded in much the same fashion as with the patients.

The

essential differences were that the POR was shortened to include only
demographic information and current rating on quality of life, and
that the IES was anchored to more varied events.

Specifically, eight

rated their reactions to physical or medical stressors (e.g., recent
separated shoulder), four rated reactions to psychosocial stressors
(e.g., separation from wife), three to the death of a loved one, three
to the near death of a loved one, and two to a recent career change.
Because of the shortened POR, sessions with control subjects were
nearly one hour shorter than with patients.
Scoring the Data
All measures except the TAT intimacy motive and the GAS rating
are objectively scored and therefore resistant to possible biases
from an hypothesis-wise scorer.

Because the GAS interviewer and

rater was the experimenter who was aware of the hypotheses of the
study, this measure was conceptualized as global rating of secondary priority in the data analysis.

Significance on this measure

could conceivably augment other findings, but it was decided that
significance on such a measure alone would hold suspicious validity.
The two-tailed nature of the experimenter's thinking on cancer
survival; that is, that survival from such trauma may have a positive,
growthful impact on some as well as a more negative impact on others,
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would argue against any systematic bias in his ratings, however.
Regarding the TAT scoring, any possible bias was eliminated by a
procedure which blinded the scorer to the participant's identification.
All 480 stories (80 participants x

6 stories/participant) were cross-

referenced by code number, then shuffled together in random fashion.
Scoring of each story then proceeded with the experimenter unaware
of its author.

RESULTS
This study has examined the psychological sequelae of successful
treatment for Hodgkin's disease in 60 young men, by comparing them to
a non-patient age-matched group of 20 men, and by exploring the effects
of disease stage and time off treatment within the patient sample.

The

dependent measures included self-report inventories of sexual dysfunction, psychological symptomatology, coping style, self-esteem, and
death anxiety, an

experimenter rating of global adjustment, interview

self-ratings, and a projective test measure of intimacy motivation.
The data were conceptualized in terms of a 2 X 2 factorial layout of patients

(~ =

15/cell) with a single comparison group

(~

= 20).

Analysis of variance (ANOVA) was selected as the most appropriate
statistical procedure.

This design, a "p x q + 1," has been discussed

by Winer (1971, pp. 468-473).

Because it has an "unwanted" cell in

the crossed layout, Winer recommends pooling the sum of squares within the comparison group with the error sum of squares and then including in the final ANOVA table a sum of squares representing the contrast
between the comparison and experimental groups.

Something very similar

to this can be done using the SPSS "ONEWAY" procedure with planned
orthogonal contrasts (Nie, Hull, Jenkins, Steinbrenner, & Bent, 1975).
Even though technically the package is conducting a one-way ANOVA
with five levels of one variable, the planned contrasts, if set up
orthogonally, will produce independent and error variance-corrected
tests for two main effects (stage and time off treatment), for the
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interaction of these two effects, and for a comparison of the patient
group as a whole

(~

= 60)

to the comparison group (N

= 20).

The

ONEWAY design and the planned contrast values are presented in Table
3.
The presentation of analyses will be organized according to
dependent measures beginning with the self-report inventories.

All

planned comparisons were performed through orthogonal contrast weights
which assessed differences between patients and non-patients (contrast
1), the main effect of disease stage within the patient group (contrast 2), the main effect of time off treatment within the patient
group (contrast 3), and the stage X time interaction (contrast 4).
As

suggested earlier, the independence of these contrasts from each

other and the fact that they are comparisons based on a priori hypotheses eliminate the risk of increase in experiment-wise error rate
due to multiple comparisons.

Except in the case of the TAT ratings,

where the study hypotheses were non-directional, one-tailed significance levels will be reported.
The study hypotheses follow the idea that disease (and therefore also treatment) severity and time off treatment are factors which
contribute to level of measureable disturbance.

Thus, the early

stage-distant and the late stage-recent patients would fall on opposite ends of the continuum from low risk to high risk, respectively.
For this reason, it was decided to study these two groups more closely in certain analyses, especially where the overall analysis
approached significance (i.e., .05 <

~ <

.10).

Because of its con-

sistency with the study's hypotheses, this approach was considered
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Table 3
SPSS ONEWAY Treatment of Data With
Planned Orthogonal Contrast Values

VARIABLE
Group
Early
Recent

Early
Distant

Late
Recent

(~=15)

(~=15)

(~=15)

Contrast 1 1
(patient vs. non-patient)

+1

+1

+1

+1

-4

Contrast 2
(stage effect)

+1

+1

-1

-1

0

Contrast 3
(time effect)

+1

-1

+1

-1

0

Contrast 4
(stage x time)

+1

-1

-1

+1

0

Late
Distant
(N=15)

NonPatients
(~=20)

1 Because of unequal cell sizes, this contrast is not orthogonal
to the others. SPSS ONEWAY makes a weighted adjustment for
this.
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justified on an a priori basis.
Self-Report Measures
Derogatis Sexual Functioning Inventory (DSFI).

The following

subtests of the DSFI were analyzed as dependent variables on the
ANOVA:

drive, gender

role, fantasy, body image, satisfaction, glo-

bal satisfaction, psychiatric symptoms (BSI- GSI), and affects
balance.

Although in some subtests the means fell in the order pre-

dicted, none of the differences was statistically significant (see
Table 4 for means).

Near significance was obtained in comparing

patients to non-patients on the number of sexual fantasies acknowledged, with the patient group being lower, !(1,75)

= 3.25, £ <.10.

Within the patient group, the difference was accounted for by the
fact that the early stage patients had a more constricted sexual fantasy life than the late stage patients, !(1,75)

= 4.29, £ <.05.

In a

follow-up test between early stage patientsandnon-patients on the
DSFI fantasy score, early stage patients were significantly lower,
~(48)

= 3.37,

£<.OS.

Brief Symptom Inventory (BSI).

As with the DSFI, close examin-

ation of group mean scores on the BSI found some of them to order in
a way consistent with the hypotheses (see Table 5).

Most differences

in means for the relevant BSI subscales were, however, also nonsignificant.

One example of this is the BSI global severity index

(GSI), which is the same as the psychiatric symptoms subscale of the
larger DSFI (refer to Table 4).

From the study hypotheses, one would

expect the early-distant group (ED) to score as the least disturbed
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Table 4
Mean Scores on the Derogatis Sexual Functioning
Inventory Subtests for the Five Study Groups*
Late
Recent

Early
Recent

Late
Distant

Early
Distant

Non-Patients

18.4

18.1

20.5

17.5

18.9

Gender Role

4.0

6.9

5.7

7.6

6.0

Fantasy

7.01,2

5. 61,2

8.11,2

5. 81,2

8.5 1

Drive

Body Image*

18.3

19.3

18.1

18.6

17.8

Satisfaction

7.9

7.7

6.7

8.2

7.7

Global
Satisfaction

5.1

5.2

4.9

4.9

4.7

Psychiatric
Symptoms(GSI)*
Affects
Balance

.57 3
1.4

~48 3
1.5

.483
1.1

.413
1.6

.463
1.2

*H1gh scores on the Body Image and Psychiatric Symptoms (GSI)
subtests reflect high impairment. On all other subtests, lower
scores reflect more disturbance.
1 c1: 60 patients vs. 20 non-patients, !(1,75) = 3.25,

£ <.10.

2c 2 : 30 early stage patients vs. 30 late stage patients, !(1,75)
= 4.29, £ <.05.
3These scores are not significantly different from each other, but
worth noting is that the mean of the patient scores ( .49) is one
full standard deviation (T score= 60) above that of the test's
normative sample (! = 344, M = .18).
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Table 5
Mean Scores on the Brief Symptom Inventory
Subtests for the Five Study Groups*

Late
Recent

Late
Distant

Early
Recent

Early
Distant

Non-Patients

Somatization

.49

.37

• 39

• 32

.23

Interpersonal
Sensitivity

.58

.40

.58

.43

.64

Depression

.65

.46

.59

.38

.52

Phobic Anxiety

.391,2

.161

.091

1
.17

.17 2

Hostility

.62

.41

.52

.48

.39

Anxiety

.59

.71

.42

.52

.54

Paranoia

• 73

.68

.68

.57

.61

Psychiatric
Symptoms (GSI) 3

.57

.48

.48

.41

.46

20.1

18.5

16.2

16.9

18.6

Positive
Symptom Total

*On

all subtests, higher scores reflect higher impairment.

lc4: Follow-up of stage X time interaction: 15 late recent
patients vs. 45 other patients, £(58) = 2.41, ~ <.01.
2Fifteen late recent patients vs. 20 non-patients, £(33) =
1.46, ~ = .077.
3see Table 4, footnote 3, for explanation.
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and the late-recent group (LR) to score as the most disturbed of the
patient groups, with the other two patient groups (ER & LD) in between,
The non-patients (NP) would be expected to score slightly better than
the ED group.
and
GSI

=

~p

.46.

<~atient =

On the GSI,

~R

= .57,

~R

= .48,

~D

= .48,

= .41,

It is worth noting that these patient scores on the
.49) fall one full standard deviation above the mean

of the BSI's normative sample of 344 male non-patients
SD

~D

= 15)(Derogatis & Spencer,

1982).

(~ge

= 46,

This is one standard deviation

in the direction of higher disturbance than the principal normative
sample of the BSI.

It is, however, also nearly one standard devia-

tion below the mean GSI score of 425 male psychiatric outpatients
(~ge

=

31, SD

= 12).

A trend toward significant lowering of phobic anxiety as measured
on the BSI was detected when comparing patients recently completing
treatment to those distantly off treatment, F(l,75) = 2.92, £ <,10.
A test of the significant stage X time interaction (C4) showed the
difference to be largely attributable to the very high score for the
late-recent group (M = .39) as compared to the other patient groups
combined

(~

= .14),

~(58)

= 2.41, £

<.01.

This late-recent group

mean score (.39) was not significantly higher than the control group
score (M

=

.17), but there did appear to be a trend toward this, t(33)

= 1.46, £ = .077 (see Table 5).
Impact of Events Scale (IES).
scores:

The IES yields two separate

intrusive thinking and avoidant thinking, which can be com-

bined to a total score.

Among the planned contrasts, a difference

between patients and non-patients on avoidant thinking was confirmed
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(see Table 6).

In following up that difference, the Least Significant

Difference procedure (LSD) was applied to the range of scores across
the groups for avoidant thinking, and the early-recent group mean was
significantly greater than the non-patient group mean (£ <.05).

In

keeping with the earlier identification of a probable "low risk
group" (ED) and a probable "high risk group" (LR), the same LSD test
was applied to the intrusive thinking scale, with attention paid only
to the comparisons of these two groups' means.

The difference was

significant (£ <.05), suggesting that there may be some additive
effect of stage and time off treatment in influencing coping style
and intrusive thinking.

See Table 6 for mean scores and relevant

comparisons.
When contrasts were set up to compare the early-distant group
to the other patients, excluding non-patients, they were found to be
significantly more well-adjusted than the other groups combined with
regard to intrusive thinking,
to the overall IES score,

~(58)

~(58) =

= 2.28,

£ <.05, and with regard

1.89, £ <.05, but not with regard

to the avoidant thinking score.
Rosenberg Self-Esteem Scale (RSES).

This is a 10-item scale

which measures the self-acceptance aspect of self-esteem.
scores reflect higher self-esteem.

Lower

There were no significant differ-

ences between groups in any of the four planned contrasts.

One

difference between means which neared significance involved the early
stage group's tendency to score higher on self-esteem
late stage group (M= 1.37), !_(1,75) = 2.47, .E.. <.10.

(!!

= • 80)

than the
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Table 6
Impact of Events Scale:

Mean Comparisons

Patient Groups
Late
Recent

Non-Patients

Late
Distant

Early
Recent

Early
Distant

Intrusive
Thinking**

8.47b

7.53

7.27

3.07b

5.00

Avoidant
Thinking*

7.47

8.07

ll.OOa

6.00

4.32a

15.94

15.60

18.27

9.07

9.32

Total**

*Cl: Patients scored significantly higher than non-patients,
!(1,74) = 5.61, E <.05.
**Early Distant (low risk) group significantly lower than other
patient groups combined.
aLeast Significant Difference (LSD), significant
bLSD significant at E <.05.

at~

<,05.
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Death Anxiety Questionnaire (DAQ).
attitudes toward death and dying.
anxiety.

As

This is a 15-item scale of

Higher scores reflect higher death

was the case with much of the DSFI and BSI, the order of

means (especially for the time off treatment effect) is in the direction predicted.

However, no planned comparisons yielded significant

differences on the DAQ.

Within the patient group,

~ecently

off treat-

ment = 8.44, and ~istantly off treatment= 7.43.
To summarize this section, planned statistical analyses of the
self-report data provided minimal support for the study hypotheses.
While the ordering of means across groups often was in the predicted
direction, rarely did the differences reach significance.

Follow-up

statistical handlingof these non-significant-but-predicted ordering
of means for all dependent measures will be described at the end of
this chapter.
Confirmed hypotheses were the following:

Early stage patients

demonstrated more constricted sexual fantasies than non-patients on
the DSFI.

Patients in general also tended to use a more avoidant

thinking style than non-patients in reference to a past traumatic
event.

While patients did not differ from this study's comparison

group on psychiatric symptomatology, they did score an average one
standard deviation above the DSFI normative male sample.

Within the

patient group, late stage patients recently off treatment had significantly higher phobic anxiety than the other patient groups combined.
They also showed more intrusive thinking about their cancer than the
early-distant patient group.

The low-risk, early-distant group did

appear to be more well-adjusted than the other three patient groups
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on the Impact of Events Scale (intrusion and total scores both lower).
Experimenter Rating:

Global Assessment Scale (GAS)

Like the self-report measures, the GAS data were analyzed via
the ANOVA with four planned contrasts.

The GAS is a global rating,

between 1 and 100, of overall psychological health and adjustment,
based primarily upon recent symptomatology.
The order of means on the GAS, from lowest to highest score,
was as follows:
78.4.

~R

= 70.0,

= 74.9,

~R

~D

= 75.7,

~D

= 77.5,

~p

=

This is the predicted order, but again the differences between

means only approached significance.
comparison (Cl), f(l,75)

= 1,88

For the patient to non-patient

( NS );

and for the recent to distant

time off treatment comparison (C3), !(1,75)

= 2.16

( NS ).

The dif-

ference between means of the low risk (ED) versus the high risk (LR)
groups was statistically significantly; however,

~(28)

= 1.88,

~

<,05.

the high risk (LR) patients also had significantly lower GAS scores
than the non-patient group,

~(33)

= 2.02,

~

<,05.

The GAS data, while they do not directly confirm the study
hypotheses, do provide further illumination.

The ordering of means

and pursuant significance testing lends further support to the identification of low risk (ED) and high risk (LR) patient groups.
Projective Testing:

TAT Intimacy Motivation

All statistical handling of intimacy motivation involved twotailed probability distributions for significance testing.

This was

because of the open-ended nature of the study hypotheses for this
measure due to the contradiction in the existing literature.
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As seen in Table 7, patients' intimacy motivation as scored on
the TAT was significantly lower than that of the non-patient group,
!(1,75)

= 5.34,

~

<.05.

The absence of other significant within-

patient comparisons suggests that this lowered intimacy motivation is
a patient-wide phenomenon which is not necessarily exacerbated by
severity of disease or ameliorated by time.

A closer look at each

story across the five groups was done to help determine if any could
be found to be more discriminating than the others.

Indeed, it

appears that the third picture (trapeze), while it yielded low scores
in all groups, did discriminate patients from non-patients in a way
similar to the total (six story) score, £(78)

= 2.36,

~

<.05.

The

open field scene scores also yielded a higher patient to non-patient
difference, but the difference did not reach statistical significance.
Table 8 presents the mean intimacy motivation scores for all patients
compared to non-patients for each story.
In summary thus far, support for the polarization of early stage
patients distantly off treatment and late stage patients recently off
treatment into low and high risk groups, respectively, has been provided by the BSI phobic anxiety subscale, the IES and the GAS.

In

addition, the projective measure of intimacy motivation has revealed
an apparent reduction in need for intimacy in the cancer sample in
general.
Interview Data:

Revised Problem Oriented Record (POR)

Most of the POR was not intended for use as a dependent measure
for hypothesis testing (see Appendix A).

Its chief purposes were to
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Table 7
Planned Comparisons of Mean
TAT Intimacy Motivation Scores (! = six stories)

Non-Patients

Disease Stage

Recent

Early

Late

~ime

M=3.73
(!=15)

,!:!=5.47
(!=15)

M=4.60c
<!=30)
M=6.15a
(!=20)

Time Off
Treatment
Distant

~tage

~3.20

~4.53

(N=l5)

(!=15)

~3.47b
(N=30)

~5.ooh
(N=30)

aCl: patients to non-patients,

M=3.87c
(!=30)
~ot=4.23

a

(~60)

~(1,75)

= 5.34,

£ <.05

hc2: early to late stage patients, ~(1, 75) = 3.42, .E.< .10
cc3: recent to distant time off treatment, F = NS
C4: stage x time interaction, F = NS
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Table 8
Patient to Non-Patient Comparisons on Mean Intimacy
Motivation Scores by Story
Mean
Patient Score

Story
1. River Scene

Mean NonPatient Score

M -M
-np ,;;...:pt

t value
NS

1.83

2.15

.32

2. Open Field Scene

.95

1. 70

• 75

1.84*

3. Trapeze

.22

.85

.63

2.36**

4. Ship Captain

.18

.20

.02

NS

5. TAT 13MF

.63

.90

.27

NS

6. TAT 12M

.42

.35

-.07

NS

4.23

6.15

1.92

TOTAL

*E. <.10
**E. <.05

2.31**
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aid in systematic collection of demographic and patient treatment
information, to gather patients' retrospective accounts and ratings
of their treatment experiences which might prove to be useful in
identifying key treatment issues vis-a-vis adaptation to illness, and
to establish problem incidence rates in the post-treatment period
with the four treatment groups collapsed into one group of 60 (see
Appendix A).

That is, most of the questions asked in the POR were

not expected to show meaningful differences between patient groups.
They were intended for the most part as frequency tabulations of
target problems.
There were, however, 16 items on or added to the POR which were
designated as testable, with predicted outcomes.
summarized under three categories:

These will now be

Quality of life ratings, pre-

and post-treatment self-ratings, and conditioned symptoms (including
survival concerns).

After this summary of planned comparisons is

presented, qualitative and quantitative summaries of patient responses
to selected interview questions, with statistical handling of differences when appropriate, will be given.
Quality of life ratings.

Unlike other categories, the quality

of life category consists of patient-to-non-patient comparisons as
well as patient-to-patient comparisons.

In order to accomplish this,

non-patient participants were asked the same questions, controlling
for time by having 10 of them discuss their response to a stressful
event six months to two years ago (M
event three to seven years ago (M

= 13.4

= 67.3

months), and 10 to an

months).

It was found that non-patients, on the average, were working
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2.5 hours per week more than they had been prior to their "stressful
event."

The patient sample, on the other hand, was working 5. 7 hours

less per week than before diagnosis.
~(68)

= 1.77,

~

This difference was significant,

<,05, and the bulk of this drop in patient return to

work was accounted for by the "high risk" late-recent group.

They were,

on the average, still working 12.5 hours less than their pre-illness
levels.

The difference was significantly different (£ <.05) from

non-patients, using the least significant difference test (see Table
9).

There were no significant differences across groups in the par-

ticipants' interview ratings of sexual or marital satisfaction,
The other quality of life indicators designated for study were
three ratings of life appreciation and overall satisfaction.

On the

first question, significantly more patients (85%) than non-patients
(55%) acknowledged an increase in life appreciation,
~

<.01.

x2 (1) =

7.74,

There were no differences within the patient group on this

rating, however, though the means did order in the predicted direction
for time off treatment.

This heightened sense of life appreciation in

the patient sample is further supported by the second rating, a 1 to
10 scaling of "how much rnore" each participant appreciated life.
Mean ratings by patients (M

=

6.13) and non-patients (M

differed significantly, F(l,75)
is the POR "Life Scale" rating.

= 11.56, £

<.001.

=

3.25) also

The third rating

This asks each participant to corn-

pare the overall quality of his current life on a "-10" to "+10"
scale, with 0 as the "no change" point, to that before his illness
("two" or "sixu years ago in the case of non-patients).

Patients did not

differ from non-patients on this measure, nor did early and late
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stage patients differ from each other.

However, the patients recently

off treatment had lower ratings than those distantly off treatment
(M= 2.3 versus 4.7, respectively),

K(l,75)

= 4.80,

~

<.os. The

life scale ratings of this group recently off treatment were also
lower than non-patients (

~=

4.6), !_(48) = 1.84,

Pre- and post-treatment self-ratings.
to patients only.

~

<.05.

These four ratings apply

They include the patients' subjective sense of

current physical stamina, sleep patterns, eating habits, and concentration ability (depressive equivalents) as compared to their recall
of pre-illness functioning (Table 9).

In all cases, disturbance was

expected to be higher in the late stage and recent treatment groups.
Overall, 57% of the patient groups (34 of 60) believed that they had
not yet regained premorbid levels of physical stamina, 27% of them
(16 of 60) felt that they were sleeping worse than before their illness, 13% (8 of 60) thought they were eating worse, and 27% (16 of
60) believed they had lost some concentration ability in the time that
had elapsed.

This compares to 5% (3 of 60) who felt they were in

better physical shape now, 10% (6 of 60) who stated they were sleeping
better, 21% (13 of 60) who said they were eating better, and 17% (10
of 60) who acknowledged better concentration.

Neither disease stage

nor time off treatment was a discriminating variable for these ratings.
Because of the non-significance of the main effects, data were collapsed across groups to highlight prevalence rates of these four
problems (see Table 9).
Conditioned symptoms and survival concerns.
refers to patients only.

This section also

Therefore, a more focused 2 X 2 ANOVA was
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Table 9
Qualify of Life Ratings

(~=80)

and Patient

Self-Ratings of Depressive Equivalents
QUALITY OF LIFE RATINGS
Return to Work
(pre-post hr/week
difference)

(~=60)

Non-Patients

Patients

(~=20)

(~=60)

+2.5

-5.7
~(68)=1.77,£<.05
(-12.5 for LR's) LSD**,z<.05

Life Appreciation
--percent acknowledging
increase

55%

85%

--1 to 10 rating of
increase

M=3.25

M=6.13

(!=20)

Recent Distant
(!=30) (!=30)

Life Scale Rating
(-10 to +10)

M=2.3

!'!=4.6

E:_(l, 75)=11.56,
.E. <.001

!'!=4. 7

!.Recent vs.
Distant
E:_(l' 75)=4. 8,
.E. <.05
2.Recent vs.
Non-Pt's,
t (48)=1. 84'
.E. <. 05

PATIENT PRE-POST RATINGS OF DEPRESSIVE EQUIVALENTS
Physical Stamina*

worse
better

57%
5%

Sleep Patterns*

worse
better

27%
10%

Eating Habits*

worse
better

13%
21%

Concentration
Ability*

worse
better

27%
17%

(~=60)

*Disease stage and time off treatment did not differentiate patients
on any of these variables.
**LSD = Least Significant Difference
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performed on these particular data.

This was done in order to provide

an analysis with a more appropriate error term by eliminating the
unused non-patient group.

Each patient was asked about the presence

(scored 1) or absence (scored 0) of nausea or related gastrointestinal
symptoms to the three conditioned stimuli:

various smells (e.g.,

rubbing alcohol, cleaning fluids), being in the treatment clinic, and
"anything else" (e.g., certain foods, songs, colors, people).

Thus,

each patient received a score ranging from 0 ("no conditioning") to
3 ("conditioning in at least three areas") for symptoms of nausea.
The same inquiry and scoring criteria were applied to actual vomiting;
and to anxiety, defined as "feeling of nervousness, or being upset
emotionally but not necessarily physically."

There had to have been

an incident within the past five months for any symptom to be scored.
The three scores were also combined to yield a total conditioning
score for each patient.

Table 10 presents the summary tables of the

treatment-related conditioning data.

As the table suggests, there

does appear to be a significant lessening of conditioned symptoms over
time.

The total conditioning score was higher in the later stage

patients (p <.05).

Closer examination of the contributions to this

total conditioning score revealed quite clearly that the stage and
time effects are almost completely accounted for by the nausea score,
where both later stage patients and those recently off treatment show
significantly greater disturbance.

Actual vomiting was expectably

rare (4 of 60 patients) and therefore non-significant across patient
variables.

The fact that conditioned anxiety does not appear to drop

off significantly over time and is no less a problem in the early
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Table 10
Analysis of Variance Summary Tables for Patient Conditioning Scores
Dependent
Variable
Total Conditioning Score

Source

9.60
13.07

Interact ion
--stage x time

1

.07

56

2.89

Main Effects
--stage
--time

1
1

3.27
3.27

Interaction
--stage x time

1

.27

56

.77

Main Effects
--stage
--time

1
1

.07
.07

1.04
1.04

Interaction
--stage x time

1

.oo

.00

56

.06

Main Effects
--stage
-time

1
1

1.07
2.40

.89
2.00

Interaction
--stage x time

1

.07

.06

56

1.20

Residual
Anxiety Score

Residual
+p <.10
*.£. <.05

F Ratio

1

Residual
Vomit Score

Mean Square

Main Effects
--stage
--time

Residual
Nausea Sea re

df
l

3.32+
4.52*
.02

4.27*
4.27*
.35
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stage patients of this sample runs counter to the study hypothesis,
and will be discussed in the following chapter.
The final three planned comparisons from the FOR relate to
patients' concerns with survival as reflected in:
of how fearful they are of recurrence (1-10 scale);

1) their rating
2) the presence

of heightened attention to one's body (e.g., checking for enlarged
nodes while in the shower);

and 3) somatic anxiety, defined as "be-

coming upset over little aches and pains which never would have
bothered you before."

The mean fear of relapse rating, where 1 = "not

at all," and 10 ="extremely so," was 4.92. A two(stage)by two (time)
ANOVA revealed no significant differences among patient groups.

Re-

garding the presence of heightened health awareness (which most
patients reported was not coupled with anxiety), 85% of 60 patients
acknowledged that their awareness of their health and concern for
symptoms had increased because of their having had cancer.

The dif-

ference between early and late stage patients (with more late stage
patients being attentive) approached significance,
.10.

x2 (1)

= 3.40, £ <

Of 60 patients, 63% reported some degree of somatic anxiety when

day-to-day functioning was disrupted by minor aches and pains.

This

was especially true when no explanation could be found for a new-found
pain or ache.

Disease stage and time off treatment were not discrim-

inating factors in the chi-square analyses of these data.
A review of the planned comparisons on interview data revealed
generally solid support for the following:

1) late stage patients

recently off treatment had the greatest difficulty with work adjustment as measured by return to premorbid number of work hours;

2) all
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patients, especially those off treatment for longer periods of time,
show a heightened appreciation for life.

However, the patients

recently off treatment rated their current life with significantly
less improvement than both the non-patients and the patients distantly
off treatment;

3) all patients, regardless of stage or time off treat-

ment, demonstrated high frequencies (greater than 25%) in three out of
four of the "depressive equivalents" surveyed in the interview;

4)

conditioned nausea appears to be worse for later stage patients (as
predicted), and tends to diminish over time (as predicted); 5) conditioned anxiety does not appear to have the same predictability (and
is therefore perhaps more a trait measure);

and 6) disease stage and

time off treatment did not discriminate patients on ratings of recurrence fear, somatic self-awareness, and somatic anxiety (again
suggesting a possible trait factor).
Following is a summary of problem areas identified by the POR
interview which were not built into the study hypotheses.
will be divided into three parts:

The summary

Retrospective treatment ratings,

ratings of treatment and post-treatment difficulties, and patient
fertility data.

While not directly relevant to the study hypotheses,

these data are added here because they indirectly bear upon questions
under investigation in that they provide further information about
the concerns and experiences of patients off treatment.
Retrospective treatment ratings.

Patients were asked many

questions about their reactions to diagnosis and treatment.

For

example, they were asked to rate, on a 1 to 10 scale, the intensity
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of their reaction to their disease symptoms before they knew of their
diagnosis (!!_ = 3.12, SD

= 2.9).

This can be compared, for instance,

to their reaction to being told the diagnosis of Hodgkin's Disease
(!!_

= 6.25,

SD

3.0), suggesting something akin to a doubling of

distress when the signalling of illness becomes identified as a life
threat.

A similar comparison emerges from patients' retrospective

ratings of their view on the seriousness of their illness (1 = "nothing at all, 11 10 = "life and death" illness) at various points along
their treatment.
(!!_

= 6.73),

present (!!_

Means order downward from the point of diagnosis

to the treatment period (M

= 5.12),

and finally into the

= 2.20).

Of the three treatment modalities used (surgery is included
here) the patients' rating of emotional reaction to chemotherapy
appears to be the most highly distressed (M

= 6.0), with radiation

and surgery remembered as somewhat less distressing (M

= 4.3

and 4.2,

respectively).
Ratings of treatment and pgst-treatment difficulties.

Tables

11 and 12 are summary tables which present the percentage of patients
who acknowledged the presence of various difficulties during treatment
and in the post-treatment period.

In reference to Table 11, informal

comparison of the change in percentages, from the treatment period
to the post-treatment period, suggests there is a drop in social irritability, depressed mood, sleep disturbance, concentration difficulty,
marital discord and sexual dysfunction after treatment ends.

The

drops in sleep disturbance and concentration difficulty are less
dramatic than the others.

Also, in light of the low base-rates
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Table 11
Patient Frequencies of Symptoms and
Psychosocial Difficulties Acknowledged In- vs. Off-Treatment

SYMPTOMS

In-Treatment

Off-Treatment

Chi Square

Irritability

68%

35%

x 2 (1)=13.36***

Depressed Mood

83%

62%

x 2 Cl)= 7. 06**

Sleep Disturbance

50%

27%

xz (1)= 6.90**

Concentration Difficulty

47%

27%

xz(l)= 5 .18*

7%

10%

NS

Contact with Mental Health 17%

18%

NS

Psychotropic Medication

22%

13%

NS

Change in Relationship
with Significant Other

~rse=45%

x 2 (2)= 8.36*

better=l8%

worse=22%
better=35%

Change in Sexual
Functioning

worse=62%
better=7%

worse=l8%
better=44%

x 2 (2)=30.60***

Suicidal Ideation

PSYCHOSOCIAL DIFFICULTIES

*E.

<.05

**E. <.01
***E. <.001
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Table 12
Patient Frequencies of Post-Treatment Difficulties
in Somatic, Psychosocial, and Occupational Areas*
SOMATIC/PSYCHOSOCIAL

Post-Treatment

Symptom Distress

67%

Physical Discomfort

48%

Sexual Difficulties

18%

Sexual Dissatisfaction

55%

Negative Post-Treatment Reaction by s/o**

30% (13 of 43)

Family Problems

38%

Change in Family Relationship(s)

worse = 13%
better = 23%

Friend Problems

30%

Change in Friend Relationships

worse = 13%
better = 25%

OCCUPATIONAL
Occupational Choice Influenced by Illness

worse = 27%
better = 5%

Still in Debt

42%

Employer Treats Differently Because of Illness

14% (6 of 43)

Co-Workers Treat Differently Because of Illness

22% (11 of SO)

Out of Work Due to Illness

2% (1 patient)

*Except where indicated, all patient percentages are based upon
an ! of 60 patients.
**s/o

= Significant

Other
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suggested by the non-patient responses to these two areas (10% complained of sleep disturbance and 5% complained of concentration
difficulty), there is some indication that sleep and concentration
difficulties tend more often to continue to plague the surviving
Hodgkin's patient over time.

These conclusions are impressionistic,

based only on frequency tabulations and unplanned post hoc comparisons.
Table 12 presents only post-treatment ratings.

Two out of every

three patients have acknowledged physical symptoms which have been
distressing to them because they bring on a fear of recurrence ("symptom distress" item).

These symptoms were typically stiff neck, swollen

glands, common flu or cold symptoms, or fatigue.

One may note the

similarity of these symptoms to the B symptoms of Hodgkin's disease.
Nearly half (48%) of them have complained of some physical discomfort,
which many of them attributed to lingering chemotherapy or radiation
effects.

Nearly one in five, as compared to none of the non-patient

sample, have acknowledged significant post-treatment sexual readjustment difficulty, but most felt they had overcome this by the time of
the interview.

Neither disease stage nor time off treatment were

associated with varying frequencies in these areas.

The 55% frequency

of sexual dissatisfaction in the patient sample (see Table 12) is
compared to a figure of 65% in the non-patient sample.

Thus, this

high figure is probably more a function of the suggestive nature of
the question than of any unusually high prevalence of sexual dysfunction.
As

Table 12 illustrates, psychosocial problems with family and
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friends were not numerous.

What is more, many of those patients who

experienced them felt they had overcome their difficulties by the.
time of the interview.

What was more striking was the fact that one-

fourth of the sample felt that the experience of cancer had brought
them closer to certain friends and family members.
it:

As one patient put
to see who I

"It forced me to set my priorities in people.

really cared about and tell them."

Such relationships were commonly

seen in the post-treatment period as much more solid because of the
heightened intensity of the relationship during the treatment period.
Regarding the occupational area, three patients changed careers
in a positive way because of their illness.

One, for example, took

up nuclear medical technology because he was so fascinated by the
radiation treatment process.

However, 27% of the men felt that their

careers had suffered in some unmeasurable (often unprovable) way.
Most such men would comment on the fact that they have avoided career
risks in favor of the security (i.e., insurance benefits) which their
pre-morbid job provided.
expenses.

}~ny

were still in debt for incurred medical

Very few people felt their employers or co-workers treated

them overtly differently because of their illness.

Of those who did,

the "different" treatment was usually in a more favorable direction
(e.g., not making him work as hard, being more understanding about
days off, etc.).

In conclusion, then,

very few complained of

overt discrimination or occupational mistreatment, but a substantial
number lamented what they perceived as missed career opportunity
because of their own felt need to retain job security.
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Patient fertility data.

This section will close with a brief

summary of the data collected on patient fertility.

As indicated_by

the fact that 62% of the patients interviewed would like to have
children, and by the patients' frequent admission of distress in this
area, the issue of compromised fertility in young men treated for
Hodgkin's disease is a critical one.

This study's finding that 90%

(20) of the 22 patients who had recent sperm counts remain sterile is
in agreement with the sterility figures of the Redman study (Redman,
1983) and others.

The 38 patients who had not been tested for fer-

tility were asked their current belief on their own status (see Table
13).

A great proportion of them (61%) believed that they had either

regained or had never lost fertility.

It is unclear whether this is

due to patient optimism, lack of information, or the result of a
doctor-patient relationship in which patients are encouraged to think
positively.

The level of distress measure in Table 13 refers to the

entire sample of patients, giving their rating (1-10) of how upsetting
their sterility is to them as well as to their significant other
(when the patient had a significant other).

The scores presented

are underestimates in that there were some patients who were extremely
upset by this (e.g., six "10" scores).
Conclusion
The self-report measures, particularly the Impact of Events
Scale, the BSI Phobic Anxiety subscale, and the DSFI Fantasy subscale,
provided a small degree of support for the study hypotheses, and
somewhat more evidence for a justified grouping of high risk (late-
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Table 13
Patient Fertility Data

Number of Patients Who Want Children in the Future
Sperm Count Data:

Patients Tested as Fertile

62% (37 of 60)
3% (2 of 60)

Patients Tested as Sterile

33% (20

Patients Not Tested

64% (38 of 60)

0

f 60)

Untested Patients' Belief in Their Fertility:
Believe Fertile (actual probability
= .10)

61% (23 of 38)

Believe Sterile (actual probability
= .90)

34% (13 of 38)

Won't Say

5% (2 of 38)

Mean Sterility Distress Rating (1-10 Scale)
Patients

2.8

Patients' Rating of Significant Other

2.7

1~

recent) and low risk (early-distant) patients.
by the Global Assessment Scale.

This was corroborated

Projective testing and interview

responses, on the other hand, have given much stronger support for the
following conclusions about Hodgkin's disease patients in general:
1) lowered capacity for intimacy in personal relationships;
heightened life appreciation which increases over time;

2)

3) high in-

cidence of symptoms which are possible depressive equivalents;

4) a

trend toward lessening of these and other symptoms and difficulties
over time;

5) significant post-treatment conditioned nausea which

abates over time;

and 6) significant post-treatment conditioned

anxiety which does not lessen significantly over time.
It was asserted at many points in this chapter that the mean
differences on various dependent measures, while not significant,
were aligned in the predicted order.

Because it seemed that the

predicted ordering of means occurred more often than expected by
chance, a post hoc analysis of the data was performed.

Essentially,

this entailed calculation of a z score based upon the binomial probability of achieving significantly more predicted mean-orders than
attributable to chance.

This analysis was done for all hypotheses

which applied to patients and non-patients.

TAT data were not in-

cluded because their hypotheses were not unidirectional.
A binomial z (Siegel, 1956) was calculated for both independent
variables, disease stage and time off treatment.
three levels:

Each variable had

early (E), late (L), and non-patient (NP) for stage;

and recent (R), distant (D), and non-patient (NP) for time off treatment.

There were 25 comparisons with unidirectional hypotheses which
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included non-patients:

Four in the interview, 15 on the DSFI (in-

cluding the BSI), three on the IES, and one each for the DAQ, RSES,
and GAS.
For the disease stage variables, eight of the 25 sets of mean
orders were in the predicted direction.

Chance probability would be

one in six, so
z

=

8 - 1/6(25)
--=----:--:----,--,--

125

X

1/6

X

= 2 • 06 (E. < • 05)

•

5/6

For the time off treatment variable, 10 of the 25 sets of mean
orders were in the predicted direction, so
10 - 1/6(25)
z =

-_--=----==----_---:-:--:-;---

_r.;:-_-;::__

lz5

X

1/6

X

= 3.13(_p_

<.05).

5/6

Thus, the trends noted throughout this chapter receive some
secondary statistical support.

While differences between means, even

when correctly ordered, rarely showed significance (except in the
interview material), the fact that the means arrange in the predicted
order far greater than chance expectation lends credence to the notion
that the impact of cancer and its treatment upon the individual, while
often subtle, is apparent and demonstrable.

DISCUSSION
The present study has provided a comprehensive overview of adaptation to survival from cancer.

Globally, the results of this study are

heartening in that very little severe psychopathology in the patient
sample was uncovered by the self-report measures, experimenter ratings,
or interview data.

In fact, the majority of patients acknowledged a

heightened sense of life appreciation and purpose as a result of the
cancer experience.

However, one must also note the significant adapta-

tional difficulties and moderate disruptions identified by this study
which balance if not outweigh the growthful component of the experience.
The findings of this study agree only in part with three disparate
conclusions about cancer survival gleaned from the literature:

1) that

cancer survival is associated with heightened psychosocial and psychosexual dysfunction (e.g., Holland, 1981,
1981);

1982b; Koocher & O'Malley,

2) that cancer survival is associated with greater life apprec-

iation and character growth (e.g., Kennedy et al., 1976);

and 3) that

cancer survival is not associated with significant change in either a
positive or negative direction (e.g., Craig, Comstock, & Geiser, 1974;
Holmes & Holmes, 1975; Li & Stone, 1976).

As the bulk of the literature

review had suggested, there appears to be some amount of truth in each
of these assertions.

At the same time, however, these assertions cannot

be offered without exceptions and qualifications.
The severity of disease at the time of diagnosis and the amount of
time elapsed since the termination of treatment both showed themselves
106
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to be important factors in selected areas of psychological functioning
and basic well-being.

This was demonstrated most convincingly when

these two factors were combined to create, out of four patient groups,
a "low risk" group (early stage at diagnosis-distantly off treatment)
and a "high risk" group (late stage at diagnosis-recently off treatment).
That is, there was substantial evidence for high risk patients showing
more adaptational difficulty than low-risk patients.
This discussion will elaborate upon these general conclusions,
and speculate about the adaptational challenges of Hodgkin's disease
survival.

To accomplish this, the study results will be presented in

two sections:

differences between patients and non-patients, and dif-

ferences within the patient group across independent variables of disease stage and time off treatment, including the prevalence of problems
within the patient group in general.
Differences Between Patients and Non-Patients
Of 25 planned comparisons between patients
patients(~=

(~ =

60) and non-

20), five produced statistically significant results.

Many of these comparisons were made possible by the anchoring of nonpatient responses to past stressful events in their own lives.
these five significant results were "positive" findings:

Two of

that more

patients displayed a heightened appreciation for life in the post-treatment period when compared to non-patient self-ratings, and that the
extent of increased appreciation for life was significantly greater in
the patient sample.

These findings are consistent with those of Kennedy

and colleagues (1976) as well as Shanfield (1980).

This suggests that
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the cancer experience acts as a catalyst to mobilize awareness of one's
mortality and subsequent improved attitude toward life.

The presence of

heightened life appreciation in the successfully treated cancer patient
is not one which is greatly contested in the literature.

The more con-

troversial issues are with regard to the presence or absence of other,
more disruptive consequences which can significantly hamper the quality
of the survivor's post-treatment life.
To the extent that quality of life can be measured by return to
pre-morbid work functioning, there would appear to be significant disruption.

Patients (especially late stage recently off treatment) showed

far greater difficulty returning to work after treatment than nonpatients did after comparison trauma.

Granted, the stressors for the

non-patient group, such as divorce, physical injury, or death of a loved
one, do not match the intensity of the stress of diagnosis and treatment of cancer.

However, in defense of the conclusion of hampered

return to premorbid work level in cancer patients, one goal of this
study is in fact to establish that these stressors (diagnosis and treatment)

constitute something more intense than the non-patient group's

various stressors.

Further support was lent to the conclusion that

post-treatment work functioning suffers by the observation that 27% of
the patient sample admitted to choosing job security over potential
career advancement because of the insurance and employment risks involved
in career change.
Another major finding was that patients demonstrated significantly
more avoidant thinking on the Impact of Events Scale.

Again, this is
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tempered by the fact that patients and non-patients had anchored their
responses to very different stressful past events:

Patients to their

cancer diagnosis and non-patients to a variety of physical and psychosocial events.

It was the intention of this study to investigate the

notion that the stress of diagnosis and treatment of Hodgkin's disease
continues through the survival period to inflict demonstrable demands
upon the person's adaptational capabilities.

Thus, when patients off

treatment for one (and even five) years use more avoidant thinking with
regard to their illness than non-patients do with regard to other
(albeit milder) past stressors, it is safe to say that the patients in
this sample still show a strong tendency to defend themselves against
the potential disruption which could result from thinking about their
treatment experiences.

While true of all patients, this was most true

of those recently completing treatment, suggesting a tapering, though
not elimination, of avoidant thinking over time.

Intrusive thinking

seems to taper more quickly, as demonstrated by the high intrusion subtest score for late stage-recent patients as opposed to very low scores
in the early stage-distant group.
While avoidant thinking is not strictly the same as denial, the
observation that patients in general tend to use avoidant thinking is
consistent with previous reports of denial as a principal coping mechanism in cancer adaptation (e.g., Hackett & Weisman, 1969; O'Malley et
al., 1979).

It would also appear that the hypothesized lifting of

denial in the service of integration as the survival period extends
received little support in that patients distantly off treatment tended
to be less avoidant but less intrusive than those recently off
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treatment.

The early stage patients distantly off treatment had signi-

ficantly less intrusive breakthrough than the late-recent group in particular and all patients in general.

This suggests that the group

distantly off treatment does not show more psychiatric symptomatology,
however, as might have been predicted by Derogatis, Abeloff, and Melisaiatos (1979), or by Rogentine and others (1978).

The formulation of

Koocher and O'Malley (1981) and Weisman and Worden (1976-77) seem to
fit this study's data better.

They would suggest that denial is impor-

tant in the beginning stages of cancer diagnosis and treatment, and
that it gradually lifts, while the patient paces his integration of the
experience according to his capability.

Actually, optimal denial might

be better termed "suppression," as it involves the capacity to identify
distress yet minimize it through activity and gradual integration.
Vaillant (1976), in his discussion of the dynamic development of character and defense structure, has also identified this defense of suppression as particularly adaptive and healthy in the face of stress,
as it combines awareness of difficulty and conflict with stoicism and
mastery.
Another significant difference between patients and non-patients,
and what is considered to be a major finding of this investigation, was
that patients were found to have lowered intimacy motivation, as measured by their projective story-telling.

There were no differences with-

in the patient group, suggesting this is a patient-wide decrease.

This

result was also corroborated by informal comparison of patient mean
scores to normative sample mean scores on those pictures (river, field,
trapeze, ship) which had nofmative data available (McAdams, 1981).
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In its broadest sense, this result would suggest that a constricpar~

tion of one's availability for warm interpersonal exchange is

of

the lingering aftermath of successful cancer treatment in young men.
A speculative explanation for this could be that the cancer experience
sets these young men apart from their peers and age-mates, and that this
sense of separateness can have a socially isolating effect.

In tl:e

interview, many patients stated that the ordeal of cancer and their
struggle to conquer it gave them a feeling of superiority over others.
They felt special, at times even "chosen" to live on.

One patient in

his mid 30's likened the ordeal to his Viet Nam experience.

He felt

embroiled in battle with his disease, and developed special, very close
relationships with his treatment staff.

However, just like a soldier

returning from war, he realized upon re-entry to "normalcy" that he had
been changed by the experience, and he did not seem to fit in.

He came

to feel that anybody who was not with him during the treatment could
never really understand its impact.

It is conceivable, then, that this

displaced but special feeling may contribute to difficulty engaging in
satisfying interpersonal relationships, especially in young men who do
not go through treatment with a significant other close at hand.
Another possible explanation for lowered intimacy motivation in
the patients could relate to apprehension and uncertainty in the face of
disruptions of their role functioning.

As suggested by Kennedy and

others (1976), Leiber and others (1976), and Sutcliffe (1979), and
referring to Erikson's (1950) general comments about young adulthood in
men, the impact of cancer and treatment upon a young man's role functioning may indeed show itself through interpersonal constriction.

These
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investigators would agree that the dependency and passivity induced by
cancer treatment constitute an impetus for counterdependent maneuvers
in the service of denial of need and reinforcement of masculine role
functioning.

It would make sense, then, that these men would tend to

constrict their motivation toward interpersonal warmth and closeness,
as a protection against the threat of the passive patient role.

Why,

then, would so many of them say that their relationships with their
wives has improved (35%), or that they feel genuinely closer with their
extended family (23%), since treatment ended?

It may be that some men,

especially those who begin the treatment ordeal with strong object ties,
actually experience enhancement of their interpersonal lives without
threat to their role-related self-esteem.

This would be consistent with

Weisman's (1975) finding that satisfying and constructive interpersonal
relationships during and after treatment were associated with longer
survival time.

On the other hand, those who are either single or un-

happily married might experience drops in intimacy capacity of a proportion great enough to lower the grand mean of all 60 patients on intimacy motivation.

The fact that 22% of patients believed that their

relationship with their significant others had worsened since treatment
ended, and that 38% experienced "family problems,'' might indirectly
support this formulation.

As one patient's wife said to the investigator

upon completion of the patient interview:

"You should interview the

spouses in this study; then you'd really find out how miserable these
patients are to live with."
In a similar vein, it is possible that the experience of dependency
and surrender in personal relationships is threatening to the post-
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treatment patient in that it bespeaks a return of the vulnerability to
illness felt during treatment.

It would make sense, then, that self-

report measures of death anxiety, somatization, and psychosexual functioning, which are under more conscious control than projective measurement of intimacy motivation, would not be significantly different than
in non-patients, because patients would be invested in denying this
vulnerability.

It is conceivable that this TAT projective test

measure was necessary to detect this somewhat subtle but important distinction between cancer survivors and age-matched men.

Another study

result which is consistent with this was the trend (£ <.10) toward
patients' displaying a more constricted sexual fantasy life on the DSFI
(early stage patients were significantly lower than non-patients,

E

<.05).

There is, then, accumulating evidence for a post-treatment interpersonal
withdrawal and constriction which is probably subtle and non-pathological, and therefore indicative of normal psychological adaptation to cancer survival in young men.
Other non-significant patient versus non-patient trends in this
investigation included:

1) patients' mean global assessment scores of

psychological functioning tended to be lower than non-patients;

2)

patients' mean somatization, phobic anxiety, and paranoia BSI subtest
scores tended to be higher (more impaired) than those of non-patients;
and 3) while patients and non-patients did not differ from each other
on the extent of psychological symptomatology in the DSFI (BSI-GSI),
both groups scored significantly higher (more impaired) than the test's
normative sample, with means differing by one full standard deviation.
The first trend noted speaks for itself:

patients off treatment
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(means within the patient group ordered as predicted) tend toward global
psychological dysfunction when compared to an age-matched sample .. The
fact that the rater was hypothesis-wise, however, casts doubt upon this
as an impressive result without corroborating evidence.

Some such evi-

dence is suggested, though, by the second and third trends noted above.
It is interesting to note that these subtests of the BSI which seem most
sensitive to patient/non-patient differences are ones which are disease
and recurrence related.

Somatization, phobic anxiety, and paranoia

are a cluster of symptoms which might depict a chronic state of apprehension and vigilance toward body concerns.

This idea, that patients

off treatment seem to be engaged in measurable, though subtle and nonpathological, amounts of constant concern over their bodies also received some support in the POR interview.

Specifically, 67% of all

patients acknowledged feeling distressed over the presence of symptoms
which remind them of their illness during the off-treatment period.
More than 80% reported a conscious increase in self- and body-awareness
with regard to physical health.

Nearly half of them have complained of

generalized post-treatment physical discomfort, and 57% complained of
decreased physical stamina which has lingered on in the months and years
following treatment.

They also readily admitted that the potential for

relapse is a chronic concern of theirs, although this fear does not
generally intrude upon their daily functioning.
To summarize, then, it would seem that the patients in this study
are living with a chronic, low-grade awareness of their physical vulnerability and life's uncertainty which results in heightened vigilance
toward their body.

Just as with the apparent lowering of intimacy
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motivation, this heightening of self-awareness and attention to one's
body appears subtle;

to an extent which does not seriously threaten

the overall psychological health of the successfully treated patient.
Putting these two observations together in a simplistic way, one can
speculate about a slight retraction of oneself from others and a trend
toward increased focusing of oneself upon one's body, during the cancer
survival period.
A final comment in this section refers to the observation that
patients and non-patients scored one full standard deviation above the
BSI normative sample on psychological symptomatology.
tions for this will be proffered.

Three explana-

One possibility is demographic, that

the age and geography of the current sample is different from the normative.

Norms for the BSI were collected on a combined urban and subur-

ban population in the Baltimore, Maryland area.
tive sample was 45.

Mean age of the norma-

The study sample was derived from the New York

metropolitan and surrounding area.

Their mean age was 31.

It is con-

ceivable that somewhat higher psychological symtomatology is normative
in the faster-paced New York City area.

Also, increasing age could be

associated with decrease in symptomatology.

Both of these demographic

explanations are weak, however, because other DSFI and BSI subtest
scores did fall within one standard deviation of the normative mean,
and because the idea of lessening psychological symtomatology from age
30 to age 45 runs counter to established developmental psychological
theory (Levinson, 1978; Vaillant, 1976).
A second possible explanation for elevated psychological symptomatology in both patients and non-patients when compared to normative
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data is that the small sample size of non-patients has resulted in
inflation of the group's mean score owing to the influence of one_or
two outliers in this small group.

While it is true there were two non-

patients who scored quite high on the BSI-GSI, the variances of the
patient and non-patient samples did not differ significantly, suggesting that this also is an inadequate explanation.
The third possibility would of course be that both patients and
non-patients truly have elevated psychological symptom profiles, which
fall between normalcy and the mean for the BSI psychiatric outpatient
sample.

Recalling that the non-patient group was selected by asking

patients to pick "men like (themselves), of similar age," this possibility is quite conceivable.

The experimenter attempted to be method-

ologically conservative by selecting non-patient comparison subjects
lvho were "informally matched for similarity" to the patients.

Perhaps

successful matching has been verified by these mutually elevated symptom
profiles.

The price paid would then be a false negative study result.

This would imply that there is in fact an elevation of psychiatric
symptomatology in the successfully treated Hodgkin's patient during the
years off treatment.
In summary, the patient to non-patient comparisons revealed little
evidence for severe psychopathology

i~

the cancer sample.

However~

there

were clearly some unique concerns and adaptational difficulties within
the patient group.

Some of these included lowered intimacy motivation,

continuation of avoidant thinking toward their illness, and elevation
of disease-related concerns.

While exploration of these patient to non-

patient scores has been of great interest, it was recognized from the
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inception of the study that separate control of factors such as disease, specific diagnosis, and treatment would be impractical.

Thus,

patient to non-patient comparisons have been viewed as a relatively
loosely controlled inquiry into the general experience of past cancer
and treatment taken together.

The core of the investigation, however,

related to the patient group only.

In a more tightly controlled design,

the 60 patients were separated into four cells identified by the two
(disease severity) by two (time off treatment) factor matrix.

This

allowed the experimenter to examine closely the effects of disease
stage (early vs. late) and time off treatment (recent vs. distant), upon
the same dependent measures, within the patient group.

The next section

will summarize the findings of this more carefully controlled inquiry.
Differences Within the Patient Group
In the most global sense, the preponderance of non-significant
findings on self-report measure comparisons would suggest that substantial differences do not exist between early and late stage patients
or between patients recently and distantly off treatment.

If one were

to judge the impact of patient variables solely on the basis of planned
significance testing, the conclusion of very little difference would be
justified.

However, it was noticed that many of the differences between

patient groups, while not statistically significant, were in the predicted direction.

The two independent variables within the patient

sample were disease (or treatment) severity and time off treatment.

It

was predicted that late stage patients would appear more disturbed than
early stage patients, who in turn would appear more disturbed than nonpatients.

Similarly, it was hypothesized that patients recently off
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treatment would be the most disturbed, followed by patients distantly
off treatment and non-patients, in that order.
The post-hoc binomial
dependent variables,

~

calculations demonstrated, for both in-

the presence of a subtle impact.

The ordering

of mean scores across the three levels (non-patients included) of each
independent variable occurred in the predicted direction more often
than attributable to chance.

Therefore, while not of primary statis-

tical significance, the numerous correct orderings lend indirect
support to the hypothesis of mild, subtle impairment in all patients.
This impairment would seem to be slightly greater in later stage patients as well as in those patients recently off treatment.

It may be

that larger sample sizes would be sufficient to boost some of these
non-significant trends to significance.

Alternatively, these trends may

be further evidence for only mild, non-pathological disruption of
psychological functioning.

This reaffirms the adaptational model of

understanding survival, which emphasizes dynamic change within normal
limits;

change which assimilates external insults and reorganizes

internal psychic structures to accommodate new demands (Silberfarb,
1982; Sutherland, 1956; White, 1976).
The self-report measures proved useful in the affirmation of low
risk and high risk patient groups, in many cases where early stage
patients distantly off treatment (low risk) were compared to late stage
patients recently completing treatment (high risk).

Global psycholog-

ical adjustment (GAS s-core), intrusive thinking about diagnosis and
treatment, phobic anxiety, and depressive symptomatology were all
significantly more impaired in the high risk group.

This appears

119
sufficient to identify late stage Hodgkin's disease patients in the
first two years off treatment as at significant risk for measurable
psychosocial maladjustment.

The reader may recall that the high risk

group showed the greatest difficulty returning to full-time work, even
when compared to all 45 other patients.

The fact that all patients

recently off treatment, including early stage patients, rated their
current life situation as significantly lower than patients distantly
off treatment (and non-patients as well) on the FOR Life Scale Rating
is considered to be a related but more general result in that it
applied to all patients recently completing treatment.
In summary of the low risk-high risk distinction, the study results suggested that disease stage and time off treatment only tended
to differentiate patients (as seen in the
tion).

post hoc binomial z calcula-

However, the identification of high and low risk groups based

on these two factors in combination was justified on the basis of
quality of life and coping style differences.
additive effect of these two variables.

This would suggest an

So, for example, having had

severe disease and treatment may not be accompanied by significant disruption three to six years off treatment, but it represents a much more
palpable vulnerability in the first two years following treatment.
This does not seem to be as clearly the case for earlier stage disease,
Where fewer dependent measures were elevated, even in the recently-offtreatment condition.

The wake of the treatment ordeal does appear to be

more problematic for later stage patients.
One exception to this low risk-high risk distinction was the study
data on conditioned symptoms.

Compared to all early stage patients,
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all late stage patients had significantly more conditioned nausea to
treatment-related stimuli such as rubbing alcohol, perfume, cleaning
fluids, and sights of the hospital or clinic setting.

This makes clear

intuitive as well as theoretical sense, since conditionability has been
associated with severity of the unconditioned stimulus, in this case
the severity of treatment (Morrow, 1982).

Evidence for the tapering,

though not elimination, of conditioned nausea over time was provided
by the study's determination that patients recently off treatment had
far more conditioned nausea than those distantly off treatment.

This

again confirms intuition and conditioning theory on extinction (Redd,
Burish, & Andrykowski, 1983).

The removal of the noxious unconditioned

stimulus (treatment) results in repeated exposure to the associated
(conditioned) environmental cues alone (smells, usually).

The passing

of time, and repeated exposure to the now-unpaired stimulus (i.e., the
conditioned stimulus is experienced alone, without the unconditioned
stimulus) results in the depotentiation of the learned associated.
Therefore, patients appear to be able to "unlearn" most of their conditioned nausea.
It was mentioned that smells usually mediated the conditioned
nausea.

This has often been recognized as the chief mediator of con-

ditioned nausea (Love, Nerenz, & Leventhal, 1982; MOrrow, 1982; Redd &
Andrykowski, 1982).

It may in fact be that this smell-mediated con-

ditioning, because it is so visceral in its connection to taste and
gustatory function, is not only the most learnable (Love, Nerenz, &
Leventhal, 1982) but also the most "unlearnable."

This is suggested,

in part, because of this study's determination of no reduction over

121
time in conditioned anxiety, which is more sight-mediated.
then, that the gradient of extinction of
steep than that of conditioned nausea.

.
conditioned anxiety

It seems,
is less

This would imply that, given

enough time, the strength of the association between now harmless cues
and anxiety will diminish.

There are three problems with this argument.

First, the constant pairing of conditioned and unconditioned stimuli
in treatment would be more likely associated with rapid extinction off
treatment because of the weak nature of this pairing schedule.

Second,

considering that taste aversions are among the most resistant to extinct ion (Redd

&

Andrykowski, 1982), one might conclude that this is an

example of that principle.

The problem with this reasoning is that

conditioned nausea, which did show significant extinction, is more
taste-mediated than anxiety.

There is a third weakness in the conclus-

ion that the anxiety measured in the patient sample represented truly
conditioned anxiety which is slow to extinguish.

This is that late

stage patients (who were treated far more aggressively) were no more
anxious than early stage patients.

If this were simply a learned

response to noxious treatment, one would have expected more aggressively treated patients to have learned more powerful associations to reminders of that treatment, as was the case with nausea.

This did not

happen with anxiety.
These flaws in the conceptualization of post-treatment anxiety
as a conditioned response which is resistant to extinction lead to
speculation about an alternative explanation.

It may be that post-

treatment anxiety is a trait characteristic and therefore evenly distributed across patient groups.

That is, patients who are anxious upon
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entering treatment experience further anxiety in response to cues
associated with noxious treatment.

This anxiety would not then be ex-

pected to diminish significantly over time, because it is as much a
reflection of premorbid disposition as it is recent conditioning.

In-

deed, patients who are more anxious upon entering treatment may be at
higher risk for increase and continued elevation of treatment-related
anxiety.

The data from this study do not resolve this question, so only

speculation is possible.

It has been shown elsewhere, however, that pa-

tients who are anxious upon entering treatment are more easily and more
strongly conditioned than those who are less anxious (Holland, 1982b;
Love, Nerenz, & Leventhal, 1982).
In summary of the data on conditioned nausea and anxiety, evidence to support lessening of conditioned nausea in less aggressively
treated patients and with the passing of time was quite convincing.
The data fit very well that which would be predicted by learning theory
and previous literature on the factors which contribute to conditioning.
On the other hand, the data for conditioned anxiety do not fit this
paradigm.

Patients were undiscriminable as to disease stage and time

off treatment.

Given the prevalence of anxiety in the sample, it is

suggested that "conditioned 11 anxiety may in fact better be understood
as trait-related anxiety exacerbated by the treatment experience rather
than strictly a learned response.
expected to manifest more

11

Such patients, incidentally, might be

conditioned 11 nausea than the non-anxious

patients, since pre-treatment anxiety has been associated with increased
risk of conditioning while in treatment (Holland, 1982b; Love, Nerenz,

& Leventhal, 1982).

This is potentially a very fruitful area for
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future investigation.

It would be very useful to know if patients at

high risk for extended off-treatment anxiety related to treatment
reminders can be predicted on the basis of pre-treatment anxiety.
This section will conclude with a discussion of the prevalence of
psychosocial problems surveyed in the patient sample which might relate
to depression or negative affects in particular.

The term "depressive

equivalents" was used in this study to refer to symptoms or difficulties not typically identified by the lay public as reflecting negative
affective states.

It was hypothesized that whereas patients might

deny depression overtly (or even be unaware of it themselves) in an
effort to look good, they would have less of an ability to deny depressive equivalents if unable to recognize them as such.
When patients' current off-treatment ratings were compared to
their own retrospective in-treatment self-ratings, they were found to
be significantly less irritable and depressed, and to be having much
less difficulty with sleep and concentration.

This is hardly surpris-

ing, given the clear disruption to smooth life functioning which treatment can impose.

Across-patients comparisons were somewhat different.

Patients recently off treatment were no more depressed or symptomatic
than those distantly off treatment (Table 9).

This runs counter to

the conclusion of D'Angio and Ross (1981) which states that psychological distress drops over time.

On the other hand, the fact that they

were also no less depressed or symtomatic is in disagreement with
other findings (Derogatis et al., 1979; Rogentine et al., 1978).

Thus,

this study's results of patient ratings on "depressive equivalents"
suggested neither increase nor decrease of symptomatology over time or
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across disease severity.
While there is no way of confirming this with normative or cornparison group data, the frequencies of patient symptomatology seem high.
An incidence rate of 57% complaining of decreased stamina is striking,
although not as high as the Greenleigh Associates' (1979) 93%
figure.

This is especially significant in light of the on-

cologist's contention that toxic chemotherapeutic and radiologic physical aftereffects should be eliminated within the first six months off
treatment.

Sleep disturbance and concentration difficulty were

problematic in just over one-quarter of the patient sample (27% each).
The fourth "depressive equivalent, 11 eating habits, was only problematic
in 13%, and had actually improved in 21% of patients.

One speculative

explanation for high incidence of fatigue, sleep difficulty and concentration difficulty, along with low incidence of eating disturbance
is that of the four functions mentioned, eating is the one which
probably has the most conscious control.

Thus, the recovered patient,

in an attempt to "do something" in order to adapt to his situation and
counteract chronic uncertainty and potential dysphoria, might embark
on a course of improved nutrition.

Frequently, patients would comment

that they had made concerted efforts to continue their struggle against
poor health in general and relapse in particular by seeking nutritional
consultation and change in eating habits.

Eating well is something

they can do to stay healthy (and deny dysphoria), while sleeping well,
feeling strong, or concentrating effectively are not so easily done.
The exploration into depressive equivalents was undertaken as an
indirect inquiry into negative affects in the surviving cancer patient.
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It appears that adaptation to cancer is truly multidimensional and it
is therefore difficult to identify clear generalizations.

The exper-

iences of diagnosis, treatment, and then extended remission constitute
major events with probable far reaching consequences.

In order to

highlight this conclusion, the next section will present three brief
case vignettes which exemplify the different vicissitudes of adaptation
and adjustment.

This will be followed by the final section which makes

suggestions for future research.
Case Examples
The first gentleman, John (a pseudonym), is a 32-year old single
man, three years off treatment for late stage illness.

By his own

description, he was an anxious, self-involved "neurotic" prior to his
illness, who had been in psychoanalytic psychotherapy for two years
before diagnosis.

He had many friends but felt close to nobody.

ing treatment he was extremely anxious and fearful of death.
veloped severe anticipatory nausea and vomiting.

Dur-

He de-

As he began to get

positive signs from his physician, that he was free of any evidence of
disease, for example, he started to feel quite proud of himself and
internally strengthened.

When treatment ended, he threw himself into

his career as a film maker and teacher.

He cut off contact with many

acquaintances and focused his energies into deepening friendships which
were more important to him.

After agreeing with

his therapist, he

terminated his therapy one year after cancer treatment ended, resolving
that he had accomplished a satisfactory amount.
John rated himself presently as more self-confident and content
than ever in his life.

As he put it, "the sense of worth I got from
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beating this illness taught me to like myself more and accept myself.
I'm not so picky about things anymore.
ently now.

And I choose my friends differ-

I look for respect and support."

paints a positive adaptational picture.

This vignette no doubt

However, there was evidence of

continued conflict in the area of fertility.

During the interview, he

joked that the experimenter's questions about his infertility and desire
for children were upsetting the balance he had achieved to date:
not ready to deal with that one yet," he said.

"I'm

"It's still a budding

issue for me now, so I can't talk about it too much or it'll upset me
and i t will be your fault (laugh)."
The second case is a 39-year old married man with three children
who will be called Michael.

Michael is a man with early stage disease,

off treatment for seven years.

He has a long premorbid history of

chronic dysphoria and low self-esteem.

His father was an alcoholic and

mother was described as particularly ungiving, demanding, and unaccepting.

Michael was married and had three children at the time of diagno-

sis.

He was a passive, dutiful husband who felt trapped in an office

job which he loathed but could never leave because of his sense of
responsibility.

As he put it, "I have always felt that my purpose in

life was to do people favors and keep them happy."
When Michael heard of his diagnosis he hardly reacted.
figured I'd see what would happen.
it in stride."

It didn't really upset me, I took

During treatment he became fascinated with the technol-

ogy of the radiation therapy
career change.

"I just

equipment~

and this fascination fueled a

When treatment ended, he went on public aid (against

his wife's wishes) so that he could study nuclear medical technology:
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"It was the first thing I really did just for me.

No one could under-

stand it, but like one of my friends told me, it's too bad I had to
almost die to get out of the work I hated."

Michael's essentially

dysphoric character was relatively unchanged by the impact of cancer
and treatment, but the cancer experience did apparently free him from
the long-felt shackles of job dissatisfaction.

He is now a successful

nuclear medical technologist.
The third case example, Timothy, is a 29-year old physician with
early stage disease, 11 months off treatment.

Timothy is single and

lives with his parents and younger brother in a suburban home out of
which he practices.

He agreed to participate in the study because he

felt he owed it to his treating physicians, but the prospect of discussing his reactions to his illness frightened him.

He had no signi-

ficant premorbid psychiatric history, but has had a spectrum of difficulties which began in treatment and have persisted until the time of
the interview.

For instance, the repeated intrusion of suicidal

ideation while driving his car and standing in high places troubled
him during the treatment and early post-treatment periods.

Related to

this obsessional reaction was the recent emergence of a need to be sure
all his bureau drawers are closed whenever he gets an article of clothing.

Symptoms such as this emerged unpreceded by evidence of a pre-

morbid obsessive-compulsive disorder.

Recurring nightmares with

repressed content also still occurred once or twice per month.

When

asked how he knew the nightmare was recurring if he could not recall
the content, Timothy explained that the feeling he has upon awakening
is the same.

When he wakes up from these nightmares, his thoughts are
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invariably "of cancer and death."
In a follow-up phone call to Timothy two weeks after the interview, he stated that the interview and testing were difficult experiences for him.

The three-hour session revived intense anxiety feelings

he had just begun to master in the past three to six months.

He added

that the disturbance he felt from the interview was ephemeral, lasting
two to three days, and that things were now back to normal.

"Normal"

for him is a state of steady reorganization and restabilization which
finds him gradually able to be more focused on his work and personal
life as time goes on.

His practice had been cut to three days per

week, but he hoped to be up to full time within another year.
One can see from these three case examples that the impact of
cancer and treatment is not universally similar and is largely determined by personal character and predisposition as well as life circumstances.

As

the study data also indicated, it is difficult to accur-

ately generalize about the cancer experience.

Much of adaptation

to survival seems to be determined by individual differences in coping
style and interpretation of the meaning which the illness carries.
Future research in this area could be very useful in more clearly
identifying the factors contributing to poor adjustment to cancer survival.

Some suggestions for further investigation are offered in the

next section.
Suggestions for Future Research
The results of this study, as well as the literature review
which preceded them, point to certain need for further investigation
into the area of psychosocial adaptation to cancer survival.

This
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study attempted to add to the fast-growing base of data by introducing
the following unique characteristics:
nostic group and sex;

Focused study of a single diag-

and isolation and examination of the effects of

disease stage and time off treatment upon adaptation to survival.

It

would be quite valuable, then, to extend the inquiry, first to female
Hodgkin's disease patients, then to other age groups in order to determine the replicability and generalizability of this study's findings.
Second, it would be useful to study other diagnostic cancer groups,
preferably those with comparably favorable prognoses first.
then

It will

become interesting to study survivors of poor prognosis cancers,

to see if they might look more psychologically troubled.
It has been emphasized that patient-wide generalizations about the
long-term sequelae of successful cancer treatment are difficult to make.
Some of the patient variables which seem to contribute to adaptation
are the meaning which the patient ascribes to the cancer experience and
the defensive characteristics and coping styles which they employ.

It

would be useful to isolate these variables and compare patient adaptation across them.
More specific study suggestions include replication and refinement of the major results of the current investigation.

The lowered

readiness of cancer survivors to engage in warm, personal relationships
has potentially far-reaching implications.

It would be useful to deter-

mine whether this lowered intimacy motivation is indeed associated with
a heightened attention to one's body and a sense of physical vulnerability; or if it is related to a counterdependent reaction against
the passivity of the patient role, or both.
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Another study result which could benefit from further investigation was the determination that conditioned nausea tended to follow a
predictable course of decline, based upon knowledge of disease stage
and length of time off treatment.

However, the same was not true for

so-called "conditioned anxiety."

If, in fact, post-treatment anxiety

in response to associated environmental cues is more a reflection of
trait susceptibility than associative learning, there may be only
insignificant lessening of disease- and treatment-related anxiety in
the post-treatment period.

It would therefore be beneficial to identify

these high risk patients during the treatment period, so that preventive measures could be taken early.

Perhaps high pre-treatment anxiety

will show itself to be a reliable predictor of continued post-treatment
"conditioned" anxiety.

S~RY

This study examined the psychological functioning of 60 men, aged
20-47, who had been treated for Hodgkin's disease, and compared them to
an age-matched sample of 20 physically healthy men.

All patients were

off treatment and free of any sign of disease for at least six months.
Besides the cancer variable, the independent variables of interest (within the patient group) were disease stage (early vs. late) and time off
treatment (6-24 months vs. 30 or more months).

There were 15 patients

in each of the four groups comprised by the above two variables.

Can-

cer survivors were expected to show heightened psychological disturbance
due to the prolonged stress of diagnosis and severe treatment, and because of uncertainty about the future.

Within the patient group, those

with later stage disease and those recently completing treatment were
hypothesized to show greater disturbance.

Dependent variables of inter-

est were psychosexual functioning, psychiatric symptomatology, intrusive
and avoidant thinking toward the past stressor of diagnosis, self-esteem,
death anxiety, global psychological adjustment, intimacy motivation, and
interview ratings of psychosocial problems and quality of life.
Patients were compared to non-patients and to themselves across
the variables of disease stage and time off treatment, in a 2x2+1 factorial ANOVA design.

The hypothesis of greater psychosocial morbidity

in the general cancer sample was partially confirmed by the significantly lowered intimacy motivation scores and a trend toward more constricted sexual fantasy lives in the cancer patients.
131

Patients also showed
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significantly more avoidant thinking toward the stressful event of
their diagnosis than the non-patients (NP's) did toward self-selected
past stressors.

Patients tended to appear more disturbed than NP's

on many self-report and interview measures, as indicated by the frequent
predicted ordering of non-significant mean differences.

On the other

hand, all patients were significantly more appreciative of life than
NP's.

It was concluded that disease stage and time off treatment were

important variables in the post-treatment adaptation of successfully
treated male Hodgkin's patients.

The identification of "low risk" and

''high risk" groups suggested a possible additive impact of disease
severity and recent treatment cessation.

A dramatic study result was

the lessening of treatment-related nausea over time and across disease
stage.

The same was not true of "conditioned anxiety," suggesting it

may be trait-related anxiety exacerbated by treatment and its reminders.
It was concluded that the experience of cancer survival does seem
to carry with it heightened psychosocial risks which do not generally
extend beyond the boundaries of normal adaptation.

However, there

was some suggestion that extended remission also brings significant life
appreciation and perhaps even character growth.

Thus, generalizations

about cancer survival are difficult to make, as adaptation seems to be
strongly influenced by individual differences.
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PROBLEM ORIENTED RECORD
(revised)
ID NUMBER

DATE - - - - - - - - Interviewer: _ _ _ _ _ __

Place of interview: _________
N/A = not applicable
= don't know
refuse answer
R
S/0 = significant other
1-10 = patient's rating of severity, on
a 1 to 10 scale, with 1 being
"not at all a problem," a;1d 10
being "an extremely severe
problem."

Chart Data:
diagnosis date:
birth date:
age at diagnosis:
date treatment began: - - - - - - - date treatment ended: - - - - - Diagnosis:
Stage:

OK

Treatment info (chart)

------------------

Months off treatment:

THE FIRST THING I NEED TO DO IS GET SOME SPECIFIC FACTS FROM YOU, LIKE YOUR
BIRTHDATE, FOR EXAMPLE.
1. SEX-----

2. DATE OF BIRTH - - - - - - - 4. Ethnicity:

5.

t~arital

3. AGE _ _ _ __

white
black
hispanic
oriental
other (specify) _ _ __

Status and Dates:

never married
married once
married 2 or more
divorced
separated
widowed

_ _ _ living with anyone?
#years: _ __
for how long?
-----separation/divorce dates:
# yrs new marriage:
when?
new s/o?
- - - when?
new s/o? _ __
_ _ _ when?
new s/o?
Cause of spouse's death:

Spouse/ s/o occupation (even if deceased):
Age of spouse:
Name
Sex
6. SIBLINGS

Age (indicate any deaths)
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7. PARENTS:

Mother: alive
dead

--

Father: alive
dead

cause:

when:

(age)

cause:

when:

(age)

Living together?
8. CHILDREN:

Name

Sex

Financially
DeQendent

~

Financially
IndeQendent

9. Education:
no formal education I some graduate school
grammar school graduate
high school graduate I equivalency
some college
college graduate
some graduate school
graduate/professional degree
10. Current occupation:

Same as before illness? _ _ _ _ _ __

full time:
paid leave:
part-time:=
unpaid leave: _ __
# hrs./week:
looking for work: yes___
SES: 0-10 10-20 20-30 30-50 50+
no___
(in thousandS) if married, include-spouse.

disability/
public assistance: _____
amount:
#

hrs work pre-ill?

# hrs work in tx?

lwk
_!.Y!Js_

-~.:.:..:.:...-

11. Whom do you now live with and what are their relationships to you?

12.

Religion?----------Practicing? Yes__ No__

# of times been to service in past month: - - -
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Can you tell me your diagnosis?
Stage?
-------13. What serious illnesses, injuries, etc., have you had?
(indicate any that occured after initial diagnosis with an"*".)

----------------------Dates

Hospitalized?

After Dx?

Do you remember when your illness was first diagnosed? - - - - - - - - /

Who told you?

- - - - - Where was it? - - - - - - - - - - - - - - -

What were the circumstances that led up to this?

-------------------

When did l9J:!. first notice something was wrong?-------------When did you first consult a physician?------What were your symptoms then? -------------------------------

What was the initial medical treatment before diagnosis? _____

How upset were you about these symptoms at that time? {1-10) - - - - - What was your reaction when you were told your diagnosis? - - - - - - - - -

FOR THE FOLLOWING QUESTIONS, PLEASE RESPOND IN TERMS OF THE TREATMENT YOU
RECEIVED FOR YOUR ILLNESS.
Were you hospitalized at all during your medical workup or treatment? ______
(if yes) When and for what? ---------------~How 1eng? _ _ _
When did you start actual treatment?________When finish? ________ _
What treatment did you have for your illness? ------·-------------
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Surgery? No

Yes

What was done? - - - - - - - - - - - - - - - - - -

- - - - - - - - - - - - - - P h y s i c a l discomfort severity?(l-10) _ __
How upsetting? (1-10) _ _
Chemotherapy? No__Yes_ What drugs do you remember?----------Physical discomfort severity?(l-10) __ _
How upsetting?(1-10) _ __
Radiation? No

Yes

Where?_ _ _ _ _ _ _ _ _ _ _ _ _,_ _ _ _ __

How long/how many times? _ _ _ _ _ _ Physical discomfort severity?(1-10)_
How upsetting?(1-10) _ __
Any other treatment (e.g., other medicine, transfusions, etc.)? No

Yes

What? - - - - - - - - - - - - - P h y s i c a l discomfort severity?(l-10) __
How upsetting?(l-10) _ _
Overall, how much distress did the treatment itself cause you?(l-10)
Please rate the physical discomfort (1-10) and level of distress ·(1-10)
which any of the following possible side effects of treatment may have
caused you (1 = none, 10 = very severe):
tiredness/weakness
nausea/vomiting
diarrhea
appetite/weight loss
hair loss
mouth sores
sexual problems
numbness/tingling
fever/chills
bad taste in mouth
8.

No_
No_
No_
No_
No_
No_
No_

Yes_
Yes_
Yes_
Yes_
Yes_
Yes_
Yes_

Physical
Physical
Physical
Physical
Physical
Physical
Physical

discomfort?(1-10)_
discomfort?(l-10)_.
discomfort?(l-10)_
discomfort?(l-10)_
discomfort?(l-10) __
discomfort?(l-10)_
discomfort?(l-10) __

Upsetting?(l-10)_
Upsetting?(l-10)_
Upsetting?(l-10)_
Upsetting?(l-10)_
Upsetting?(1-10)_
Upsetting?(l-10)_
Upsetting?(1-10)_

No_ Yes_ Physical discomfort?(l-10)_ Upsetting?(1-10)_
No_ Yes_ Physical discomfort?(l-10)_ Upsetting?(1-10)_
No
Yes
Physical discomfort?(l-10)_ Upsetting?(l-10)_

Did you find the general hospital care to be a problem, e.g., admitting procedures, etc? No_ Yes_ How much of a problem?(1-10) _ _

10. Did you find the care given by the nursing staff to be a problem (e.g., long
waits for service, indifference, etc.)?No_ Yes_ How much a problem?(l-10) _ _
43. Was taking time off from your home activities to be in treatment a problem?
No_ Yes_ How much a problem?(l-10) _ _ How many days? - - - · - - - Was taking time off from work to be in treatment a problem for you?
No
Yes
How much a problem?(l-10)_ _ How many days? _ _ _ _ __
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97.

Was the treatment a difficult experience in general for you?
No_ Yes_ How much of a problem? (1-10) _ _

68.

Did you have any financial burdens as a result of your treatment or illness?
No_ Yes_ How much a problem?(1-10) _ _ Still in debt? No_ Yes_
What% of medical expenses were paid for by insurance/public assistance?
0%
5-25%
26-50%_ 51-75%
76-95%
100%_
Did your illness or treatment result in a loss of job or income for you?
No_ Yes_ Explain
How much a problem?(1-10) _ _

117. While in treatment, did you experience yourself as being more irritable or
on edge in your relations with people?
No_ Yes_ How much a problem?(1-10) _ _
116. While in trea-ment, did you go through periods of feeling low, down, or
blue? No_ Yes_ How long {%of time)?
How much a problem?(l-10) _ _
119. While in treatment, did you have any trouble sleeping?
No_ Yes_ How long (% of time)?
How much a problem?(1-10) _ _
121. While in treatment, did you have any trouble concentrating?
How much a problem?{l-10) _ _
No_ Yes_ How long (% of time)?
While in treatment, did you ever take any medicicine for your mood or sleep?
No_ Yes_ What/how long? - - - - - - - - - - - - - - - - - During the treatment period (including pre-treatment wait), did you have any
contact with a professional counselor (e.g., psychiatrist, psychologist,
social worker, clergy)?
No Yes How much?
For what?_ _ _ _ _ _ _ _ __

73.

While in treatment, were there any changes in your relationship with your
spouse (s/o)? No Yes What?
---------------------- - - - - - - - - - - - H o w much a problem?(1-10) _ _

70.

Did you talk to your spouse (s/o) about what was wrong with you?
No_ Yes_ Was it helpful?_ _ _ __
Did your sex life change during treatment? No

Yes_ How?_ _ _ _ __

- - - - - - - - - - - - - - - - - - H o w much a problem?{l-10) _ _
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IF NO S/0:
Did your dating habits during treatment change? No_ Yes_ How? _ _ _ __
- - - - - - - - - - - - - - - HJw much a problem?(l-10) _ _
Did your sex life change during treatment? No

Yes

How?

- - - - - - - - - - - - - - - H o w much a problem?(l-10) _ _
ALL:
Was there any other major life change you experienced while you were in
treatment? No Yes What?

------------------

-----How much a problem

then?(1-10)_~

Problem now?(1-10) _ __

NOW I'D LIKE TO ASK YOU SOME QUESTIONS ABOUT YOUR DOCTOR(S):
Who was your main doctor during your treatment?
Same as your follow-up doctor?_ _ if no, follow-up M.D.: _ _ _ _ __
Did your treating doctor explain your illness and treatment to you? _ __
What would you say about the amount of information given to you by the
doctor who explained the treatment?
_far too much for me to absorb
_somewhat more than necessary
_just about the right amount
_not quite enough
_far too little
Please rate your treating doctor (1-10) on each of the following qualities:
Understanding of my feelings (l-10) _ _
Available to talk to (1-10) _ _
Informative about my illness and treatment (1-10) _ _
NOW I'D LIKE TO SHIFT OUR DISCUSSION TO THE PERIOD BETWEEN THE END OF YOUR
TREATMENT AND RIGHT NOW.
Since you completed treatment, have you noticed any symptoms that have
concerned you? No_ Yes_ What?__________________
115. How concerned are you about what is wrong with you now?(1-10) _ _
Has your doctor been concerned about a recurrence or other serious
complication? No_ Yes_ When and What?_ _ _ _ _ _ _ _ _ _ _ _ __
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Have plans for follow-up after treatment been a problem for you?
No Yes
In what way?_____________________
- - - - - - - - - - - - - H o w much a problem?{1-10) _ _
Have there been times when you have felt left on your own (abandoned) by
your doctor or the hospital staff since you completed treatmer1t?
No_ Yes How much a problem?{l-10) _ _
How often do you come in for follow-up? ______________
medical procedures have been done since you have been off treatment?
(e.g., x-rays, blood tests, angiograms, etc.)

W~.at

96.

Did you find these procedures upsetting in any way?
No_ Yes_ How upsetting?{1-10) _ _

108. What other procedures are you expecting to undergo?__________
How worried are you about them?(1-10)_ _
2.

Have you experienced any physical discomfort since ending treatment?
No Yes When?
Any in past month?_ _ __
How much of a problem?{l-10) _ _

116. Since completing treatment, have you experienced feeling low, down, or
blue? No_ Yes_ When?_ _ _ _ _ _ _in the past month?______
How upsetting?(l-10) _ _
Since completing treatment, have you ever thought of hurting yourself on
purpose? No_ Yes When?
Ever before?_________
Have you taken any medication for pain, mood, or sleep since completing
in past month?_ __
treatment? No Yes_ Pain what?
Mood_ what?_______ in past month?_ __
Sleep~hat?
in past month? _ __
117. Since completing treatment, have you ever experienced yourself as being more
irritable or on edge in your relations with people?
No_ Yes How much a problem?{l-10) _ _
75.

Have you had any sexual difficulties? No_ Yes_ How much problem?{l-10) _ _

76.

Is your sex life what you'd like it to be? No_ Yes

Problem?(1-10) _ _
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Is your sex life what your partner would like it to be? Yes
How much a problem for you?(l-10)
for partner?(1-10)
73.

No_

Do you find ~changes in your relationship with your partner since you
completed treatment? No_ Yes_ What?

----------------------------

-----------How much a problem?(1-10)_ _
69.

Has your partner's reaction to your illness been a problem in any way?
No_ Yes_ How?
Problem?(l-10) _ _
Are you talking to your partner about what was wrong with you?
No___Are there times you would like to talk and find you can't?
No_ Yes_ How disturbing is (was) this for you?(l-10)__
(70)
Yes_Is it helpful? No Yes How disturbing is this?(1-10)
(71)
Are there times you-woul~like to talk and find you can'~
No_ Yes_ How disturbing is (was) this for you?(1-10)__
(72)

IF NO S/0:
87.

Have there been any changes in your pattern of dating since treatment
ended? No_ Yes What?_____________________________
-----------How much a problem?(l-10) _ _

ALL:
FAMILY (excluding s/o)
77.

Has your family's reaction to all this been a problem for you in any way?
No_ Yes_ How much a problem now? _ _ How much problem before?(l-10) _ _
Are you talking to your family about what was wrong with you?
No
Are there times you would like to talk and find you can't?
-No_ Yes_ How disturbing is this?(l-10)__
Yes_ Is it helpful? Yes_ No_ How disturbing is this?(1-10)__
Are there times you would like to talk and find you can't?
No_ Yes_ How disturbing is this?(l-10)__

84.

(78)
(79)
(80)

Has there been a change in your role in your family as a result of your
i 11 ness? No_ Yes What?__________________________
- - - - - - - - - Problem? (1-10) _ _

85.

Do you find any changes in your relationships with family members as a
result of your illness? No_ Yes_ With whom and what?___________
- - - - - - - - - Problem?(l-10) _ _
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FRIENDS
94.

Have your friends' reactions to your illness and treatment been a problem
for you in any way? No_ Yes How?
________________Problem now? ( 1-10 )_ _
Are you talking to your friends about what was wrong with you?
No
Are there times you would like to talk and find you can't?
-No_ Yes_ How disturbing is this for you?(1-10)__
Yes_ Is it helpful? Yes_ Nu__ How disturbing is this?(1-10)__
Are there times you would like to talk and find you can't?
No_ Yes_ How disturbing is this for ~ou?(l-10)__

(88)
(89)
(90)

Has there been a change in your role (or relationships) with friends as a
result of your illness? No__ yes--H
__ ow.? _ _ _ _ _ _ _ _ _ _ _ _ __
- - - - - - - - - - - - - - - - - - Problem?{l-10) _ _
Did your doctor describe future possible risks to your health which might result
from treatment? No_ Yes What?___________________

(if not mentioned) ...

mentioned(x)

Recurrence? No_ Yes_ How upsetting?{l-10) _ _
Future illness {2nd malignancy)? No_ Yes_ How upsetting?{1-10) _ _
Organ failure? No_ Yes_ How upsetting?{l-10) _ _
Infection? No_ Yes_ How upsetting?(l-10) _ _
Sterility? No_ Yes_ How upsetting?(l-10)_ _
Other?
How upsetting?(1-10) _ _
Overall, how much distress did hearing of these risks cause you at that time?(1-10) ____
How much distress do they cause you now?(l-10) _ _
What, if any, bodily change has occurred as a result of your surgery {treatment)?
- - - - - - - - - - - - - - - - - - - - - P r o b l e m ? ( l - 1 0 )_ _
How has it affected your sexual activity?________________
Has this been a problem for you? No_ Yes_ (1-10) _ _
How about for your partner? No_ Yes_ (1-10) _ _
What exactly were you told about your future capacity to father children?_ ___
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What is your current potential to father children (excluding sperm
banking)?
Since your treatment ended, have you had any tests (e.g., sperm counts) to
see if you could have children? No_ yes Results?__________
H01-1 much of a problem is this for you?{l-10) __ for your s/o?(l-10) __
Were you
if
Have you
if

offered sperm-banking before treatment began?
yes, did you accept? No_ Yes
had any children since treatment ended? No Yes
yes, through sperm banking? No_ Yes

Are you interested in having (more) children?
No
reason:a already have enough
-b-never wanted children
c wanted once but changed mind
if c ... did you change your mind because of illness?
Yes_ What are your plans?___________________

FOR THE NEXT GROUP OF QUESTIONS, COMPARE YOUR LIFE BEFORE THE FIRST SIGN OF YOUR
ILLNESS TO RIGHT
- -NOW:
29. Compared to life before your illness, has there been a change in the activities
you enjoy doing alone? No Yes How much of a problem?(1-10) ____
30.

Compared to life before your illness, ha~ there been a change in the activities
you enjoy doing with your family? No_ Yes_ How much a problem?(1-10) ____

31.

Compared to life before your illness, has there been a change in the activities
you enjoy doing with your friends? No_ Yes_ How much a problem?{l-10}_ __

32.

Compared to life before your illness, has there been a change in your usual
housework routine? No_ Yes_ How much a problem?(l-10) ____

36.

Compared to life before your illness, has there been a change in your own
ability to do personal care? No_ Yes_ How much a problem?_ _
Compared to life before your illness, has there been a change in your
Problem?( 1-l0) ____
physical abilities (e.g., running, walking)? No Yes

38.

(if children) Compared to life before your illness, has there been a change
in your usual child raising activities? No_ Yes Problem?( 1_10 )_ _

81.

Compared to life before your illness, has there been a change in your
interactions with family (excluding s/o)? No_ Yes_ Problem?(1-10) ____

83.

Compared to life before your illness, has there been a change in the number
of phone calls/letters with family? No Yes fewer?
Problem?(l-10) __
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91.

Compared to life before your illness, has there been a change in your
interactions with friends? No_ yes_ How muc h a pro bl em.?( 1- 10) _ _

93.

Compared to life before your illness, has there been a change in the
number of phone calls/letters with friends? No yes fewer? __
How much a problem?(l-10)__
-

119. Compared to 1ife before your illness, have you had a major change in
sleeping habits? No Yes What
Problem?(l-10) _ _
120. Compared to 1ife before your illness, have you had a major change in
eating habits? No Yes
What
Problem?(1-10) _ _
121. Compared to life before your illness, have you noticed a change in your
concentrating ability? No Yes What
Problem? (1-10 )_ _
50.

(if employed/in school) Compared to life before your illness, has taking
time off from work or school been a problem? No Yes How much?( 1_1o)
still a problem? No_ Yes_ How much?(l-10) _ _
--

43.

Compared to life before your illness, has taking time off from your home or
other activities because of your health been a problem for you?
No_ Yes How much of a problem?(l-10)_ _

68.

Do you feel that you curren~ have any financial burdens because of your
illness and treatment? No_ Yes_ How much a problem?(l-10) _ _
Have you begun contact with a professional counselor (psychiatrist, psychologist,
social worker, clergy) since treatment ended?
No_ Do you feel it would be helpful? No_ Yes_ In what way?_ _ _ _ __
Yes

For what problem?_______________________
How much/long?_ _ _ _ _ _ _ _ _ Helpful?___________

IF EMPLOYED
51.

52.
53.

Did your career plans change as a result of illness?-=--Are your work responsibilities different from before your illness?
No_ Yes_ less responsibility? No_ Yes_ How upsetting?(l-10) _ _
Job before illness? · - - - - - - - - - J o b now?_________
Same company?
Same fie 1d?______~--if yes or no:
Does your current employer know about your illness? No_ Yes_Problem?\1-10)_
Does your employer treat you any differently because of your illness?
No_ Yes_ How upsetting is this for you?(l-10) _ _
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if yes or no:
Problem?\1-10)

54.

Do your co-workers know about your illness? No __ Yes

55.

Do your co-workers treat you any differently because of your illness?
No Yes How upsetting is this for you?(l-10) _ _

IF LOOKING FOR WORK
56.

Are you encountering any difficulties in looking for work due to your
illness? No__ Yes_ How much of a problem?(l-10) _ _

58.

Are you experiencing any difficulties with employment agencies or prospective
employers due to your illness? No__ Yes_ How much a problem?(1-10) _ _

57.

Are you telling prospective employers or employment agencies about your
medical condition? No__ Yes__ How much of a problem?(l-10) _ _

59.

Do you need to acquire a new skill or retraining of any kind due to your
illness? No__ Yes __ How much a problem?(1-10)_ _

~

IF NOT WORKING OR RETIRED DUE TO ILLNESS
60.

How much of a problem is it for you not to be working?(1-10) _ _

IF NOT WORKING - IN SCHOOL
61.

Did you lose any time from school/training due to your illness? No__ Yes __
Explain
Problem?(l-10) _ _

63.

Does the school administration (including teachers) treat you any differently
due to your illness? No_ Yes_ How much of a problem?(1-10) _ _

65.

Have you told your school administration about your medical condition?
No_ Yes__ in either case, how much a problem?(1-10) _ _

64.

Do your classmates treat you any differently due to your illness?
No_ Yes_ How much a problem?(l-10) _ _

62.

Do your classmates know about your illness? No_ Yes __ Problem?(1-10) ____

66.

Have you had to change your career plans due to your illness?
No__ Yes_ How much a problem?(1-10) _ _still a problem?

I'D LIKE TO ASK YOU JUST A FEW GENERAL QUESTIONS BEFORE WE STOP.
How has the experience of your illness and treatment affected your outlook on
1ife?
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Do you feel that you appreciate life and just being alive more fully than you
did before your illness? No_ Yes_ How much more?(l-10) _ _
Are you more likely to see people around you as worried over petty vr trivial
things, as a result of your experience with your illness? No Yes
do you get impatient with them? No_ Yes_Problem?(1-10L_How serious did (do) you feel your illness was (is):
1. When you were told your diagnosis?(l-10) _ _
2. When you were awaiting treatment? (1-10) _ _
3. When you were gettin~ treatment? {1-10)_ _
4. Now
(1-10)_ _

1 = not at all serious
10 = extremely serious
(life and death)

What are your plans for the future? - - - - - - - - - - - - - - - - - - How much has your illness affected your plans?(1-10) _ _
Do you talk to your partner (or close family if no partner) about the future?
No_ Yes_ (in either case) How much a problem?(l-10) _ _
Are there any problems we haven't touched on yet?_ _ _ _ _ _ _ _ _ _ _ __
During work-up?_ _ _ _ _ _ _ _ _ _ _ _ _ ___:How
During treatment?
How
After treatment?
How
Right now?
How

much
much
much
much

problem?(l-10) _ _
problem?(l-10) _ _
problem?(1-10) _ _
problem?(l-10) _ _

Any other co!llllents?_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

LIFE SCALE
IF A "0" MEANT THAT YOUR LIFE WAS JUST THE WAY IT WAS BEFORE YOU WERE ILL, AND A
"+10" MEANT THAT EVERYTHING WAS TOTALLY DIFFERENT AND BETTER, AND A "-10" MEANT
THAT EVERYTHING WAS TOTALLY DIFFERENT BUT WORSE, WHERE WOULD YOU PLACE YOURSELF
ON SUCH A SCALE?
-10 9 8 7 6
Different but worse

5

4

3

2

1 0 1 2 3
Same as before

4

5

6 7 8 9 +1D
different but better
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Nausea?
-tx now

Stimulus

-- --

Vomiting?
now

-tx

-

I

expla nation

Anxiety?
no~-.·
-tx

-·------

smell
clinic
(waiting room
or chemo room)
other?
(food, siiht
or so.und?

--

-

--

Do 1itt 1e aches and pains upset you more now than they used to before your
illness? No
Yes
Problem?(l-10)

---

Do you check over your body moreso now than you used to? No Yes
Prob 1em? ( 1-10 )_ __
How

~1orried

are you about recurrence?(l-10) __

If you do have a recurrence, and your doctor recomends returning to treatment,
will you:
_ _definitely go back
_ _probably go back
_ _really couldn't say (could go either way)
_____probably not go back
_ _definitely not go back

APPENDIX B
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INSTRUCTIONS
Bel~ you will be asked to report certain attitudes and opinions, and provide info~ation
about· some of your> sexual experiences. These questions are foaused on your thoughts 'lnd ·
feelings. Your answers and responses will be kept in the utmost confidenae, and only those
members of the staff direatZy involved with your treatment will have aaaess to this information. It will not be made avaiZable to anyone else unless you request it. The inventory is divided into 10 sections, and in each seation you are asked something slightly
different. In some you are asked to answer questions, LJhile in others you are asked to
desaribe yourself. We also ask about problems you may be having and about some of your
sexual thoughts, fantasies, and experiences.

L1ch seation has a brief instruation LJhich will tell you LJhat you are to do in that section.
Please LJork quiakly, and do not skip any-ttems. If you have any questions, please ask the
teahniaian to help you.

SECTION I
Bel~ are some statements concerning general info~ation about sexual functioning.
Please
read each statement carefully. Once you have read it, indicate !Jhether you agree LJith the
statement or not by marking TRUE for those you agree with, and FALSE for those you do not.

TRUE
1.

2.
3.

4.
5.
6.

7.

8.
9.
10.
11.
12.

13.
14.
] 5.

16.

17.
18.
19.
20.
21.

22.
23.
24.
25.
26.

USUALLY MEN ACHIEVE ORGASM MORE QUICKLY THAN WOMEN
0
HAVING INTERCOURSE DURING MENSTRUATION IS NOT A HEALTHY PRACTICE
0
THE PENIS MUST BE ERECT BEFORE EJACULATION MAY OCCUR
0
SIMULTANEOUS ORGASM IS NOT NECESSARY FOR A GOOD SEXUAL RELATIONSHIP
0
MASTURBATION BY EITHER PARTNER IS AN INDICATOR OF POOR MARITAL ADJUSTMENT
0
A WOMAN WHO HAS HAD A HYSTERECTOMY CAN NO LONGER EXPERIENCE ORGASM
0
MEN REACH THE PEAK OF THEIR SEXUAL DRIVE IN THEIR LATE TEENS WHILE WOMEN
REACH THEIR PEAK DURING THEIR 30'S
0
A WOMAN CAN BECOME PREGNANT DURING MENSTRUATION
0
MOST MEN AND WOMEN LOSE INTEREST IN SEX AFTER AGE 60
0
A MALE'S ORGASM IS MORE SATISFYING THAN A FEMALE'S ORGASM
0
THE PROPHYLACTIC (RUBBER) PROTECTS AGAINST CONCEPTION AND AGAINST VENEREAL
DISEASE
0
LUBRICATION IN THE FEMALE SHOWS SEXUAL EXCITEMENT LIKE THE MALE'S ERECTION
0
ORAL-GENITAL SEX IS UNHEALTHY BECAUSE IT ENHANCES THE POSSIBILITY OF
CONTRACTING VENEREAL DISEASE
0
WOMEN WHO HAVE FANTASIES DURING INTERCOURSE ARE DISSATISFIED WITH THEIR SEX
LIVES
0
FREQUENCY OF INTERCOURSE IS AN ACCURATE MEASURE OF SUCCESS OF A RELATIONSHIP 0
A WOMAN MAY BE BROUGHT TO ORGASM BY MANUAL STIMULATION OF HER GENITALS
0
MENOPAUSE IN A WOMAN CREATES A SHARP REDUCTION IN HER SEXUAL DRIVE
0
WOMEN DESIRE SEX ABOUT AS FREQUENTLY AS MEN
0
AN EFFECTIVE FORM OF CONTRACEPTION IS DOUCHING AFTER INTERCOURSE
0
AFTER INTERCOURSE THERE IS A PERIOD WHEN A MAN CANNOT RESPOND TO SEXUAL
STIMULATION
0
FEMALES CAN MAINTAIN A SEXUAL RESPONSE THROUGH MULTIPLE ORGASMS
0
MOST WOMEN ARE ABLE TO ENJOY SEX EVEN WITHOUT EXPERIENCING ORGASM
.0
THE BIGGER THE PENIS THE MORE SATISFYING IT IS TO THE FEMALE IN INTERCOURSE
0
A WOMAN CAN NO LONGER BECOME PREGNANT ONCE MENOPAUSE HAS BEGUN
0
ERECTION IN THE MALE IS BROUGHT ABOUT BY CONGESTION OF BLOOD IN THE PENIS
0
THE CLITORIS IS NOT A PARTICULARLY SENSITIVE AREA OF THE FEMALE'S GENITALS
0

PAGE 2

FALSE
0
0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0

0
0

0
0
0
0
0
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::>tCTlvi~

II

::e:__;:.: are a list of sexual experiences that people have. We would Uke to know which of
tr:~s~ ~e~,:::" ber4viors you ~~ve experienced.
Please indicate those experiences you have
r:ers~>::::ZZ~· f:ai Cb ;:Z:1ciY~g a chec:k ( [v] ) under the YES column for that experience. If
~:u nave r~t.~d ;f:e experience place your check under-the NO column. In addition, if you
r~ve ;;c.:..i :;t:e o;x;:erie;oe during the past two months please place an additional check under
;;.-;e c: Lrm ,zarkei p;s; 60 J ..US. Make your marks care fuZZy and do not skip any items.
l.
2.
3.
4.

5.
6.
7.

a.
9.
10.
11.
12.
13.
14.
15.
16.
17.
l8.

19.
20
21.
22.
23.
24.

:·:ALE LYI:;G PRC:;E ON FD!ALE
(CLOTHED)
.STRCKI::G A:m ?ET'l"D:G YOUR SEXUAL FARTtlER'S GENITALS
E:RC7IC DlBRACE
(CLOTHED)
I::TERCOURSE-V.ZIGI::AL E:-JTRY FRCM REAR
UW::;G GE:HTALS CARESSED BY YOUR SEXUAL PARTNER
!·lUICAL ORAL STI;.IULATION OF GENITALS
ORAL STI:·!ULATION OF YOUR PAR'I'NER' S GE:-iiTALS
I:;T£RCOUE.SE-SIDE BY SIDE
KI.OSI:;G OF s;:;;;siTIVE (NON-GENITAL) AREAS OF THE BODY
I::IERCOURSE-SITTING POSITION
:.~;.:..;::

fD

DAYS

PAST

I1J

DAYS

00

[]
[ ]
[]
[ ]
[]
[ ]
[]
[ ]
[]
[]
[ ]
[ ]

[]
[ ]
[]
[ ]
[]
[ ]
[]
[ ]
[]
[]
[ ]
[ ]

YES

00

[ ]

[ ]

[ 1

[1

[]

[]

[ ]
[ ]
[ ]

f_;vi:;G YOUR A:<AL AREA CARESSED
3REAST PETTING (CLOTHED)
CARESSH;G YOUR PARTNER'S A..';AL AREA
I:<T£RCOt;RSB-FEi<!ALE StiPERIOR POSITim<
olU'l"CAL PETTI1<G OF GENITALS TO ORGASM
u:,v:::G YOt;R GEtaTALS ORALLY STIHULATED
HUTUAL Lll'iDRE.SSING OF EACH OTHER
SLEP KISSING
It:TERCOURSE-HALE SUPERIOR POSITION
ASAL r:;TERCOURSE
KISSING ON THE LIPS
BREAST PETTING (NUDE)

S~CTI Or-.J

2eZow

KISSH:G FENALE 'S NUDE BREASTS

PAST

YES

[ ]
[ ]
[ ]

[]
[ ]
[]
[ ]
[]
[ ]
[]
[ ]
[]
[]
[ ]
[ ]
[ ]
[ ]
[ ]

[ 1

[ 1

[ 1

[]
[ ]

[]
[ ]

[]
[ ]

[ 1

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ ]

[ 1

[ ]

[ ]

[ ]

Ill

~'e ~o~Zd

Zike you to indicate the frequency with which you typically engage in certain
activities. Please indicate how often you experience each of the sexual activities
ceZow by cr.ecki~g ( [v] ) the category that is closest to your personal frequency. Categories
ra:r.ge :;rem "::cr ;._;: ALL" to "4 OR :.JORE rn.fES A DAY". Please do not skip any items.
ser~z

1. INTERCO\JRSE
2. HASTURBATION
3. KISSING AND PETTING
4. SEXUAL

F~'TASIES

NOT
AT
ALL
[ 1
[ ]
[ 1
[ 1

LESS
THA..'I 1
:·!ONTH
[ ]
[ 1
[
[

1
1

1-2
MONTH
[ ]
[ ]

[ 1
[ 1

1
WEEK
[ ]
[ ]
[ 1
[ ]

2-3

4-6

WEEK
[ ]
[ 1
[ 1
[ 1

V."'EEK
I ]
[ ]
[ 1
[ 1

5. WHAT WOULD BE YOUR IDEAL FREQUENCY OF SEXUAL WTERCOURSE ?

6. AT ;,ru;T AGE DID YOU F.rRST BECOME INTERESTED IN SEXUAL ACTIVITY ?
7. AT :-/HAT AGE DID YOU FIRST HAVE SEXUAL INTERCOURSE ?

PAGE 3

1

2-3

DAY
[
1'
[ 1

DAY
[ ]

4 OR
MORE
DAY
[ ]

[ 1
[ 1
[ 1

[
[
[

[ ]
[

1
1

1
1
1
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SECTION

IV

BeZc.'.J c;.;'e a seY"':es of stater:er.ts about various aspects of sexuaZ behavior. w'e wouZd Zi~e
to know to ~"hat e:rtent you agree or disagree with each one. Flease indicate hm; m-.;.ch yc:;_;
ag-::-ce or C.is-::gr.-e ?.'itl: eaah statement by plaO"~r.g tl:e appropriate nW'"her fnm the aZterna::~~'e:s l:eZc-_, in ti:e space alongside the statement.
PZease do r.ot s7<.ip GY':d statenents
C.Y~,i_ :..'C )1 k_ Cj t,;.{ :Ji<. :~~ •

-2
S:!'.c::GLY
DISP.GP.EE

-1
DISAGF.t.E

0
NEITHER
AGREE NOR DISAGREE

1
AGREE

2
STRCNGLY
AGREE

1.

FFE~!ARITAL INTERCOURSE IS BENEFICIAL TO LATER MARITAL AWUSTMENT

2.

HC~!OSEX"UALITY IS PERVERSE AND L'NHEALTHY

3.

SEX IS ~lC.S.~.LLY RIGP.T ONLY WHEN IT IS INTENDED TO PRODUCE CHILDREN
CF.AL SEX CA.."' BE l-.S PLEASURABLE AS H."''ERCOURSE
IT IS m:N.:l.Tl;RAL FOR THE FE!".ALE TO BE THE INITIATOR IN SEXUAL RELATIONS
1'J'..STCE3A'IION IS A PERFECTLY NCR'!AL, HEALTHY SE:xt:AL BEHAVIOR
EXTP.A:·L'L'UT!'L SEX IllEVITABLY LEADS TO SERIOUS
PROBLE!-'.S AND GREAT DIFFIITLTY
IN ::-:.:: ?!.'SF.U.GE
KC:·L~-J SEOULD !-.'"EVER BE CONSCIOVSLY SEDUcriVE Btrr SHOULD t-JAIT UPON TilE ATTE!;TIC~JS
OF ::;.:: Y..'c."<
VE\HNG EROTIC FILMS IS ENJOYABLE AND STI:.!ULATING BL."!AVIOR
: ?.LS x:D FEY.;LES SHOULD ASS Ul>:E BOTH ASS£ RTI VE Al:O PASSIVE ROLES DURING n;TE FCOGRSE
;~:D FCt;.EF U.Y
~-~CST HC~!OSEXUALS ARE HIGP.LY DISTURBED PEOPLE AND A DA.i.'-:GER TO SOCIETY
x_;y SEXt-;.L BEHAVIOR BETI·:EEN Tl-10 CONSENTING ADULTS SHOULD BE VIEWED AS NOR!-!AL
~~C?...:..:.ITY SHCt:LD ~Jar BE A CO!JSIDERATION IN SEXVAL BEHAVIOR
!:lFESSI:lG IN VARIOUS COSTUMES TO ENHA.i.'<CE SEXUAL ENJOY~NT SHOULD BE VIE':,'ED .'\5
CP.E:.;!IVE SEX
:SOCKS l·iHICH CONTAIN PASSAGES EXPLICITLY DESCRIBING SEXUAL ACJ'S ARE USUALLY
JUST T!'.P.SH
C0CFLES THAT HAVE SEX BEF'OP.E MARR!l>.GE t;SUALLY REGRET IT LATER CN
WIIT~l·ll-.PPING IS ACCEPTABLE IF ALL FOUR PARTNERS AGREE
MAr..ES LCSE PESPECT FOR FEI-'.ALES WHO ALLCW TEEM TO HAVE PRH!ARITAL PiTERCOURSE
NLi''JAL HhS'IURBATION IN A MARRIED COUPLE IS A POOR StiBSTITUI'E FOR IN'I'ERCOC:<SE
PROSTITUTES ARE HJ.:>IO.RAL .";}lD DEGRP.DING A.i."<D HAVE NO PLACE IN SOCIETY
HU:;..' GE!.;ITP.IS AFE SCMEl-iHAT DISGUSTING TO LOOK AT
HOLDING A..'D TOUCHI:-<G MY PAP;rtlER' S BODY IS EXCITING AND THRILLING
GF-Ot;P SEX IS A BIZARRE AND DIS GUSTING IDEA
EXTF.AY"~RI'I'AL SE:X1JAL AFFAIRS CAN :.'.AKE PEOPLE BETTER :.'.ARITAL PA:RT!:ERS
COC:rLES S:iOL'LD EXPERIMENT WI7H VARIOUS POSITIONS OF INTERCOURSE TO El\1-l;.:;CE
':"C:EIR SEXL"AL EX?EFJENCES
:-:?.STURBA'IION FANTASIES ARE HEALTHY FORMS OF SEXCAL RELEASE
HO.'!OSEXUALITY IS SIMPLY A QUESTION OF SEXUAL ORIENTATION AND Nor GCOD OR BP.D,
SICK OR HE.li.LTHY
ORAL-GENITPL SEX IS NOT WITHIN THE RANGE OF NOR!-!AL SEXUALITY
A PICTURE OF A NCDE WOI-'.AN CAN BE A BEAL'I'IFUL AND EXCITING THING TO LOO.'< AT
PORNOGRAPHY IS PERVERSE AND DISGUSTING IN GENERAL A.i."lD PARTICULARLY HAR'!FUL
IN TilE HA.i."JDS OF YOU1lG PEOPLE

4•

5.
6•

7•
S.

9•
"-0 •

11.
12 •
12.
14.

15.
16.

17.
18.
19.
20 •
21.
22 •
23 •
24.
25 •
26 •
27 •
28.
29 •
30 •

PAGE 4
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SECT! Ofi
c.o ~
c•:::nc:f:,z:~...

::;:_•. }

V

z:st

cf ;:rcbler".t> :~r.d c:cr-rZair.ts tl:a.t peapl€ scr?et-:.r7:es have. PZeaee read each one
h.;'ter ;;c:.;, rune icr.e so, pwcse fiU in cr.e of the r.UJ"'bered spaces to the right

7:-::::t 2·t:~St .::'".£.~~:J?.Y>.•.1::;s EO~·; :-!l.-701 THAT PE:CBLE~! H.~ BCTHEPED CR DISTP.ESSED YCU IN THE FAST TWO WEEKS
r:;~·:r.7_-~l t;G ~-.:,o_:_y. :._'J.::~~ c-·LZ-y a;:;;-7::.J)':te:r~ed s;ace fer ea.e71. f:ecC Zer-7 O:d de not skip any i te.'7'.s-.- -

,,~

HC\'i :·VCH W!:PE YCXJ

2. FAI:;:;-~·iESS OR DIZZI:-.;ESS

3.

'IHE ID2.'\. T!:ihT sc:.:r:c::E
ELSE Cri:l Cct:TP.CL YCt.:R
:.;r ~iD

t-:0.'1 r.'IJCH \!ERE YOU
:bOThERED BY :

1:

:son<::F:E.D BY :

J

=0=

=1= =2= =3=

27. LIFFICG"LTY Mi'J<ING
DECISIC:iS

=0=

=1= =2= =3= =4=

29. FEELING AFRP.ID TO TRP.VEL
ON Bl'SES, SlB',•:AYS OR
TRAINS
=0=

=0=

=1= =2= =3= =4=

5.

'!'RO:;'E.:.E

=0= =1= =2=

7. Fl\INS

=4=

=0= =1= =2= =3= =4=

SF.::..c·ss

~..?PAID

I~·r

=2= =3= =4=

=0=

=l=

=2=

=3=

=4=

31. E;.VI!'iG 70 AVOID CER'::'IIN

?LACES OR ACTI-

VI :'IES EE:CACSE TI-IEY
FRl 3:17E~J YQU
3 2. Y::CR

33.

=0= =1= =2= =3= =4=

=0=

~1=

=2= =3= =4=

E!':I::I~·iG

=C= =1= =2= =3= =4=

~-~::~;r;,

=C= =1= =2= =3= =4=
=0= =1= =2=

GOING BL;..l;K

=3=

=4=

::-i..·~.s~~ss

JR

P.:-.RTS OF

:n::P. 2CDY

=0= =1= =2= =3= =4=

iCR YJGR

s:~s

=0= =1= =2• =3= =4=

Tr~:::~:.::~c;

:::~

SC;RED FOR ~0

REi'.SON
13. TE:-lFER OU':'BGRSTS THAT
YGU COULD NOT C01'TRDL

=0= =1= =2= =3= =4=

=G=

15. FEELI:;r; BLO':KED Ill
GE:L·'i'ING THI~;GS D~:-.~-:E

=0= =1= =2=

16. FEELING LOl'ELY

=0= =1=

=0=

=1= =2= =3= =4=

~1=

=2~
=2~

=3=

=4=

IN :·HI:iGS

=0= =1= =2= =3= =4=

=3= =4=

39.

K::YED C?
':"EOUGHTS OF I:·E.;':H

~0.

41.
42.
43.

=1= =2= =3= =4=
=1= =2= =3= =4=

20. YOUR FEELINGS BEING
EASILY WJll.T

=('= =.1= =2= =3= =4=

21. FEELING THAT PEOPLE ARE
l:c.;FRIE:lDLY OR D:SLIKE
YOU

=0= =1= =2= =3= =·~=

22. FEELING I!:FERIOP TO
OTHERS

=0= =l= =2= =3= =4=

23. :lAUSEA OR UPSET STCI'~;·::H

=0= =1= =2= =3= =4=

24. FEELI~<G TliAT YOU ARE
v;;,;::;-;Er:: OR ':i'A:..'\.ED ABCCT
BY ,J:iiERS

=0=

25. TPOCBLE Flo.:,LlNG .;SLEEP

=0= =1= =2= =3= =4=

=~=

=2= =3= =4=

IN FARTS

FEF.LI~JG

44.

=0=
=0=

:;::E'LI.~G T(;E_;_l(

C? y.:,c;p o•CDY

39.

=3= =4=

13. FEELH<G :1::; n;:-:::REST
19. FEELI:;G F£;,RFL'L

=0=

36. TROUBLE CO~!CE:iTRJI.TH:G

=0= =1= =2= =3= =4=

14. FO:EI.IriG LC:IELY E\·'EN l'.'EEN
YOU l.P.E (liTH P2CFLE

17. FI:.ELI:;G BLL'E

35. F:O:ELr:G HOPELESS ABOUT
TEE ;:;.;':"'.:?.£

3 7.

11. POOR !.?PETITE

~6.

=l=

:JFi.N

10. FE~L:~;G 'I'HAT Y':ST :.:~OPLE
c;~;~~-OT EE "i'RUS l:"ED
==0= =l= =2= =3= =4=

S~DDE:-.;LY

=1= =2= =3= =4=

"'0= =l.= =2= =3= =4=

T~I~GS

A:~~JOYED

r:,; HEART CR CEEST

FEE:I~:G

9. T;i.,:.,UG:iTS OF
~·~R LIFE

12.

BREATH

=C= =1= =2= =3= =4=

6. :;2.:Lr::G EASILY
::-. I2.RI7.-"'l.';2D

8.

=3=

~

29. TP.Ot.:BLE GETTING YOUR

?£~~:C$ER.!~JG

fin::Gs

=0=

30. HOT OR COLD SPELLS

FLri:-!E F0R :-:JST GF YOGR

~

0

c:

4. FEELI:IG CTHEF.S ?.RE TO
TF.CU3L£S

..

~

E

45.

TE:~SE

=0= =1= =2= =3= =4=

OR
=0= =l= =2= =3= =4=
C~E

=0=

DYI~~G

t:RG.ES TC BEAT
I~lJ'~..~~RE CR HAR.'1 SC~~oNE
H.:;VI}:G rF.GES 'ro EE~AK
OR 5!-1h3H T:-i:~JGS
FEELI::G ~RY SELF CONSCI·Jr.;s :·:I':H C:'HERS
FEELI~;G T"'!~ASY IN
:?Ci:DS
::E\~R ?:SELI~..:G CLOSE ::J
r.:;C':iOER ?E?.SCN
SFELLS OF TERROR OR

=l=

=2= =3= =4=

p._;"',t!~JG

foR

F~rLI~~

=0= =1= =2= =3= =4=
=J= =1= =2= =3= =4=
=0= =1= =2= =3~ =4=
=C= =1= =2= =3= =4=

=0=

=l= =2= =3= =4=

=G= =1= =2= =3= =4=

f~.SIC

46. GETTING INTO FREQGENT
.".RGUXESTS
47. FEELI~G ~IER'.'CUS \'.'HEN
YOU APE LEFT ALONE
48. C"f!"'RS '''"T GT'J"'IG Yr"'J
FR:i?::R c?EDIT
YouR
;;..:HIE'v-E:YENTS

49.

=1= ..,2= "'3= =4=

co

=0=

=1= =2= =3= =4=

=0= =1= =2= =3= =4=

=0=

=1= =2= =3= =4=

R~c~ 7 ES~

You .::O~L;:m'T~SIT STILi
=O= =1= =2=
50. FEELING CF i>CF.:'XL!:SS:;ESS=O= =l= =2=
51. FEELING ~E,PLE I'IILL TAKE
.;;r;v.~;:-.:c_-:;E CF YCU IF YOU
LET ':'HE!1
=0= =1= =2=
52. F:::EL!:;c;s C'F .:;t.'ILT
=u'-" =1= oo2=
53. 7.-iE r::::A TE.!:.'T SC,~·!E'T~ING

P..."·."ii:JG TO C~(:K .:--...'JD
;y__:.i;b;:.E C:iE::K ~,"H-~.:' YOU DO =0= =1= =2= =3= = <=
Plv3£ 5

=3= =4=
=3= =4=
=3= =4=
=3= =4=

=0= =l= =2= =3= =4=
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SECTION

VI

Edo~•

is a list of words that describe the way people sometimes feel. We would Zike you to
t.3 :z !iS ::hether you hcro·e been having ar:y of these fee Zings during the past !!:!2_ ~· Please
[;ccHcate the deg:rxe to z.1hich y01.. have typicaZZy felt each emotion by fiZZing in one of the
1::,~.:-en::d spa:Jes that best describes your experience.

..
" .,.."

~

~

c:"

..

...

:

§

;

E

.,

0

...

~

0
=2=
=2=
=2=
=2=
=2=

=3=
=3=
=3=
=3=
=3=

0
=4=
=4=
=4=
=4=
=4=

=2=
=2=

=3=
=3=
=3=
=3=
=3=

=4=
=4=
=4=
=4=
=4=

26.
27.
28.
29.
30.

MISERABLE
GUILTY
E:-JRAGED
DELIGHTED
RELAXED

=0=
=0=
=0=
=0=
=0=

=1=
=1=
=1=
=1=
=1=

=2=
=2=
=2=
=2=
=2=

=3=
=3=
=3=
=3=
=3=

=4=
=4=
=4=
=4=
=4=

=1=
=1=
=1=
=1=
=1=

=2=
=2=
=2=
=2=
=2=

=3=
=3=
=3=
=3=
=3=

=4=
=4=
=4=
=4=
=4=

31.
32.
' 33.
34.
35.

VIGOROUS

=0=
=0=
=0=
=0=
=0=

=1=
=1=
=1=
=1=
=1=

=2=
=2=
=2=
=2=
=2=

=3=
=3=
=3=
=3=
=3=

=4=
=4=
=4=
=4=
=4=

=1=
=1=
=1=
=1=
=1=

=2=
=2=
=2=
=2=
=2=

=3=
=3=
=3=
=3=
=3=

=4=
=4=
=4=
=4=
=4=

36.
37.
38.
39.
40.

=0=
=0=
=0=
=0=
=0=

=1=
=1=
=1=
=1=
=1=

=2=
=2=
=2=
=2=
=2=

=3=
=3=
=3=
=3=
=3=

=4=
=4=
=4=
=4=
=4=

11. BLt'~·EWORTHY
12. RESECITFUL
15. BlERGETIC

=0=
=0=
=0=
=0=
=0=

16. LOV::;G
17. TE::sE
18. WCRTHLESS
19 . J.S HA:-:E D
20 . A.'\GFCi

=0=
=0=
=0=
=0=
=0=

GLAD
.._ ..,, CALM

..

...
=1=
=1=
=1=
=1=
=1=

=2=

1'1

c:

~

0
=0=
=0=
=0=
=0=
=0=

=1=
=1=
=1=
=1=
=1=

5. Hr.PPY

~

.,
-.,

CHEERFUL
SATISFIED
ACTIVE
FRIENDLY
ANXIOUS

=0=
=0=
=0=
=0=
=0=

3. P.EGF.ETFUL
4. IRRITABLE

-

.,

.,

~

21.
22.
23.
24.
25.

6. ?LEASED
7. EXCITED
B. Pr>.SSIONATE
9. T!!I...ID
10. ECP=:U:SS

... ::Hl

...

..."

0
=4=
=4=
=4=
=4=
=4=

=1=
=1=
=1=
=1=
=1=

~:;:: ?.'.'OUS

.. .. j
" .," .,l

~

=3=
=3=
=3=
=3=
=3=

0
=0=
=0=
=0=
=0=
=0=

l.

.,
.,

0
=2=
=2=
=2=
=2=
=2=
=2=
=2=

AFFECTIO~ATE

AFRAID
trriHAPPY
REMOR:>EFUL
BITTER
JOYOUS
CONTENTED
LIVELY

WARM

SECTION
?dcr,y is a Zist of personality characteristics that are often used to describe people.

:.·~·u!d

VI I
~ie

:ike you to describe yow"Se lf in terrr.s of these characteristics. To do this, please
-:> Hcate the degree to which each trait is typical of you--in other :.:ore!E, hOI.J r'!UOh of each
:J':cZracter=:stic you have. Use the nurriJere'd scale given belcv, and place the a;::prcpricte
'::-rier alo>1gsidB each trait.
0

1

NOT J..'I ALL

1. SYMPATHETIC
2. DECISIVE
3. FRIVOLOUS

A LITTLE BIT

[
[

[

5. SENTHIENTAL

[
[

6. RATIONAL

[

4. PRACTICAL

[
8. CONFIDENT
[
9. m:.w:;ssiONATE [
10. VIGOROUS
[
7. SECRETIVE

11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

2

3

4

HODERATELY

QUITE A BIT

EliTPE~!ELY

SENSITIVE
[
INDEPENDENT [
[
DOHESTIC
BOLD
[
rEP EN DENT
[
ADVENTUroUS(
FELINE
[
STroNG
[
FLIRl'ATIOUS [
MECHANICAL [

.PAGE

6

1
1
1
1
1
1
1
]

1
1

21.
22.
23.
24.
25.
26.
27.
28.
29.
30.

GRACEFUL
[
[
DOMINANT
[
SEDUCTIVE
AtJrHORITATIVE [
[
WHI!>'.SICAL
ATHLETIC
[
[
FASHIONABLE
[
AGGRESSIVE
[
GENT I.E
[
ASSERl'IVE

1
1
1
1
1
1
1
1
]

1
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SECTION VIII
In th-!-s scCJticn :Je have Usted a Va:t'iety of ser..<aZ ideas, and fantasies that people sonet ~.,<Js ;u:;e. ;.;8 :..'c'A Zd Zike you to indicate which of these fantasies you have experienced
either in c!a~;:h•c:rs or> ire=s "-'hile asleep. For each fantasy th.at you have experienced
pZ::z.:1e a e;:er;:;k ({I} ~n the S;'ace alongside tr.at item.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

{
{
{
{
{
{
{
{
{
{
{
{
{
{
{
{
{
{
{
{

}
}
}
}
}
}
}
}
}
}
}
}
}
}
}
}
}
}
}
}

HAVING ~lORE THAN ONE SEXUAL PARTNER AT THE SAME TII"E
HAVING n;TERCOUR.SE IN UNUSUAL POSITIO:-JS
p_wi:~G SEXUAL RELATIONS WITH ANIHALS
i.'HI?PING OR BEATING YOUR SEXUAL PARTNER
FGRCI:'G A PART.-IER TO SUBHIT TO SEXUAL ACTS
DRESSING IN CLOTHES OF THE OPPOSITE SEX
USirlG ARTIFICIAL DEVICES FOR SEXUAL STIHULATION
BEI~IG A PROSTITUTE
FORBIDDEN LOVER OR MISTRESS IN SEXUAL ADVENTURES
HG:·lOSEXUAL FANTASIES
~.ATES\'IAPPING FANTASIES
BEI:<G TIED UP OR BOUND DURING SEXUAL ACTIVITIES
DEGR~DING A SEX PART.-IER
BEING SEXUALLY DEGRADED
ANAL INTeRCOURSE
DRESSING IN EROTIC GAR'~NTS
SEXUAL INTERCOURSE
FANTASIZING THAT YOU ;RE OF THE OPPOSITE SEX
O!V.L-GEmTAL SEX
BEING FORCED TO SUE:1IT TO SEXUAL ACTS

SECTION IX
Belew are sol":e state~:ents ac-nceP1ing how you vie"w your body. Please indicate to wh.at degree each of the fe!lZo:,;ing stc.terr:ents is tr-v~e of' 'JOU by aircZing the nur.:cer that best decc:eices '.lOUr ex:::erience. .'lote that Part A is for both sexes, Pa:t't B is for nen ody, an:i
?xrt C i~ for 1J~rr:en only.
"v

~

./3'

"" ...,s""

,?""

1.

2.
3.
4.

s.

6.
7.
8.
9.
10.

I AM LESS ATTRACTIVE TH.ll.N I WOULD LIKE TO BE
I A.'1 TOO FAT
I ENJOY BEING SEEN IN A BATHING SUIT
I AM TOO THIN
I \·lOULD BE EMBARAS SED TO BE SEEN NUDE BY A
LOVER
I AM TOO SHORT
THERE ARE PARTS OF MY BODY I DON'T LIKE AT ALL
I A..'1 TOO TALL
I HAVE TOO HUCH BODY HAIR
MY FACE IS ATTRACTIVE
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PART A (BOTH SEXES)
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0
0
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0

1
1
1
1

0
0
0
0

1
1
1
1
1
1

0
0

2

3

2

3

4
4

2
2

3
3

4
4

2
2
2
2
2

3

3
3
3
3

4
4

2

3

4
4

4
4
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PART B (MEN ONLY)
11.
12.
13.

14.
15.

I HAVE A ~~LL PROPORTIONED BODY
I AM SATISFIED WITH THE SIZE OF
MY PENIS
WOMEN WOULD FIND MY BODY ATTRACTIVE
I AM WELL-COORDINATED AND ATHLETIC
I AM PLEASED WITH THE PHYSICAL CONDITION OF MY BODY

0
0
0

1
1
1

2
2
2

3
3
3

4
4
4

0

1

2

3

4

0

1

2

3

4

PART C (WOMEN ONLY)
16.
17.
18.

19.
20.

I HAVE A SHAPELY AND WELL PROPORTIONED
BODY
I HAVE ATTRACTIVE BREASTS
MEN WOULD FIND MY BODY ATTRACTIVE
I HAVE ATTRACTIVE LEGS
I AM PLEASED WITH THE WAY MY VAGINA
LOOKS

SECTION X

Below are some statements about sexual satisfaction. Please indicate whether each statement is true of you by checking either true or false for each item.

TRUE
1.
2.

3.
4.
5.
6.
7.
8.
9.
10.

USUALLY, I AM SATISFIED WITH MY SEXUAL PARTNER
I FEEL I DO NOT HAVE SEX FREQUENTLY ENOUGH
THERE IS NOT ENOUGH VARIETY IN MY SEX LIFE
USUALLY AFTER SEX I FEEL RELAXED AND FULFILLED
USUALLY, SEX DOES NOT LAST LONG ENOUGH
I AM NOT VERY INTERESTED IN SEX
USUALLY, I HAVE A SATISFYING ORGASM WITH SEX
FOREPLAY BEFORE INTERCOURSE IS USUALLY VERY AROUSING
FOR ME
OFTEN, I WORRY ABOUT MY SEXUAL PERFORMANCE
USUALLY 1 MY PARTNER AND I HAVE GOOD COMMUNICATION
ABOUT SEX

T

FALSE

T
T

F
F
F
F
F
F
F

T
T

F
F

T

F

T
T
T

T

GSSI - Below is a rating scale upon which we would like you to record your perso1wl
evaluation of how satisfying your sexual relationship is. The rating is simple.
Make your evaluation by pZacing a check in the appropriate box that best describe<
your present sexuaZ relationship.
{ } B COULD NOT BE BETTER

{
{
{
{
{
{
{
{

}
}
}
}
}
}
}
}
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7
6
5

4
3
2
1
0

EXCELLENT
GOOD
ABOVE AVERAGE
ADEQUATE
SOMEWHAT INADEQUATE
POOR
HIGHLY INADEQUATE
COULD NOT BE WORSE

APPENDIX C
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~EMORIAL HOSPITAL
12i5 YCRK AVENUE
NEW YORK. N.Y. 10021

PATIENT JN'JESTIGAiiVE CONSENT FO,RM
C::NSE~;T rCP. ~EW PROCEDURE. STUuY OR DRUG UNOEii CLINICAL INVESTIGATION

p

PATIENT

I have been asked to participate in a study of psychological adjustment
to the successful treatment of Hodgkin's disease. The chief investigator of
this project is Jirrmie.C.B. Holland, M.D.~ a ·Memorial Hospital attenaing
physician.
~articipation in tnis study will entail approximately two hours of rny
time and will be scheduled at my convenience. I will be interviewed briefly.
then asiu~d to ccmpiete five snort questionnaires, followed by an exercise in
which I will tell imaginative stories to some pictures. A member of the
study staff will be with me the entire time, and answer any questions I
might have. This person, David Cella, can be reached for further questioning
at (212) 794-8229. If I don't call him, he will phone me within the next
month as a routine follow-up.

I understand that participation in this study is voluntary, and that I
will receive no direct benefit by participating. I know that I can withdraw
from the study at any time, and that my medical treatment will in no way be
influenced by such a decision. I also·know that, short of withdrawing from
the project, I may decide not to answer any question or set of questions,
and still continue with the intervie·.~.

I have been informed that the study will involve questions about personal
sexual matters, death-related concerns, self esteem, uncertainty, anxiety, and
stress. All information I disclose to the stuay investigator will be kept in
the strictest confidence and used only for research purposes. My name will
not appear on any document or publication which might emerge from this project.
While there are no physical risks involved in my taking part in this
study, a few of the questions might revive emotional experiences which may
at one time have been distressing. However, the interviewer will be available
to discuss this with me should it occur.
With the above in mind, I,
, agree to participate
in the study described above. It has been explained to my satisfaction, and I
have been given the opportunity to discuss it further.
SIGNED: _....;....._ _ _ _ _ _ __

DATE: ~-------I have fully explained to the participant the nature and purpose of the
study described above.

Signature of research staffperson
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MEMORlAl HOSPiiAL
1275 YORK AVEt;UE
NEW YCRK. N.Y. 10021

~.

w

PATIENT INVESTIG.lTIVE CONSENT FORM
CN;SENT FOR NEW PROCEDURE. STUDY OR DRUG ·u~IOEA CLINICAL INVEST!GA no~

c

CONTROL

I

been asked to participate, as a me~ber of a comp!rison grouo, in a
>tudy of the successful treatment of Hodgkin's disease. The chief investigator
of this prcject is Jirrmie C.B. Holland, t~.D., a Memorial Hospital attending
physician.
~~ve

Participation in this study will entail approximately two hours of rr:y t~me,
and will be sched~led at mv convenience. I wi11 be interviewed brieflv, then
asi.ed -;;o COi.lp1ete five :>nort questionnaires, f;:;11~a•Cd :;.y .lr. exercise in .vr.icn ~
will tell imaginative stories to some pictures. A member of the study staff
'.<iill be with me the entire time to answer any questions r might have. This
person, David Ceila, can be reached for further questioning at {212) 794-8229.
If I don't call him, he will phone me within the next month as a routine follow-up.
I understand that participation in this study is voluntar~. and that I will
receive no direct benefit by participating. I know that I can withdraw from the
study at any time. I also know that, short of withdrawing from the project, I
may decide not to answer any question or set of questions, and still continue
with the interview.
·

I have been informed that the study will involve questions about personal
sexual matters, death-related concerns, self esteem, uncertainty, anxiety, and
stress. All information I disclose to the study investigator will be kept in
the strictest confidence and used only for research purposes. My name will not
appear on any document or publication which might emerge from this project.
While there are no physical risks involved in my taking part in this
study, a few of the questions might revive emotional experiences which may at
one time have been distressing. However, the interviewer will be available
to discuss this with me should it occur.
With the above in mind, I,
, agree to participate
in the study described above. It has been explained to my satisfaction, and I
have been given the opportunity to discuss it further.
SIGNED: - - - - - - - - - - DATE: - - - - - - - I have fully explained to the participant the nature and pur?ose of the
study described above.

Signature of research staffperson
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